id;id_2;nct_id;any paper (0=no paper, 1=article, 2=non-publication equivalent like abstract or poster);publication found (1=linked in registry, 2=google search - trial number, 3=google search - PI + intervention, 4=google, either via trial number or search terms);pmid;publication date (only fill in if no PMID available);comments from doublecheck;last_update_submitted_date;registration_date;summary_results_date;study_type;phase;enrollment;recruitment_status;title;start_date;completion_date;primary_completion_date;has_summary_results;allocation;masking;main_sponsor;is_multicentric;principal_investigator_1;principal_investigator_2;principal_investigator_3;study_chair_1;study_chair_2;study_director_1;study_director_2;unspecified_official;sub_investigator;registration_year;start_year;completion_year;primary_completion_year;affiliation;initial doublecheck (1=yes);main sample rater
750;40;NCT01165450;0;;;;2 participants study/summary results,Terminated d/t no supply of study drug;20.04.2015;15.07.2010;07.04.2015;Interventional;Phase 2;2;Terminated;Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects;2011-11-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2014;2014;UCSF;;Samruddhi
781;147;NCT00004259;1;1;15234047;15.07.2004;phase 1 pilot arms of a phase 3 study;28.08.2019;28.01.2000;25.05.2017;Interventional;Phase 3;230;Completed;Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas;2000-06-01T00:00:00Z;2018-05-14T00:00:00Z;2015-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2000;2000;2018;2015;UCSF;;Susanne
482;205;NCT00812708;1;1;18812117;01.10.2008;study started in 2003, first interrip report in this publication;07.12.2021;19.12.2008;01.06.2018;Interventional;Not Applicable;72;Completed;Clinical Evaluation of Morcher Artificial Iris Diaphragms;2003-04-09T00:00:00Z;2021-12-07T00:00:00Z;2014-06-20T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2008;2003;2021;2014;UCLA;;Mario
672;284;NCT00506909;1;1;20615494;07.07.2010;;30.08.2019;23.07.2007;30.08.2019;Interventional;Not Applicable;21;Terminated;Oxytocin Add on Study for Stable Schizophrenic Patients;2008-03-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2007;2008;2014;2014;UCSD;;Susanne
866;603;NCT00501709;1;3;20659093;01.08.2010;;30.04.2020;12.07.2007;NA;Interventional;Phase 1/Phase 2;10;Completed;Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus;2007-02-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2016;2016;UCSF;;Stefanie
460;138;NCT00114530;1;1;20800376;26.08.2010;;12.05.2021;15.06.2005;05.05.2017;Interventional;Phase 2/Phase 3;75;Completed;Scleroderma: Cyclophosphamide or Transplantation;2005-06-01T00:00:00Z;2016-04-01T00:00:00Z;2016-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);NIH;TRUE;NA;NA;NA;University of California, Los Angeles Rheumatology;NA;NA;NA;NA;NA;2005;2005;2016;2016;UCLA;;Emmanuel
700;557;NCT01306539;1;1;21184765;22.12.2010;;31.07.2019;28.02.2011;NA;Interventional;Not Applicable;20;Completed;Neuropsychiatric Effects of Deep Brain Stimulation in Patients With Parkinson's Disease;2008-07-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;NA;Double;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2008;2014;2014;UCSD;;Stefanie
760;64;NCT01702246;1;1;21477202;08.04.2011;24(in registry) vs 26(pub);26.10.2016;04.10.2012;15.01.2016;Interventional;Phase 1/Phase 2;24;Completed;Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease;2012-02-01T00:00:00Z;2015-06-01T00:00:00Z;2015-05-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCSF;;Samruddhi
;312;NCT01103921;1;3;21849529;17.08.2011;all seem to report subgroups, 21849529 seems the earliest reporting a primary outcome;25.05.2017;13.04.2010;NA;Interventional;Not Applicable;214;Completed;The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks;2008-10-01T00:00:00Z;2014-01-01T00:00:00Z;2014-01-01T00:00:00Z;FALSE;Non-Randomized;Double;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;University of California, Davis;;NA;NA;2010;2008;2014;2014;UCD;1;
877;612;NCT01156584;1;1;22070930;09.11.2011;;16.05.2018;01.07.2010;NA;Interventional;Phase 1;54;Completed;A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma;2010-07-01T00:00:00Z;2016-08-18T00:00:00Z;2016-08-18T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2016;2016;UCSF;;Emmanuel
290;182;NCT01852032;1;3;22380376;01.03.2012;;19.03.2018;29.10.2012;13.02.2018;Interventional;Not Applicable;23;Completed;Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis;2010-11-01T00:00:00Z;2016-03-04T00:00:00Z;2016-03-04T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2010;2016;2016;UCD;;Samruddhi
852;330;NCT00957229;1;1;22670904;07.06.2012;;16.12.2020;05.08.2009;08.10.2020;Interventional;Phase 2;41;Completed;To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS);2009-08-01T00:00:00Z;2014-01-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;2014;UCSF;;Samruddhi
306;357;NCT00694889;1;1;22992330;07.08.2012;;12.05.2016;09.06.2008;NA;Interventional;Phase 1/Phase 2;144;Completed;Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia;2007-08-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;TRUE;"University of California, San Francisco; San Francisco VA Medical Center; NCIRE - The Veterans Health Research Institute";NA;NA;NA;NA;University of California, Davis;University of California, San Francisco;NA;NA;2008;2007;2015;2015;UCD, UCSF;;Emmanuel
628;72;NCT02111993;1;3;23051838;10.10.2012;;20.05.2019;09.04.2014;08.03.2016;Interventional;Not Applicable;60;Completed;Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation;2011-08-01T00:00:00Z;2015-06-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2011;2015;2015;UCSD;;Samruddhi
517;448;NCT01076829;1;3;23320544;07.03.2013;participant number higher, outcome same?;09.06.2014;25.02.2010;NA;Interventional;Not Applicable;10;Completed;Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes;2009-07-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2010;2009;2014;2014;UCLA;;Nicole
511;442;NCT00996528;1;1;23435303;01.06.2013;;06.10.2021;15.10.2009;NA;Interventional;Phase 3;1239;Active, not recruiting;Neighborhood Alcohol & HIV Prevention in South African Townships (Philani);2007-09-01T00:00:00Z;2025-09-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Department of Psychiatry & Biobehavioral Sciences, Semel Institute, UCLA;NA;NA;NA;NA;NA;NA;NA;NA;2009;2007;2025;2015;UCLA;;Stefanie
770;109;NCT00458393;1;1;23435697;01.07.2013;;29.10.2021;06.04.2007;27.12.2016;Interventional;Phase 3;2499;Completed;Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men;2007-06-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;TRUE;Randomized;Double;NIH;TRUE;J. David Gladstone Institutes, University of California San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2014;2014;UCSF;;Stefanie
147;296;NCT00375830;1;1;23455520;01.07.2013;pilot phase of trial as per protocol;11.11.2019;11.09.2006;19.10.2019;Interventional;Phase 2;114;Completed;Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases;2006-01-01T00:00:00Z;2019-03-14T00:00:00Z;2017-04-17T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2006;2006;2019;2017;Stanford;;Susanne
432;31;NCT01699789;1;1;23649787;07.05.2013;;22.06.2021;27.09.2012;06.05.2014;Interventional;Not Applicable;1246;Completed;Community Partners in Care is a Research Project Funded by the National Institutes of Health;2009-01-01T00:00:00Z;2016-05-31T00:00:00Z;2016-05-31T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;"RAND Corporation, UCLA Semel Institute; Harbor-UCLA Medical Center, UCLA Semel Institute; UCLA Semel Institute";NA;NA;NA;NA;NA;NA;NA;NA;2012;2009;2016;2016;UCLA;;Nicole
543;472;NCT01642719;1;2;23811325;28.06.2013;;17.07.2019;13.07.2012;NA;Interventional;Phase 1;200;Completed;Chronic Moderate Sleep Restriction in Older Adults;2012-07-01T00:00:00Z;2018-12-01T00:00:00Z;2017-08-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2018;2017;UCLA;;Stefanie
279;110;NCT00134056;1;3;23871417;17.07.2013;publication found trhough one linked in registry, but was not linked;08.10.2021;22.08.2005;04.01.2017;Interventional;Phase 3;1038;Completed;S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy;2006-08-01T00:00:00Z;2016-02-01T00:00:00Z;2016-02-01T00:00:00Z;TRUE;Randomized;Triple;NETWORK;TRUE;NA;NA;NA;University of California, Davis;University of Southern California;NA;NA;NA;NA;2005;2006;2016;2016;UCD, USC;;Mario
889;624;NCT01398046;1;1;23980906;10.09.2013;;24.04.2015;05.07.2011;NA;Interventional;Phase 1;10;Completed;Effects of Gastric pH on the Pharmacokinetics of Dasatinib;2011-08-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCSF;;Mario
307;358;NCT00810160;1;1;23993139;29.08.2013;;11.07.2017;15.12.2008;NA;Interventional;Phase 1;59;Completed;The Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants;2009-06-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2008;2009;2015;2015;UCD;;Emmanuel
280;116;NCT00470548;1;1;24013936;08.09.2013;;05.01.2018;03.05.2007;17.01.2017;Interventional;Phase 1/Phase 2;49;Terminated;Abraxane and Alimta in Advanced Solid Tumors;2007-04-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;NA;NA;NA;University of California, Davis;NA;NA;NA;NA;NA;2007;2007;2014;2014;UCD;;Nicole
686;348;NCT01317277;1;1;24078868;03.09.2013;;03.08.2021;16.03.2011;06.05.2021;Interventional;Not Applicable;75;Completed;Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users;2011-04-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCSD;;Stefanie
695;552;NCT01171586;1;1;24200517;06.11.2013;;03.12.2014;26.07.2010;NA;Interventional;Not Applicable;318;Completed;mDiet: A Text Message Intervention for Weight Loss;2010-05-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;2014;UCSD;;Emmanuel
809;229;NCT01286259;1;3;24336828;12.12.2013;;29.06.2020;27.01.2011;06.11.2018;Interventional;Not Applicable;16;Completed;Short-term Disulfiram Administration to Accelerate the Decay of the HIV Reservoir in Antiretroviral-treated HIV Infected Individuals;2011-01-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCSF;;Nicole
524;455;NCT01324973;1;1;24382767;01.01.2014;;30.06.2014;28.03.2011;NA;Interventional;Not Applicable;60;Completed;Web-Based Weight Management for Individuals With Mental Illness;2012-03-01T00:00:00Z;2014-04-01T00:00:00Z;2014-04-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2014;2014;UCLA;;Emmanuel
902;637;NCT01507558;1;1;24423476;11.01.2014;;04.01.2018;09.11.2011;NA;Interventional;Not Applicable;22;Completed;Dexamethasone Infusion to the Adventitia to Enhance Clinical Efficacy After Femoropopliteal Revascularization;2010-12-01T00:00:00Z;2016-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2010;2016;2015;UCSF;;Nicole
;4;NCT00074152;1;1;24439313;16.01.2014;18650162 is a study protocol, 29443653 is a final analysis with more patients - see addition to the protocol;23.05.2017;10.12.2003;07.04.2015;Interventional;Phase 3;162;Completed;"Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer";2002-07-01T00:00:00Z;2016-08-22T00:00:00Z;2014-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;Stanford Cancer Center, CA, USA;NA;NA;NA;NA;NA;2003;2002;2016;2014;Stanford;1;
753;45;NCT01012713;1;3;24547791;19.02.2014;;16.06.2015;10.11.2009;28.05.2015;Interventional;Phase 4;30;Completed;Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis;2010-06-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;UCSF Department of Dermatology;NA;NA;NA;NA;UCSF Department of Dermatology;NA;NA;NA;2009;2010;2014;2014;UCSF;;Samruddhi
314;364;NCT01270217;1;1;24553532;01.03.2014;;06.07.2017;03.01.2011;NA;Interventional;Not Applicable;200;Completed;Behavior and Driving Safety Study II;2010-12-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2011;2010;2015;2015;UCD;;Emmanuel
863;349;NCT01614067;1;3;24636401;14.03.2014;;20.05.2021;02.05.2012;20.05.2021;Interventional;Phase 4;30;Terminated;Delayed Start to Ovarian Stimulation;2012-05-01T00:00:00Z;2014-09-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;UCSF Center for Reproductive Health and Fertility Preservation;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSF;;Stefanie
413;430;NCT01876602;1;1;24770461;17.04.2014;;14.05.2018;10.06.2013;NA;Interventional;Not Applicable;140;Completed;Test of an Intervention to Increase Physical Activity Among School Children;2011-04-01T00:00:00Z;2017-03-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2013;2011;2017;2017;UCI;;Mario
433;38;NCT01061671;1;1;24836125;18.05.2014;;08.12.2017;02.02.2010;29.01.2015;Interventional;Phase 3;885;Terminated;Simvastatin Therapy for Moderate and Severe COPD;2010-03-01T00:00:00Z;2014-01-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;Harbor-UCLA Research & Education Institute;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;2014;UCLA;;Mario
747;32;NCT01248065;1;1;24838406;01.05.2014;;23.07.2014;24.11.2010;18.06.2014;Interventional;Phase 3;408;Completed;Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma;2011-04-01T00:00:00Z;2014-01-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2014;2014;UCSF;;Mario
392;173;NCT02410629;1;3;24885076;30.04.2014;;10.06.2021;02.04.2015;09.01.2018;Interventional;Not Applicable;17;Completed;To Determine the Therapeutic Effect of the Music Glove and Conventional Hand Exercises to Subacute Stroke Patients;2015-03-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCI;;Stefanie
699;556;NCT01280838;1;1;24885949;20.05.2014;;26.05.2015;19.01.2011;NA;Interventional;Not Applicable;400;Completed;Safer Sex Intervention for Male Clients of Female Sex Workers in Tijuana, Mexico;2011-01-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSD;;Nicole
900;635;NCT01479634;1;1;25022596;24.09.2014;;03.03.2016;22.11.2011;NA;Interventional;Not Applicable;279;Completed;Early HIV Therapy in Patients With High CD4 Cell Counts;2011-10-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco, San Francisco, CA, USA;NA;NA;University of California, San Francisco, San Francisco, CA, USA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSF;;Stefanie
521;452;NCT01158508;1;1;25072112;01.11.2014;;23.11.2016;25.06.2010;NA;Interventional;Phase 1;20;Completed;Remote Ischemic Preconditioning in Subarachnoid Hemorrhage;2010-04-01T00:00:00Z;2014-07-01T00:00:00Z;2014-01-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles David Geffen School of Medicine, Departments of Neurosurgery and Radiology;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;2014;UCLA;;Emmanuel
751;43;NCT00948896;1;1;25093754;05.08.2014;;26.10.2015;27.07.2009;30.04.2015;Interventional;Phase 3;600;Completed;Chemopreventive Therapy for Malaria in Ugandan Children;2010-06-01T00:00:00Z;2014-04-01T00:00:00Z;2014-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2009;2010;2014;2014;UCSF;;Mario
328;378;NCT01773447;1;3;25129615;14.08.2014;;29.03.2017;15.01.2013;NA;Interventional;Not Applicable;47;Completed;Set-back Suture Versus Traditional Vertical Mattress Suture;2011-08-01T00:00:00Z;2014-04-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2011;2014;2014;UCD;;Susanne
;388;NCT01769326;1;1;25273359;01.10.2014;;05.06.2017;16.11.2012;15.02.2017;Interventional;Not Applicable;40;Completed;Influence of Timing on Motor Learning;2012-09-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2016;UCI;1;
396;180;NCT00842764;1;3;25275274;01.11.2014;;01.04.2021;11.02.2009;06.02.2018;Interventional;Not Applicable;7;Completed;Minimally Invasive Holmium:YAG Laser Blepharoplasty;2009-01-01T00:00:00Z;2014-09-01T00:00:00Z;2014-09-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Otolaryngology, UCIMC;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;2014;UCI;;Stefanie
342;392;NCT02062866;1;1;25372450;01.03.2015;;15.04.2015;01.11.2013;NA;Interventional;Not Applicable;50;Completed;Evaluation of Purse-String Closure Vs Second Intention;2013-04-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCD;;Susanne
818;239;NCT01083628;1;1;25373390;05.11.2014;;02.07.2019;19.02.2010;21.12.2018;Interventional;Not Applicable;85;Completed;Text Messaging and Cognitive Behavioral Therapy for Depression;2014-01-01T00:00:00Z;2017-04-01T00:00:00Z;2016-09-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2014;2017;2016;UCSF;;Samruddhi
557;486;NCT01867944;1;1;25403522;18.11.2014;;23.11.2016;29.05.2013;NA;Interventional;Not Applicable;100;Completed;Perineal Self-Acupressure;2013-06-01T00:00:00Z;NA;2014-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;NA;2014;UCLA;;Nicole
449;98;NCT00883129;1;1;25452309;01.12.2014;;06.02.2017;16.04.2009;06.11.2016;Interventional;Phase 2;142;Completed;Comparison of Therapeutic Regimens for Scleroderma Interstitial Lung Disease (The Scleroderma Lung Study II);2009-09-01T00:00:00Z;2015-11-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;"University of California, Los Angeles; UCLA School of Public Health";NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;2015;UCLA;;Stefanie
886;621;NCT01308775;1;1;25469673;02.12.2014;;06.03.2015;24.02.2011;NA;Interventional;Not Applicable;102;Completed;Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast Cancer;2011-01-01T00:00:00Z;2015-03-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2014;UCSF;;Nicole
738;593;NCT02566278;1;1;25515107;01.06.2015;Subject to discussion;08.07.2019;26.09.2015;NA;Interventional;Not Applicable;20;Terminated;Determination of Upper Airway Collapsibility During Routine CPAP Titration;2015-10-20T00:00:00Z;2016-07-25T00:00:00Z;2016-07-25T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSD;;Samruddhi
836;293;NCT00488982;1;3;25557266;09.12.2014;;29.10.2019;18.06.2007;07.10.2019;Interventional;Phase 2;125;Completed;Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC);2007-04-01T00:00:00Z;2014-05-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2014;2014;UCSF;;Emmanuel
754;50;NCT01313936;1;3;25602966;20.01.2015;Phase I/II vs Phase I in registry;26.01.2019;10.03.2011;14.07.2015;Interventional;Phase 1;32;Completed;High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma;2011-03-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCSF;;Samruddhi
748;33;NCT01036009;1;1;25644958;31.01.2015;Not OA;18.05.2016;17.12.2009;21.10.2014;Interventional;Phase 2;43;Completed;A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies;2009-10-01T00:00:00Z;2015-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;2014;UCSF;;Samruddhi
888;623;NCT01396941;1;3;25658017;06.02.2015;;13.07.2021;15.07.2011;NA;Interventional;Not Applicable;10;Completed;Effects of Sleep Duration and Architecture on Insulin Sensitivity;2011-05-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCSF;;Nicole
685;342;NCT01390077;1;1;25665838;10.02.2015;;23.03.2021;05.07.2011;21.12.2020;Interventional;Phase 2/Phase 3;8;Completed;Nitisinone (NTBC) In Different Age Groups Of Patients With Alkaptonuria;2011-01-01T00:00:00Z;2016-07-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2016;2016;UCSD;;Stefanie
278;108;NCT00895310;1;1;25667107;10.02.2015;;28.02.2017;06.05.2009;22.12.2016;Interventional;Phase 2;30;Completed;Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy;2009-05-01T00:00:00Z;2015-05-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Davis Health System;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;2014;UCD;;Nicole
383;71;NCT02020863;1;1;25690834;17.02.2015;;20.04.2016;19.12.2013;08.03.2016;Interventional;Not Applicable;40;Completed;Closed-Loop Fluid Administration System Using Hemodynamic Monitors;2012-11-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2014;2014;UCI;;Stefanie
876;611;NCT01019850;1;2;25695691;18.02.2015;;11.12.2015;24.11.2009;NA;Interventional;Phase 1;27;Completed;N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma;2010-03-01T00:00:00Z;2015-02-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;UCSF Medical Center at Parnassus;NA;NA;NA;NA;NA;NA;NA;NA;2009;2010;2015;2014;UCSF;;Mario
767;87;NCT01062009;1;3;25700179;19.02.2015;;19.08.2019;02.02.2010;16.08.2016;Interventional;Phase 1/Phase 2;24;Completed;Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children;2008-11-01T00:00:00Z;2014-11-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2010;2008;2014;2014;UCSF;;Samruddhi
409;428;NCT01602536;1;1;25707037;23.02.2015;pilot phase of trial as per protocol;04.12.2015;17.05.2012;NA;Interventional;Not Applicable;280;Completed;Twitter-enabled Mobile Messaging for Smoking Relapse Prevention;2012-01-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCI;;Susanne
881;616;NCT01220336;1;2;25755034;01.03.2015;;17.10.2014;11.10.2010;NA;Interventional;Not Applicable;441;Completed;Study of Medical Assistant Health Coaching in Primary Care for Patients With Chronic Conditions;2011-04-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2014;2014;UCSF;;Nicole
308;359;NCT00944281;1;1;25816354;27.03.2015;;11.07.2018;21.07.2009;NA;Interventional;Not Applicable;3220;Completed;Optimal Amount of Zinc to Include in a Lipid-based Nutrient Supplement (LNS);2010-05-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;University of California, Davis;NA;NA;NA;2009;2010;2014;2014;UCD;;Emmanuel
504;328;NCT02008396;1;1;25818246;25.03.2015;;16.12.2021;06.12.2013;18.09.2020;Interventional;Phase 2;12;Completed;Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults;2014-02-01T00:00:00Z;2017-08-01T00:00:00Z;2017-08-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2017;2017;UCLA;;Nicole
774;127;NCT01280812;1;1;25872754;13.04.2015;first is a protocol, mind you none of the publications actually publish the results?.?;01.09.2020;23.11.2010;24.03.2017;Interventional;Not Applicable;210;Completed;Applying Mobile Persuasive Technologies to Increase Physical Activity in Women;2011-02-01T00:00:00Z;2015-04-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2015;2015;UCSF;;Emmanuel
338;388;NCT01979497;1;1;25875131;01.08.2015;;15.04.2015;01.11.2013;NA;Interventional;Not Applicable;39;Completed;Adhesive Strips in Dermatologic Surgery: Is Cosmetic Appearance Improved?;2013-08-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCD;;Stefanie
451;101;NCT01657461;1;1;25882376;17.04.2015;;07.04.2017;02.08.2012;15.11.2016;Interventional;Not Applicable;196;Completed;Solitaire? With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial;2012-12-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;Randomized;None (Open Label);INDUSTRY;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCLA;;Samruddhi
964;696;NCT02078739;1;1;25887324;07.02.2015;;26.01.2015;24.02.2014;NA;Interventional;Not Applicable;14;Completed;Tele-yoga Program in COPD and Heart Failure;2013-06-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Non-Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2014;2014;UCSF;;Stefanie
267;48;NCT01027884;1;1;25907158;20.04.2015;;23.09.2015;08.12.2009;15.06.2015;Interventional;Phase 3;65;Completed;Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD);2009-07-01T00:00:00Z;2014-04-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;2014;UCD;;Susanne
377;34;NCT01841619;1;3;25918617;16.03.2015;;14.07.2015;21.04.2013;08.12.2014;Interventional;Early Phase 1;16;Completed;IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus;2013-03-01T00:00:00Z;2014-11-01T00:00:00Z;2014-11-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCI;;Mario
556;485;NCT01844414;1;1;25932697;01.05.2015;;26.05.2015;21.03.2013;NA;Interventional;Not Applicable;600;Completed;UCLA-Amity Parolee Health Promotion Study;2010-02-01T00:00:00Z;2015-05-01T00:00:00Z;2014-01-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2010;2015;2014;UCLA;;Mario
896;631;NCT01466998;1;1;25932840;01.05.2015;;05.05.2014;01.11.2011;NA;Interventional;Not Applicable;123;Completed;Menopausal Treatment Using Relaxation Exercises (MaTURE);2012-01-01T00:00:00Z;2014-04-01T00:00:00Z;2014-04-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2011;2012;2014;2014;UCSF;;Susanne
144;282;NCT01806675;1;1;25965900;12.05.2015;;21.09.2019;05.03.2013;14.08.2019;Interventional;Phase 1/Phase 2;25;Completed;18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy;2013-03-04T00:00:00Z;2019-04-01T00:00:00Z;2016-12-07T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2019;2016;Stanford;;Emmanuel
878;613;NCT01164163;1;3;25976292;13.05.2015;;22.10.2014;15.07.2010;NA;Interventional;Phase 1;49;Completed;INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease;2010-09-01T00:00:00Z;NA;2014-10-01T00:00:00Z;FALSE;NA;None (Open Label);NETWORK;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;NA;2014;UCSF;;Mario
403;324;NCT02049944;1;3;26003059;21.05.2015;;12.01.2021;24.01.2014;01.09.2020;Interventional;Phase 4;30;Completed;Increased Cefazolin During Cesarean Delivery in Obese Population;2013-08-01T00:00:00Z;2014-12-01T00:00:00Z;2014-09-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2014;2014;UCI;;Nicole
340;390;NCT02031718;1;1;26017816;01.09.2015;;26.02.2015;07.01.2014;NA;Interventional;Not Applicable;98;Completed;Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone;2014-01-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2014;2014;UCD;;Stefanie
440;68;NCT01373918;1;3;26024828;11.07.2016;;10.05.2016;06.06.2011;22.02.2016;Interventional;Phase 4;41;Terminated;Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders;2010-12-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2011;2010;2014;2014;UCLA;;Nicole
713;569;NCT01837147;1;1;26071863;10.06.2015;;05.02.2020;06.04.2013;NA;Interventional;Not Applicable;51;Completed;Using Technology to Improve Physical Activity Levels Among Postmenopausal Women (The Active & Aware Study);2013-04-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCSD;;Emmanuel
436;46;NCT01672723;1;2;26098729;22.06.2015;;10.12.2015;20.08.2012;29.05.2015;Interventional;Not Applicable;34;Completed;Neuropharmacological Basis of Social Connection: The Role of Opioids;2012-10-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCLA;;Nicole
271;88;NCT01294306;1;3;26106072;23.06.2015;;18.10.2016;10.02.2011;23.08.2016;Interventional;Phase 2;80;Completed;MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy;2011-02-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;NA;None (Open Label);NIH;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCD;;Samruddhi
735;590;NCT02485756;1;1;26197260;18.07.2015;;06.06.2019;26.09.2013;NA;Interventional;Not Applicable;42;Completed;Counseling on the Interaction of Hormonal Contraceptives and Antiepileptics;2013-06-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;NA;NA;NA;NA;NA;UCSD;NA;NA;NA;2013;2013;2014;2014;UCSD;;Nicole
623;51;NCT01664559;1;1;26241253;01.07.2015;;18.11.2015;28.06.2012;22.07.2015;Interventional;Not Applicable;67;Completed;Pain Control for Intrauterine Device Placement: A Trial of Ketorolac Prior to Intrauterine Device Placement;2012-07-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;University of California, San Diego;NA;NA;NA;2012;2012;2014;2014;UCSD;;Nicole
509;440;NCT00852358;1;2;26260077;26.07.2015;;22.01.2016;25.02.2009;NA;Interventional;Not Applicable;9;Completed;A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I;2009-06-01T00:00:00Z;2015-04-01T00:00:00Z;2015-04-01T00:00:00Z;FALSE;Randomized;None (Open Label);INDIV;TRUE;Los Angeles Biomedical Institute at Harbor-UCLA;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;2015;UCLA;;Mario
693;550;NCT01112839;1;1;26282657;17.08.2015;;17.06.2015;26.04.2010;NA;Interventional;Not Applicable;692;Completed;Reducing Breast Cancer Recurrence With Weight Loss;2010-05-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;2015;UCSD;;Nicole
702;559;NCT01359982;1;1;26296952;19.08.2015;;19.05.2015;23.05.2011;NA;Interventional;Phase 1;26;Completed;Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects;2011-09-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSD;;Nicole
566;495;NCT01944904;1;1;26300782;07.08.2015;;27.02.2017;04.09.2013;NA;Interventional;Not Applicable;18;Completed;Investigation of the Ability of a Supplement to Increase Good Bacteria in the Human Intestine and Blood Sugar Levels;2013-09-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;UCLA Department of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCLA;;Nicole
435;42;NCT01238575;1;2;26315981;28.08.2015;;18.03.2020;29.10.2010;30.04.2015;Interventional;Phase 4;62;Completed;Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder;2011-12-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2014;2014;UCLA;;Mario
589;517;NCT02268682;1;1;26316264;28.08.2015;;09.01.2017;15.10.2014;NA;Interventional;Not Applicable;558;Completed;Explore Transplant at Home: Improving Low-Income ESRD Patients' Transplant Knowledge;2014-07-01T00:00:00Z;2016-08-01T00:00:00Z;2016-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCLA;;Nicole
894;629;NCT01462422;1;3;26333044;01.09.2015;automatically indexed link is a meta analysis;13.06.2014;27.10.2011;NA;Interventional;Not Applicable;3032;Completed;Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India;2011-12-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCSF;;Stefanie
519;450;NCT01103531;1;1;26371404;03.09.2015;;30.11.2015;31.03.2010;NA;Interventional;Not Applicable;135;Completed;Exercise to Improve Outcomes of Treatment for Methamphetamine Users;2010-03-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCLA Integrated Substance Abuse Programs;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;2015;UCLA;;Nicole
909;643;NCT01606657;1;2;26416494;23.09.2015;;01.05.2017;21.05.2012;NA;Interventional;Not Applicable;201;Completed;Irrigation Versus no Irrigation for Cutaneous Abscess;2010-08-01T00:00:00Z;2015-04-01T00:00:00Z;2014-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCSF, Community Regional Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2012;2010;2015;2014;UCSF;;Stefanie
726;581;NCT02188875;1;2;26431257;02.06.2015;;02.10.2019;10.07.2014;NA;Interventional;Not Applicable;67;Completed;Fitbit One and Text Messaging Prompts to Promote Physical Activity in Overweight/Obese Adults;2013-01-01T00:00:00Z;2014-01-01T00:00:00Z;2014-01-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;University of California, San Diego;NA;NA;NA;NA;NA;2014;2013;2014;2014;UCSD, UCSF;;Nicole
487;222;NCT02233478;1;3;26471685;28.08.2015;pico matches - 2 arms instead of 3 but else matching;15.08.2019;15.08.2014;25.09.2018;Interventional;Not Applicable;18;Completed;Comparing the Effect of Whey and Soy Protein on the Absorption of Pomegranate Polyphenols in the Human Body;2014-08-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;UCLA Department of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCLA;;Emmanuel
573;502;NCT02074579;1;2;26486374;31.01.2016;;28.04.2017;24.02.2014;NA;Interventional;Phase 2;101;Completed;A Safety and Efficacy Study of Daikenchuto (TU-100) to Relieve Abdominal Bloating in Female Subjects With Irritable Bowel Syndrome;2014-07-01T00:00:00Z;2016-04-01T00:00:00Z;2016-04-01T00:00:00Z;FALSE;Randomized;Quadruple;INDUSTRY;FALSE;Oppenheimer Family Center of Neurobiology of Stress, UCLA;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCLA;;Mario
697;554;NCT01198418;1;3;26487300;01.06.2016;Article not OA, Intervetion and outcome matching from snippet;08.05.2020;08.09.2010;NA;Interventional;Not Applicable;181;Completed;A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH);2010-07-09T00:00:00Z;2017-11-09T00:00:00Z;2017-10-18T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;NA;NA;NA;University of California, San Diego;NA;NA;NA;NA;NA;2010;2010;2017;2017;UCSD;;Samruddhi
269;83;NCT01316510;1;1;26545203;01.06.2016;;03.10.2017;14.03.2011;14.07.2016;Interventional;Not Applicable;24;Completed;Probiotics in Infants With Gastroschisis;2011-03-01T00:00:00Z;2015-08-01T00:00:00Z;2015-02-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCD;;Nicole
762;74;NCT01272635;1;1;26575060;17.11.2015;;01.11.2016;07.01.2011;11.03.2016;Interventional;Phase 3;607;Completed;Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.;2011-03-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;"University of California, San Francisco; UCSF Benioff Children's Hospital Oakland";NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSF;;Samruddhi
325;375;NCT01715038;1;1;26607935;25.11.2015;;24.05.2017;18.10.2012;NA;Interventional;Not Applicable;4011;Completed;Effectiveness of LNS and MNP Supplements to Prevent Malnutrition in Women and Their Children in Bangladesh;2011-10-01T00:00:00Z;2015-10-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2015;2015;UCD;;Stefanie
533;464;NCT01438320;1;1;26621580;01.12.2015;;18.03.2015;14.09.2011;NA;Interventional;Phase 1;34;Completed;Q-Trial in Patients With Hepatitis C;2011-07-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Non-Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCLA;;Mario
439;65;NCT00451204;1;1;26621682;29.11.2015;;10.05.2016;22.03.2007;20.01.2016;Interventional;Phase 2;158;Completed;A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS);2007-03-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;University of California, Los Angeles (UCLA), Los Angeles, CA;NA;NA;NA;NA;University of California, Los Angeles (UCLA), Los Angeles, CA;NA;NA;NA;2007;2007;2014;2014;UCLA;;Emmanuel
329;379;NCT01808664;1;1;26640973;01.02.2016;;24.02.2020;20.11.2012;NA;Interventional;Not Applicable;61;Completed;Promoting Patient-Centered Counseling to Reduce Inappropriate Diagnostic Tests;2013-04-01T00:00:00Z;2014-12-01T00:00:00Z;2014-09-01T00:00:00Z;FALSE;Randomized;Double;OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2014;2014;UCD;;Samruddhi
775;128;NCT01461707;1;1;26649879;01.05.2016;;24.10.2017;26.10.2011;24.03.2017;Interventional;Not Applicable;30;Completed;The MOTHER (Mobile Technologies to Help Enhancing Regular Physical Activity) Trial for Pregnant Women;2012-10-01T00:00:00Z;2014-06-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2014;2014;UCSF;;Emmanuel
350;400;NCT02306980;1;1;26658119;10.12.2015;;21.07.2017;01.12.2014;NA;Interventional;Not Applicable;12;Completed;Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota;2013-10-01T00:00:00Z;2016-06-01T00:00:00Z;2015-04-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2016;2015;UCD;;Nicole
380;57;NCT02070237;1;1;26658126;10.12.2015;;22.10.2015;20.02.2014;23.09.2015;Interventional;Phase 1;90;Completed;Comparing Anti-XA Levels in Post-Cesarean Patients Undergoing Enoxaparin Thromboprophylaxis;2013-08-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;"Memorial Health Care System; University of California Irvine";NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2014;2014;UCI;;Emmanuel
814;235;NCT01723384;1;2;26674372;01.05.2016;;15.04.2019;02.11.2012;07.12.2018;Interventional;Phase 2;30;Completed;Intermittent Naltrexone Among Polysubstance Users;2013-05-01T00:00:00Z;2014-11-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2014;2014;UCSF;;Nicole
273;97;NCT00661193;1;3;26725184;25.12.2015;;19.02.2020;17.04.2008;04.11.2016;Interventional;Phase 2;59;Completed;S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer;2008-12-01T00:00:00Z;2016-12-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of California, Davis;NA;NA;NA;NA;NA;2008;2008;2016;2015;UCD;;Nicole
737;592;NCT02544867;1;1;26735919;06.01.2016;;04.09.2015;04.09.2015;NA;Interventional;Not Applicable;30;Completed;Optimizing Sedentary Behavior Interventions to Affect Acute Physiological Changes;2013-09-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2015;2013;2014;2014;UCSD;;Mario
288;135;NCT02596750;1;2;26762206;01.04.2016;;02.11.2018;31.10.2015;17.04.2017;Interventional;Not Applicable;21;Completed;The Effect of Microneedle Pretreatment on Topical Anesthesia;2014-01-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2015;2015;UCD;;Nicole
434;39;NCT01534910;1;1;26764322;13.01.2016;;09.03.2017;14.02.2012;20.02.2015;Interventional;Phase 4;65;Completed;Effect of Aged Garlic Extract on Atherosclerosis;2012-05-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCLA;;Samruddhi
749;37;NCT01554241;1;2;26782853;01.01.2016;;13.02.2015;12.03.2012;23.01.2015;Interventional;Not Applicable;86;Completed;Optimizing Vitamin D in the Elderly;2012-09-01T00:00:00Z;2014-09-01T00:00:00Z;2014-09-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSF;;Samruddhi
873;608;NCT00871299;1;3;26808973;26.01.2016;in publication other (obsolete) ID is cited;01.12.2014;27.03.2009;NA;Interventional;Not Applicable;173;Completed;Practicing Alternative Techniques to Heal From Depression: The PATH-D Study;2009-09-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;2014;UCSF;;Emmanuel
703;560;NCT01424007;1;1;26811166;25.01.2016;;01.07.2019;24.08.2011;NA;Interventional;Not Applicable;245;Completed;Metabolism, Exercise and Nutrition at UCSD (MENU Study);2011-12-01T00:00:00Z;2016-09-01T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2016;2016;UCSD;;Emmanuel
526;457;NCT01360203;1;1;26857383;01.03.2016;;10.05.2016;18.05.2011;NA;Interventional;Not Applicable;1437;Completed;Better Effectiveness After Transition - Heart Failure;2011-10-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCLA;;Samruddhi
;361;NCT02594969;1;2;26875771;07.06.2016;23617366 - is another study, with children, not the PI involved;25.05.2017;10.07.2014;NA;Interventional;Not Applicable;20;Completed;The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis;2014-01-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCD;1;
386;93;NCT02682498;1;3;26897490;30.01.2016;;05.07.2017;03.02.2016;31.10.2016;Interventional;Phase 4;38;Completed;Comparing Post-Op Narcotic Usage in Patients Receiving Periarticular Exparel vs. Standard Periarticular Joint Inj;2013-10-01T00:00:00Z;2015-08-01T00:00:00Z;2015-07-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2016;2013;2015;2015;UCI;;Mario
867;604;NCT00655239;1;1;26903238;22.02.2016;;04.01.2019;07.04.2008;NA;Interventional;Not Applicable;143;Completed;Effectiveness of Neuroadaptive Cognitive Training in Adolescents at Risk for Psychosis;2008-06-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;"University of California, San Francisco; San Francisco VA Medical Center; NCIRE - The Veterans Health Research Institute";NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2008;2008;2016;2016;UCSF;;Stefanie
921;654;NCT01743820;1;1;26906747;20.02.2016;;16.01.2015;26.11.2012;NA;Interventional;Phase 2;81;Completed;Phase2a Primaquine Dose Escalation Study;2013-09-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2014;2014;UCSF;;Emmanuel
587;515;NCT02262962;1;1;26908675;10.02.2016;;20.06.2016;03.10.2014;NA;Interventional;Not Applicable;251;Completed;Well-Child Care Redesign: A New Model of Care for Children in Low-Income Families;2005-06-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCLA Department of General Pediatrics;NA;NA;NA;NA;NA;NA;NA;NA;2014;2005;2015;2015;UCLA;;Nicole
620;35;NCT01766713;1;1;26929777;01.03.2016;;01.07.2020;09.01.2013;10.12.2014;Interventional;Phase 2;50;Completed;Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis;2013-01-01T00:00:00Z;2014-09-01T00:00:00Z;2014-08-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCSD;;Emmanuel
322;372;NCT01618552;1;1;26956140;08.03.2016;;30.11.2015;08.05.2012;NA;Interventional;Not Applicable;182;Completed;Training Doctors to Support Patient Self-Care of Depression;2013-04-01T00:00:00Z;2015-05-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2015;2015;UCD;;Nicole
698;555;NCT01229696;1;2;26962712;01.05.2016;;07.04.2016;27.10.2010;NA;Interventional;Phase 4;150;Completed;Continuous Popliteal Nerve Blocks: Effect of Perineural Catheter Tip Location Relative to the Sciatic Nerve Bifurcation on Postoperative Analgesia;2010-10-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;2015;UCSD;;Nicole
448;96;NCT02347488;1;2;26983051;01.05.2016;;20.03.2017;08.01.2015;03.11.2016;Interventional;Phase 4;30;Completed;Endotracheal Tube Holder and Bite Guard Research;2015-02-01T00:00:00Z;2016-01-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2015;UCLA;;Nicole
998;727;NCT02420561;1;3;26985728;17.03.2016;;08.06.2015;07.04.2015;NA;Interventional;Not Applicable;307;Completed;Motivational Interviewing to Reduce Substance Use Among Depression Patients;2010-10-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2010;2014;2014;UCSF;;Stefanie
281;122;NCT00814788;1;1;27019001;28.03.2016;;05.01.2018;24.12.2008;06.03.2017;Interventional;Phase 2;24;Completed;Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer;2008-12-01T00:00:00Z;2016-01-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2016;2015;UCD;;Emmanuel
890;625;NCT01404520;1;1;27036163;01.04.2016;;30.11.2015;10.05.2011;NA;Interventional;Not Applicable;70;Completed;Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL);2011-06-01T00:00:00Z;2015-05-01T00:00:00Z;2014-05-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;UCSF and CIRE;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2014;UCSF;;Nicole
;168;NCT01114282;1;1;27040320;04.04.2016;;05.07.2016;29.04.2010;NA;Interventional;Phase 1;11;Completed;Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MM;2010-08-01T00:00:00Z;NA;2014-02-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;NA;2014;Stanford;1;
925;657;NCT01772485;1;1;27070409;12.04.2016;;10.09.2019;14.01.2013;NA;Interventional;Not Applicable;31;Completed;Online Neuroplasticity Training for Remediation of ADHD in Adolescent Children (ONTRAC);2013-01-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;FALSE;Randomized;Double;INDUSTRY;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCSF;;Mario
;507;NCT00352599;1;3;27081657;22.02.2016;;18.11.2016;13.07.2006;NA;Interventional;Phase 1;44;Completed;Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1);2009-09-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2006;2009;2014;2014;UCLA;1;
447;95;NCT02046200;1;3;27087145;18.04.2016;;10.07.2018;14.01.2014;03.11.2016;Interventional;Phase 1/Phase 2;11;Completed;Development of Ivermectin for Alcohol Use Disorders;2014-02-01T00:00:00Z;2015-03-01T00:00:00Z;2015-03-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;2014;2014;2015;2015;UCLA;;Emmanuel
391;144;NCT02075658;1;1;27130263;27.04.2016;;16.01.2018;01.11.2013;23.05.2017;Interventional;Not Applicable;60;Completed;A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation;2003-01-01T00:00:00Z;2014-09-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2013;2003;2014;2014;UCI;;Stefanie
799;198;NCT01210664;1;1;27133597;28.04.2016;;12.06.2018;23.09.2010;07.05.2018;Interventional;Phase 1;16;Completed;T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs;2010-11-01T00:00:00Z;2017-01-01T00:00:00Z;2016-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;NA;NA;NA;University of California, San Francisco;NA;University of California, San Francisco;NA;NA;NA;2010;2010;2017;2016;UCSF;;Stefanie
919;652;NCT01728909;1;1;27137199;03.05.2016;;17.05.2019;07.11.2012;NA;Interventional;Early Phase 1;64;Completed;Methadone Oxytocin Option;2012-05-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California San Francisco, San Francisco Veterans Affairs Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSF;;Emmanuel
759;62;NCT01829516;1;3;27159342;01.05.2016;;25.06.2016;09.04.2013;09.12.2015;Interventional;Phase 4;32;Completed;Intranasal Oxytocin and Social Cognition, Implicit Preferences and Craving in Alcohol Drinkers;2013-05-01T00:00:00Z;2014-11-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCSF;;Samruddhi
654;258;NCT01154192;1;2;27166718;01.07.2016;;22.04.2019;29.06.2010;29.03.2019;Interventional;Phase 3;24;Completed;Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS);2011-08-01T00:00:00Z;2014-09-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;UCSD School of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2014;2014;UCSD;;Nicole
705;562;NCT01593943;1;1;27167981;11.05.2016;;03.12.2014;04.05.2012;NA;Interventional;Phase 3;2162;Completed;Gender Equity-Focused, Male-Centered Family Planning for Rural India;2012-03-01T00:00:00Z;2014-09-01T00:00:00Z;2014-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSD;;Nicole
956;688;NCT01988194;1;1;27181130;01.05.2016;data extraction in process;04.06.2020;05.11.2013;NA;Interventional;Not Applicable;238;Completed;Pragmatic Research eXamining Inpatient Symptoms;2013-11-01T00:00:00Z;2015-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2014;UCSF;;Samruddhi
452;102;NCT02120027;1;3;27196574;15.04.2016;;18.01.2017;17.04.2014;18.11.2016;Interventional;Phase 3;558;Terminated;52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D);2014-02-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;NA;NA;NA;Digestive Health and Nutrition Clinic. University of California, Los Angeles, CA, USA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCLA;;Stefanie
715;571;NCT01936441;1;1;27213646;01.07.2016;;21.10.2015;03.09.2013;NA;Interventional;Not Applicable;106;Completed;MsFLASH-04: Pilot Trial: Telephone Behavioral Therapy for Menopause-related Sleep Disturbance;2013-11-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCSD;;Nicole
;712;NCT01834287;1;1;27234302;28.05.2016;no cost effect analyses (28228368);19.01.2021;12.04.2013;NA;Interventional;Not Applicable;207;Completed;Pasos Hacia La Salud - Physical Activity Intervention for Latinas;2011-12-01T00:00:00Z;2015-03-01T00:00:00Z;2015-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2011;2015;2015;UCSD;1;
779;145;NCT01913340;1;2;27244862;02.05.2016;;26.06.2020;29.07.2013;23.05.2017;Interventional;Phase 1/Phase 2;50;Completed;Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO);2013-09-01T00:00:00Z;2016-09-01T00:00:00Z;2016-01-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCSF;;Nicole
525;456;NCT01351220;1;1;27282431;01.06.2016;;28.07.2016;06.05.2011;NA;Interventional;Not Applicable;1100;Completed;Community Dissemination of an Evidence-based Colorectal Cancer (CRC) Screening Intervention;2010-07-01T00:00:00Z;2015-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;2011;2010;2015;2014;UCLA;;Stefanie
450;100;NCT02641249;1;1;27304988;15.06.2016;;29.03.2017;18.12.2015;14.11.2016;Interventional;Not Applicable;19;Completed;Non-invasive Intervention for Apnea of Prematurity;2014-10-01T00:00:00Z;2016-02-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2016;2015;UCLA;;Emmanuel
330;380;NCT01811329;1;1;27313850;07.03.2016;;09.08.2021;11.03.2013;NA;Interventional;Not Applicable;38;Active, not recruiting;Determine How Consumption of Dairy Fat Fractions Rich in Phospholipids and Proteins Influence Inflammation in the Fed State-Phase 1;2013-08-01T00:00:00Z;2027-01-29T00:00:00Z;2014-06-17T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;"UC Davis; University of California, Davis";NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2027;2014;UCD;;Mario
309;360;NCT00970866;1;1;27391572;06.07.2016;Earliest trial to assess primary outcomes and closer sample size to set one;23.02.2022;01.09.2009;NA;Interventional;Not Applicable;3499;Completed;Efficacy of Lipid-Based Nutrient Supplements (LNS) for Pregnant and Lactating Women and Their Infants;2009-11-01T00:00:00Z;2017-12-15T00:00:00Z;2017-12-15T00:00:00Z;FALSE;Randomized;Triple;OTHER;TRUE;"UC Davis; University of California, Davis";NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2017;2017;UCD;;Samruddhi
277;107;NCT01963403;1;1;27419258;15.07.2016;;04.04.2017;10.10.2013;19.12.2016;Interventional;Phase 4;26;Terminated;Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive;2013-12-01T00:00:00Z;2015-09-01T00:00:00Z;2015-07-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;University of California, Davis;NA;NA;NA;2013;2013;2015;2015;UCD;;Mario
851;329;NCT01643382;1;1;27423055;24.09.2016;;13.10.2020;16.07.2012;18.09.2020;Interventional;Not Applicable;60;Completed;Hyperglycemia in Renal Transplantation;2012-08-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;UCSF Department of Surgery;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSF;;Nicole
;690;NCT00787059;1;1;27437887;01.05.2016;;06.02.2018;06.11.2008;NA;Interventional;Phase 1/Phase 2;56;Completed;AC6 Gene Transfer for CHF;2010-07-01T00:00:00Z;2017-11-16T00:00:00Z;2015-01-01T00:00:00Z;FALSE;Randomized;Quadruple;INDIV;TRUE;"UCSD; VA San Diego Healthcare System; Veteran's Medical Research Foundation; University of California, San Diego";NA;NA;NA;NA;"UCSD; VA San Diego Healthcare System; Veterans Medical Research Foundation";NA;NA;NA;2008;2010;2017;2015;UCSD;1;
633;121;NCT02264353;1;1;27442715;01.11.2016;;06.08.2019;17.09.2014;02.03.2017;Interventional;Phase 4;44;Completed;The Impact of Arousal Threshold in Obstructive Sleep Apnea;2014-09-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCSD;;Emmanuel
518;449;NCT01090245;1;1;27459163;01.04.2016;;09.05.2017;16.03.2010;NA;Interventional;Not Applicable;202;Completed;Using Incentives to Improve Parolee Participation and Attendance in Community Treatment;2010-04-01T00:00:00Z;2014-08-01T00:00:00Z;2014-01-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;2010;2010;2014;2014;UCLA;;Samruddhi
608;536;NCT02745405;1;1;27465666;28.07.2016;;15.04.2016;11.04.2016;NA;Interventional;Not Applicable;109;Completed;Implications of Wearing a Fat Suit;2014-04-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2014;2014;2014;UCLA;;Samruddhi
627;69;NCT02213510;1;2;27470060;13.09.2016;;18.05.2016;07.08.2014;29.02.2016;Interventional;Not Applicable;40;Completed;ZIPS Study - Zip Incision aPproximation vs. Suture;2014-08-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCSD;;Stefanie
674;287;NCT01946282;1;3;27481306;02.08.2016;found from the one linked in registry, but was not linked;18.03.2020;13.09.2013;11.09.2019;Interventional;Not Applicable;8565;Completed;Evidence-Based Colorectal Cancer Screening for the Uninsured;2013-11-01T00:00:00Z;2017-04-01T00:00:00Z;2017-04-01T00:00:00Z;TRUE;Randomized;Double;OTHER;TRUE;NA;NA;NA;NA;NA;University of California, San Diego;NA;NA;NA;2013;2013;2017;2017;UCSD;;Mario
270;86;NCT02136498;1;1;27489247;03.08.2016;;11.10.2017;09.05.2014;15.08.2016;Interventional;Not Applicable;66;Completed;My Mobile Advice Program: A Randomized Pilot Feasibility Study;2014-10-01T00:00:00Z;2016-02-01T00:00:00Z;2016-02-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCD;;Samruddhi
707;564;NCT01671514;1;2;27491778;05.08.2016;;01.06.2015;20.08.2012;NA;Interventional;Not Applicable;21;Completed;Effects of Dark Chocolate on Exercise Capacity, and Mitochondrial Structure and Function;2012-07-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;Assistant Professor of Medicine, University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSD;;Samruddhi
467;159;NCT02095106;1;3;27496823;01.09.2017;;26.10.2017;20.03.2014;14.08.2017;Interventional;Not Applicable;27;Completed;Waterproof Casting for Pediatric Distal Radius Fractures;2014-04-01T00:00:00Z;2015-10-01T00:00:00Z;2015-10-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;UCLA, Orthopaedic Institute for Children;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCLA;;Samruddhi
621;41;NCT01893346;1;1;27503642;23.09.2016;;01.09.2017;26.06.2013;09.04.2015;Interventional;Phase 1;35;Completed;Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections;2013-07-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);INDUSTRY;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCSD;;Samruddhi
856;334;NCT02397408;1;1;27513849;11.08.2016;;27.10.2020;04.03.2015;27.10.2020;Interventional;Phase 2;18;Completed;11C- and 18F-Choline PET/MR Imaging for Prostate Cancer;2015-04-09T00:00:00Z;2015-06-30T00:00:00Z;2015-06-30T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2015;2015;UCSF;;Mario
629;76;NCT02111980;1;2;27550834;06.10.2016;;06.12.2019;09.04.2014;12.04.2016;Interventional;Not Applicable;50;Completed;RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators;2014-03-01T00:00:00Z;2015-05-01T00:00:00Z;2015-03-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCSD;;Mario
917;650;NCT01686724;1;1;27566117;01.07.2016;;14.06.2019;16.07.2012;NA;Interventional;Not Applicable;504;Completed;Study of the Collaborative Life Skills Program;2012-09-01T00:00:00Z;2016-06-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2015;UCSF;;Nicole
816;237;NCT00313729;1;3;27571885;01.02.2017;;22.01.2019;11.04.2006;08.12.2018;Interventional;Phase 2;120;Completed;Temozolomide in Treating Patients With Low-Grade Glioma;1999-05-01T00:00:00Z;2017-06-12T00:00:00Z;2014-09-25T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2006;1999;2017;2014;UCSF;;Samruddhi
949;681;NCT01939704;1;1;27599265;07.11.2016;;16.12.2019;06.09.2013;NA;Interventional;Not Applicable;1809;Completed;Community to Clinic Linkage Program at SFGH;2013-10-01T00:00:00Z;2019-10-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2019;2015;UCSF;;Stefanie
972;704;NCT02109601;1;1;27599452;06.09.2016;sample size deviation (45 vs 98) and mention in publication of original sample plan of 100 and results mentions patients enrollment in ongoing/preliminary findings;05.02.2020;03.04.2014;NA;Interventional;Not Applicable;98;Completed;Patient-Centered Tablets: Applications for Inpatient Admissions;2013-11-01T00:00:00Z;2015-02-01T00:00:00Z;2014-11-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2015;2014;UCSF;;Samruddhi
720;575;NCT02071264;1;1;27600733;06.09.2016;TRN not mentioned, but similar PICO,subject to discussion;24.04.2021;23.02.2014;NA;Interventional;Not Applicable;100;Completed;Effects of an HIV Intervention Among Sex Workers in the Philippines;2013-08-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2016;2016;UCSD;;Samruddhi
778;143;NCT02290184;1;1;27608829;08.09.2016;;03.04.2019;08.11.2014;22.05.2017;Interventional;Not Applicable;45;Completed;PilAm Go4Health Weight Loss Program to Prevent Heart Disease;2014-11-01T00:00:00Z;2017-08-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2016;UCSF;;Emmanuel
69;126;NCT01781637;1;3;27609658;05.09.2016;different outcome, sample used for detecting antibody responses to peanuts in registry link pub;11.01.2022;30.01.2013;23.03.2017;Interventional;Phase 1/Phase 2;36;Active, not recruiting;Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial;2013-01-01T00:00:00Z;2025-10-01T00:00:00Z;2015-10-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;NA;NA;NA;Stanford University;NA;NA;NA;NA;NA;2013;2013;2025;2015;Stanford;;Samruddhi
468;160;NCT01781806;1;3;27632233;01.01.2017;;04.04.2018;29.01.2013;24.08.2017;Interventional;Phase 4;328;Completed;A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services;2013-05-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCLA;;Stefanie
636;165;NCT01289275;1;1;27647058;01.10.2016;;11.02.2020;31.01.2011;26.10.2017;Interventional;Phase 4;1270;Completed;Smoking Cessation in Hospitalized Smokers;2011-08-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCSD;;Samruddhi
772;114;NCT01810289;1;1;27658873;27.08.2016;;02.11.2018;11.03.2013;09.01.2017;Interventional;Not Applicable;12024;Completed;"The ""START"" (a Streamlined ART Initiation Strategy) Study";2013-04-01T00:00:00Z;2016-08-01T00:00:00Z;2016-08-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCSF;;Emmanuel
916;649;NCT01686178;1;1;27697952;01.10.2016;;16.10.2017;12.09.2012;NA;Interventional;Not Applicable;17422;Completed;Countering Young Adult Tobacco Marketing in Bars;2012-09-01T00:00:00Z;2017-07-02T00:00:00Z;2017-07-02T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2017;2017;UCSF;;Emmanuel
446;94;NCT02701387;1;3;27699890;03.10.2016;no NCT-ID;01.11.2016;29.02.2016;01.11.2016;Interventional;Not Applicable;7;Completed;Effect of Implant Thread Design on Implant Stability Quotient (ISQ) in Early Healing Period;2014-08-01T00:00:00Z;2015-04-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2014;2015;2015;UCLA;;Susanne
438;63;NCT01080794;1;1;27708129;05.10.2016;;02.03.2017;03.03.2010;12.01.2016;Interventional;Not Applicable;61;Completed;rTMS for Motor and Mood Symptoms of Parkinson's Disease;2010-05-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;TRUE;Randomized;Double;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;2014;UCLA;;Stefanie
351;401;NCT02318732;1;1;27729440;11.10.2016;;29.11.2021;12.12.2014;NA;Interventional;Not Applicable;20000;Active, not recruiting;Evaluation of California's Armed and Prohibited Persons System;2015-02-01T00:00:00Z;2022-12-31T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2022;2016;UCD;;Emmanuel
275;104;NCT01812837;1;3;27730625;22.12.2016;28514458 reports another trial ID;24.05.2017;13.03.2013;02.12.2016;Interventional;Not Applicable;51;Completed;The Use of Microneedles in Photodynamic Therapy;2012-07-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2014;2014;UCD;;Emmanuel
768;91;NCT01879826;1;1;27749608;01.01.2017;;13.01.2020;13.06.2013;24.10.2016;Interventional;Not Applicable;81;Completed;Pediatric Laser Acupuncture and Renal Biopsy;2013-07-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCSF;;Stefanie
341;391;NCT02062853;1;3;27778164;24.10.2016;;17.07.2017;26.11.2013;NA;Interventional;Not Applicable;44;Completed;Continuous Quality Improvement (CQI) Pilot Study Evaluating the Utility of an Educational Video;2012-11-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2016;2016;UCD;;Susanne
765;81;NCT00997035;1;3;27787540;01.12.2016;Unsure about this one. This study has MUTTI and MUTTII but this publication uses the NCT number of MUTTI but number of enrollment matches - publication seems to cite wrong registration, intervention etc. do match our trial;04.02.2019;14.10.2009;09.06.2016;Interventional;Phase 3;240;Completed;The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo;2010-05-01T00:00:00Z;2016-03-01T00:00:00Z;2016-01-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;Proctor Foundation, UCSF;NA;NA;NA;NA;NA;NA;NA;NA;2009;2010;2016;2016;UCSF;;Stefanie
914;648;NCT01670175;1;3;27793021;04.04.2017;reports trial identifier in full text but not found in Google via this ID;20.06.2017;17.08.2012;NA;Interventional;Phase 1;21;Completed;Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors;2012-08-01T00:00:00Z;2016-09-01T00:00:00Z;2016-09-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2016;UCSF;;Emmanuel
631;90;NCT01123161;1;1;27834742;10.11.2016;;18.02.2017;27.04.2010;29.09.2016;Interventional;Phase 2/Phase 3;120;Terminated;The Intravascular Cooling in the Treatment of Stroke 2/3 Trial;2010-06-01T00:00:00Z;2015-05-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;NA;NA;NA;NA;NA;University of California, San Diego;NA;NA;NA;2010;2010;2015;2015;UCSD;;Susanne
817;238;NCT00773604;1;1;27903810;30.11.2016;sample size deviation, however other aspects similar with mention of NCT;12.02.2019;07.10.2008;18.12.2018;Interventional;Not Applicable;9;Completed;Deep Brain Stimulation in Patients With Dystonia;2008-06-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2015;2015;UCSF;;Samruddhi
528;459;NCT01382069;1;1;27907978;01.12.2016;first reported trial has sample size deviation, hence next considered - since trial ID mentioned sample size deviation is ok, first one chosen (SW);29.06.2017;25.03.2011;NA;Interventional;Phase 1;100;Completed;Phase 1 Study of Dimethandrolone Undecanoate in Healthy Men;2012-03-01T00:00:00Z;2017-05-01T00:00:00Z;2017-02-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;TRUE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2017;2017;UCLA;;Samruddhi
874;609;NCT00947206;1;1;27986352;13.12.2016;;06.05.2014;24.07.2009;NA;Interventional;Not Applicable;909;Completed;Lay Health Workers and Colorectal Cancer Screening Among Chinese Americans;2009-09-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;2014;UCSF;;Mario
1029;757;NCT02861352;1;1;28003206;21.12.2016;;20.11.2020;04.08.2016;NA;Interventional;Not Applicable;18;Completed;An Evaluation of Zinc Status Biomarkers;2011-03-01T00:00:00Z;2015-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2016;2011;2015;2014;UCSF;;Samruddhi
656;264;NCT02330627;1;3;28060463;06.01.2017;;05.11.2021;24.12.2014;01.05.2019;Interventional;Not Applicable;29;Completed;Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes;2014-04-01T00:00:00Z;2016-03-01T00:00:00Z;2015-07-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2015;UCSD;;Samruddhi
906;641;NCT01557608;1;3;28063866;04.01.2017;;10.01.2020;28.02.2012;NA;Interventional;Not Applicable;754;Completed;Characterization and Treatment of Chemotherapy Neuropathy;2012-04-01T00:00:00Z;2015-12-08T00:00:00Z;2015-12-08T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCSF;;Susanne
848;323;NCT01784419;1;1;28068001;09.01.2017;;08.09.2020;03.02.2013;24.08.2020;Interventional;Not Applicable;10;Completed;Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients;2013-10-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCSF;;Nicole
458;132;NCT01983930;1;1;28088925;16.01.2017;;14.12.2017;30.10.2013;10.04.2017;Interventional;Not Applicable;81;Completed;Memory Training Versus Yogic Meditation Training in Older Adults With Mild Cognitive Impairment;2013-09-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;UCLA Semel Institute;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCLA;;Susanne
572;501;NCT02025998;1;3;28091532;16.01.2017;found through linked study;19.02.2016;19.12.2013;NA;Interventional;Phase 1;24;Completed;Development of Ibudilast for Alcohol Use Disorder;2013-12-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCLA;;Mario
459;137;NCT02437253;1;3;28119823;15.01.2017;no NCT-ID;16.08.2017;05.05.2015;03.05.2017;Interventional;Phase 1/Phase 2;2;Completed;Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI;2015-05-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCLA;;Susanne
544;473;NCT01683643;1;1;28132701;30.12.2016;;09.05.2017;05.09.2012;NA;Interventional;Not Applicable;800;Completed;Screening, Brief Intervention, and Referral to Treatment for Offenders;2012-04-01T00:00:00Z;2017-03-31T00:00:00Z;2017-03-31T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCLA Integrated Substance Abuse Programs;NA;NA;NA;NA;UCLA Integrated Substance Abuse Programs;NA;NA;NA;2012;2012;2017;2017;UCLA;;Stefanie
1006;735;NCT02480257;1;3;28138319;16.01.2017;;11.06.2017;10.06.2015;NA;Interventional;Not Applicable;26;Completed;UCSF TARA Study: Training for Awareness, Resilience and Action;2014-01-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2015;2015;UCSF;;Samruddhi
908;642;NCT01594918;1;3;28161323;01.02.2017;;20.07.2017;07.05.2012;NA;Interventional;Phase 1;25;Completed;Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer;2012-06-01T00:00:00Z;2017-06-23T00:00:00Z;2016-08-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2012;2012;2017;2016;UCSF;;Susanne
741;596;NCT02671734;1;3;28191495;01.01.2017;;29.01.2016;25.01.2016;NA;Interventional;Not Applicable;77;Completed;Improving the Informed Consent Process for Youth Undergoing Pediatric Endoscopy and Their Parents;2014-06-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);INDIV;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2016;2014;2014;2014;UCSD;;Nicole
953;685;NCT01967992;1;1;28193599;13.02.2017;;12.10.2015;18.10.2013;NA;Interventional;Phase 2;25;Completed;Examining the Effects of Diet on Health With an Online Program;2013-10-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCSF;;Mario
985;714;NCT02242890;1;3;28237522;10.02.2017;;15.09.2015;15.09.2014;NA;Interventional;Not Applicable;40;Completed;Pilot #2 of Social Network Intrauterine Contraceptive (IUC) Intervention;2015-02-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2015;2015;UCSF;;Susanne
947;679;NCT01931553;1;1;28272589;01.03.2017;;14.05.2015;16.08.2013;NA;Interventional;Not Applicable;1200;Completed;A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine;2013-09-01T00:00:00Z;2014-12-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCSF;;Nicole
840;304;NCT03040466;1;3;28287823;13.03.2017;;09.09.2020;23.01.2017;31.01.2020;Interventional;Not Applicable;180;Completed;Comparing Treatment of Urolithiasis Between Disposable and Reusable Ureteroscope;2014-08-01T00:00:00Z;2016-09-01T00:00:00Z;2016-09-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Urology, University of California San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2017;2014;2016;2016;UCSF;;Nicole
898;633;NCT01474382;1;3;28292340;15.01.2017;;28.08.2014;11.11.2011;NA;Interventional;Phase 4;150;Completed;Study of OraVerse for Safety and Efficacy in Pediatric Dental Patients;2012-02-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;Triple;INDUSTRY;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2014;2014;UCSF;;Stefanie
782;148;NCT01869699;1;3;28319467;01.07.2017;;11.07.2017;31.05.2013;09.06.2017;Interventional;Phase 4;41;Completed;Effects of Intravenous Acetaminophen on Body Temperature and Hemodynamic Responses in Febrile Critically Ill Adults;2013-09-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCSF;;Stefanie
679;303;NCT02662023;1;3;28319550;01.04.2017;;24.02.2021;20.01.2016;29.01.2020;Interventional;Phase 4;24;Completed;Continuous TAP Blocks: Relative Effects of a Basal Infusion vs. Repeated Bolus Doses;2016-02-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2016;2016;UCSD;;Samruddhi
389;120;NCT02259699;1;3;28330753;19.03.2017;;08.03.2019;15.05.2014;21.02.2017;Interventional;Not Applicable;124;Completed;Ovarian Cancer Patient-Centered Decision Aid;2014-12-01T00:00:00Z;2016-12-31T00:00:00Z;2016-12-31T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCI;;Samruddhi
869;605;NCT00720733;1;1;28333512;23.03.2017;;05.03.2015;21.07.2008;NA;Interventional;Not Applicable;160;Completed;Intervention for (Those) Recently Informed of Seropositive Status (IRISS);2008-09-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2014;2014;UCSF;;Samruddhi
787;163;NCT01327274;1;3;28342579;15.03.2017;;09.10.2018;30.03.2011;24.10.2017;Interventional;Not Applicable;15;Completed;Multicenter Trial of Magnetic Mini-Mover for Pectus Excavatum;2011-12-01T00:00:00Z;2018-05-01T00:00:00Z;2016-11-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2011;2011;2018;2016;UCSF;;Mario
441;73;NCT00794508;1;1;28346229;27.03.2017;;21.04.2021;19.11.2008;09.03.2016;Interventional;Phase 2;10;Completed;MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID;2008-11-01T00:00:00Z;2015-01-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2015;2014;UCLA;;Susanne
965;697;NCT02083744;1;2;28348704;20.07.2014;;13.02.2020;25.02.2014;NA;Interventional;Not Applicable;42;Completed;Project Fluido: Fluid Watchers;2013-06-01T00:00:00Z;2014-12-22T00:00:00Z;2014-12-22T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2014;2014;UCSF;;Mario
758;61;NCT01930435;1;3;28353039;28.03.2017;;11.07.2017;20.08.2013;01.12.2015;Interventional;Not Applicable;20;Completed;Study of Personalized Sterile Humidification Device for Mucositis in Head and Neck Cancer Patients;2013-07-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCSF;;Mario
969;701;NCT02105779;1;1;28368179;01.03.2017;;03.04.2019;11.03.2014;NA;Interventional;Not Applicable;172;Completed;Optimizing Cognitive Remediation Outcomes in Schizophrenia;2009-12-01T00:00:00Z;2016-07-26T00:00:00Z;2016-05-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2009;2016;2016;UCSF;;Stefanie
938;670;NCT01874977;1;1;28378441;06.12.2017;;10.05.2016;05.06.2013;NA;Interventional;Not Applicable;96;Completed;Trial of a Physical Activity Intervention for RA Fatigue;2013-11-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCSF;;Samruddhi
723;578;NCT02136212;1;3;28384621;31.03.2017;Unsure if this is the right publication;31.08.2017;08.05.2014;NA;Interventional;Not Applicable;57;Completed;Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia;2013-04-01T00:00:00Z;2016-09-01T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2016;2016;UCSD;;Stefanie
541;470;NCT01627366;1;2;28418767;18.04.2017;;29.07.2016;04.06.2012;NA;Interventional;Not Applicable;500;Completed;Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors;2012-08-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCLA;;Stefanie
989;718;NCT02261740;1;2;28419385;01.10.2017;;30.09.2016;01.10.2014;NA;Interventional;Not Applicable;16;Completed;Program to Overcome Pelvic Pain With Yoga;2014-10-01T00:00:00Z;2016-06-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSF;;Susanne
303;341;NCT01716195;1;1;28434660;20.04.2017;;24.02.2021;25.10.2012;21.12.2020;Interventional;Phase 2;18;Completed;Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer;2012-10-01T00:00:00Z;2020-10-01T00:00:00Z;2017-03-08T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2020;2017;UCD;;Nicole
903;638;NCT01535508;1;2;28437142;16.02.2017;;08.10.2019;14.02.2012;NA;Interventional;Phase 2/Phase 3;10;Completed;Open Label Clinical Trial of Vitamin D in Children With Autism;2012-02-01T00:00:00Z;2015-12-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCSF;;Susanne
776;139;NCT02344316;1;2;28437521;01.06.2017;;13.08.2021;12.01.2015;05.05.2017;Interventional;Phase 2;31;Completed;Bringing Relief to Adolescents Naturally Using Melatonin for Migraine;2015-05-01T00:00:00Z;2016-04-01T00:00:00Z;2016-04-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSF;;Samruddhi
313;363;NCT01261299;1;3;28437852;15.05.2017;;05.01.2018;09.12.2010;NA;Interventional;Early Phase 1;21;Terminated;Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer;2010-12-01T00:00:00Z;2016-11-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;NA;NA;NA;University of California, Davis;NA;NA;NA;NA;NA;2010;2010;2016;2016;UCD;;Samruddhi
1036;764;NCT03115372;1;3;28440872;25.04.2017;unsure. No trial id, only subgroup (each ethnic group separately published?) 27564924 is mentioned in a review as well but cites another registration;27.07.2020;11.04.2017;NA;Interventional;Not Applicable;982;Completed;Lay Health Worker Outreach in Increasing Colorectal Cancer Screening in Asian Americans;2012-02-01T00:00:00Z;2015-09-01T00:00:00Z;2015-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2017;2012;2015;2015;UCSF;;Nicole
455;118;NCT01608295;1;2;28444658;25.04.2017;;12.04.2018;25.05.2012;01.02.2017;Interventional;Phase 4;65;Completed;Vilazodone for Treatment of Geriatric Depression;2012-07-01T00:00:00Z;2015-09-01T00:00:00Z;2015-09-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCLA;;Mario
548;477;NCT01720654;1;1;28468648;04.05.2017;;04.08.2014;29.10.2012;NA;Interventional;Not Applicable;165;Completed;Expedited Partner Therapy for MSM in Peru;2012-08-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCLA;;Stefanie
469;161;NCT00955968;1;1;28489856;10.05.2017;;12.11.2021;07.08.2009;30.08.2017;Interventional;Phase 4;1653;Completed;IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women;2010-01-01T00:00:00Z;2016-08-31T00:00:00Z;2016-08-31T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;NA;NA;2009;2010;2016;2016;UCLA;;Emmanuel
993;722;NCT02327559;1;1;28499376;12.05.2017;;23.05.2017;23.06.2014;NA;Interventional;Not Applicable;33;Completed;Prenatal Education About Reducing Labor Stress (PEARLS);2011-10-01T00:00:00Z;2015-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2011;2015;2014;UCSF;;Stefanie
962;694;NCT02028533;1;3;28503120;25.05.2016;sample size deviation within limit, TRN and outcome similar;17.05.2019;03.01.2014;NA;Interventional;Phase 1;30;Completed;Cocaine Opioid Oxytocin Option - Limited;2014-07-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2014;2014;2014;2014;UCSF;;Samruddhi
289;166;NCT02594644;1;1;28514458;01.07.2017;;30.10.2018;31.10.2015;03.11.2017;Interventional;Not Applicable;32;Completed;The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy;2014-11-06T00:00:00Z;2016-06-22T00:00:00Z;2016-06-22T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2016;2016;UCD;;Nicole
857;336;NCT02611882;1;1;28522741;18.05.2017;;26.11.2020;29.09.2015;03.11.2020;Interventional;Phase 2;225;Completed;Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients;2015-12-18T00:00:00Z;2016-10-24T00:00:00Z;2016-10-24T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSF;;Nicole
498;306;NCT01129440;1;1;28526003;19.05.2017;;20.02.2020;21.05.2010;10.02.2020;Interventional;Phase 2;597;Completed;Glass Ionomer Sealant and Fluoride Varnish Study to Prevent Early Childhood Caries;2011-06-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;2010;2011;2016;2016;UCLA, UCSF;;Stefanie
461;140;NCT02377063;1;2;28526852;19.05.2017;;06.08.2019;18.02.2015;17.05.2017;Interventional;Not Applicable;25;Completed;The Effect of Fruit/Vegetable Drinks on the Human Intestine;2015-04-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCLA Department of Medicine, Division of Clinical Nutrition;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2015;2015;UCLA;;Nicole
554;483;NCT01762553;1;1;28530433;22.05.2017;;16.02.2016;04.01.2013;NA;Interventional;Not Applicable;1533;Completed;TEA for Families and Children: A Randomized Intervention Trial;2011-05-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;NPI-Center for Community Health, UCLA;NA;NA;NA;NA;NA;NA;NA;NA;2013;2011;2015;2015;UCLA;;Nicole
987;716;NCT02256592;1;2;28541799;25.05.2017;;02.05.2017;01.10.2014;NA;Interventional;Phase 1;18;Completed;Fecal Microbiota Transplantation in HIV;2014-10-01T00:00:00Z;2017-03-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSF;;Stefanie
887;622;NCT01350011;1;1;28549161;02.04.2018;;08.11.2018;05.05.2011;NA;Interventional;Phase 3;175;Completed;Tobacco Intervention in Buprenorphine Treatment;2011-04-01T00:00:00Z;2016-12-01T00:00:00Z;2016-04-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2016;2016;UCSF;;Mario
988;717;NCT02257203;1;2;28553726;29.05.2017;;16.09.2016;24.09.2014;NA;Interventional;Not Applicable;82;Completed;Primary Care Beverage Study;2014-10-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCSF;;Susanne
696;553;NCT01197443;1;1;28558104;01.07.2017;;30.11.2015;17.08.2010;NA;Interventional;Not Applicable;152;Completed;Parents as the Agent of Change for Childhood Obesity;2010-11-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;2015;UCSD;;Stefanie
357;407;NCT02457338;1;1;28558732;30.05.2017;;09.08.2021;27.05.2015;NA;Interventional;Not Applicable;120;Active, not recruiting;Infant Microbiota and Probiotic Intake Study;2014-11-01T00:00:00Z;2027-06-07T00:00:00Z;2016-07-15T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2027;2016;UCD;;Nicole
992;721;NCT02323893;1;3;28572504;01.06.2017;;14.05.2018;16.12.2014;NA;Interventional;Phase 1;6;Completed;Study of Kinetics, Dosimetry & Safety of [18F]F-AraG, a Positron Emission Tomography Imaging Tracer in Healthy Humans;2015-02-01T00:00:00Z;2017-12-31T00:00:00Z;2017-12-31T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;2017;UCSF;;Stefanie
880;615;NCT01200043;1;1;28579536;01.06.2017;both studies have TRN, but latter asseses the outcome mentioned in registry more clearly;07.05.2018;09.09.2010;NA;Interventional;Not Applicable;54;Completed;Metabolic Impact of Fructose Restriction in Obese Children;2010-07-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;2014;UCSF;;Samruddhi
136;249;NCT01120639;1;3;28586949;07.02.2017;The primary outcomes of this institutional review board approved prospective phase 1/2 trial are pending;04.08.2021;07.05.2010;07.02.2019;Interventional;Phase 1/Phase 2;30;Completed;Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform;2010-04-01T00:00:00Z;2020-11-15T00:00:00Z;2016-11-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2020;2016;Stanford;;Samruddhi
318;368;NCT01540318;1;1;28609532;13.06.2017;;15.01.2019;31.01.2012;NA;Interventional;Not Applicable;925;Completed;Utility of Abdominal Ultrasound in the Evaluation of Children With Blunt Trauma;2012-02-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UC Davis School of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2016;UCD;;Nicole
994;723;NCT02341027;1;1;28610898;10.06.2017;;11.02.2020;09.01.2015;NA;Interventional;Not Applicable;205;Completed;Immediate Versus Interval Postpartum Use of the Levonorgestrel Contraceptive Implants: a Randomized Controlled Trial;2015-01-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSF;;Nicole
622;49;NCT00958217;1;1;28632462;20.06.2017;;22.02.2016;11.08.2009;26.06.2015;Interventional;Not Applicable;154;Completed;Intervention for Veterans With Depression, Substance Disorder, and Trauma;2009-12-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;None (Open Label);FED;FALSE;VA San Diego Healthcare System, San Diego/University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;2014;UCSD;;Nicole
773;123;NCT00265850;1;1;28632865;20.06.2017;;28.04.2020;14.12.2005;13.03.2017;Interventional;Phase 3;2334;Completed;Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer;2005-11-01T00:00:00Z;2018-01-01T00:00:00Z;2015-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2005;2005;2018;2015;UCSF;;Nicole
846;319;NCT01637402;1;1;28655452;03.06.2017;;03.08.2020;06.07.2012;07.07.2020;Interventional;Phase 2;41;Completed;A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer;2013-03-13T00:00:00Z;2017-02-27T00:00:00Z;2017-02-27T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2012;2013;2017;2017;UCSF;;Nicole
709;566;NCT01693874;1;1;28686822;01.07.2017;;21.07.2014;29.03.2012;NA;Interventional;Phase 1/Phase 2;103;Completed;Mindfulness-based Stress Reduction and Cognitive Function in Stress and Aging;2011-10-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2014;2014;UCSD;;Susanne
922;655;NCT01751685;1;1;28689306;08.07.2017;;05.08.2019;03.12.2012;NA;Interventional;Not Applicable;99;Completed;Study of Hyperkyphosis, Exercise and Function-SHEAF;2013-02-01T00:00:00Z;2019-05-31T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2019;2016;UCSF;;Nicole
635;136;NCT02508259;1;1;28695149;26.05.2017;;21.06.2019;22.07.2015;01.05.2017;Interventional;Phase 1/Phase 2;10;Completed;University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial;2015-05-01T00:00:00Z;2016-04-01T00:00:00Z;2016-03-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSD;;Samruddhi
311;362;NCT01079247;1;1;28697050;01.10.2017;;19.07.2021;26.02.2010;NA;Interventional;Not Applicable;347;Completed;A Trial of Restrictive Versus Traditional Blood Transfusion Practices in Burn Patients;2010-02-28T00:00:00Z;2016-09-28T00:00:00Z;2016-09-28T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2016;2016;UCD;;Samruddhi
;299;NCT02603926;1;3;28707277;01.10.2017;;13.11.2018;05.11.2015;17.10.2018;Interventional;Phase 2;6;Completed;Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone;2015-10-01T00:00:00Z;2017-12-01T00:00:00Z;2016-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UC Davis MIND Institute;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2016;UCD;1;
769;99;NCT02023918;1;2;28713554;03.05.2017;;20.04.2017;24.12.2013;09.11.2016;Interventional;Phase 2;6;Completed;Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes;2014-01-01T00:00:00Z;2015-12-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2015;2015;UCSF;;Stefanie
822;248;NCT00221338;1;1;28727581;01.10.2017;;25.08.2020;19.09.2005;05.02.2019;Interventional;Phase 3;750;Completed;Clinical Trial of Gabapentin to Decrease Postoperative Delirium and Pain;2006-01-01T00:00:00Z;2014-07-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Francisco, CA, USA;NA;NA;NA;NA;NA;NA;NA;NA;2005;2006;2014;2014;UCSF;;Samruddhi
282;124;NCT01676714;1;2;28736761;25.07.2017;;05.01.2018;27.08.2012;17.03.2017;Interventional;Phase 2;10;Completed;Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer;2013-02-01T00:00:00Z;2016-06-01T00:00:00Z;2016-01-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2016;2016;UCD;;Nicole
545;474;NCT01687634;1;1;28755042;01.12.2017;;12.05.2017;07.09.2012;NA;Interventional;Not Applicable;203;Completed;Home Visiting for Low Income, Pregnant Women;2012-10-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2016;UCLA;;Susanne
780;146;NCT00823459;1;3;28759109;31.07.2017;;24.07.2020;13.01.2009;24.05.2017;Interventional;Phase 2;58;Completed;Everolimus in Treating Patients With Recurrent Low-Grade Glioma;2009-01-23T00:00:00Z;2017-11-13T00:00:00Z;2017-06-12T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2017;2017;UCSF;;Stefanie
337;387;NCT01925248;1;2;28761664;07.07.2017;;24.05.2017;31.07.2013;NA;Interventional;Not Applicable;32;Completed;Can Whey Protein Improve Glycemic Control in Type 2 Diabetes?;2013-07-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCD;;Susanne
788;164;NCT01693250;1;1;28768612;02.08.2017;PILOT;09.08.2019;19.09.2012;24.10.2017;Interventional;Not Applicable;40;Completed;iStart Smart for Teens for Healthy Weight Management;2015-04-01T00:00:00Z;2016-12-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2015;2016;2016;UCSF;;Emmanuel
601;529;NCT02620488;1;2;28769584;14.07.2017;;01.05.2017;05.10.2015;NA;Interventional;Not Applicable;28;Completed;A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease;2015-09-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Non-Randomized;Single;OTHER;FALSE;UCLA Pediatric Pain and Palliative Care Program;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2015;2015;UCLA;;Susanne
;416;NCT02086123;1;3;28782603;03.08.2017;;23.04.2021;20.11.2013;NA;Interventional;Not Applicable;87;Completed;Randomized Study Comparing the Use of Epidural Analgesia to Intravenous Narcotics for Laparoscopic Colorectal Resection.;2012-05-01T00:00:00Z;2015-04-01T00:00:00Z;2015-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2015;2015;UCI;1;
611;539;NCT02898844;1;2;28810464;02.06.2017;;12.09.2016;08.09.2016;NA;Interventional;Not Applicable;164;Completed;Randomized Controlled Experiment of Dieting in Pairs;2013-10-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2013;2014;2014;UCLA;;Samruddhi
929;661;NCT01819987;1;3;28826348;08.07.2017;TRN not mentioned, similar PICO;09.05.2017;18.03.2013;NA;Interventional;Phase 1/Phase 2;32;Completed;HomeTech Healthy Lifestyle Program for Mothers With Young Children;2014-01-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2016;2016;UCSF;;Samruddhi
1035;763;NCT03113526;1;1;28837725;01.12.2017;;06.12.2017;10.04.2017;NA;Interventional;Not Applicable;53;Completed;Neck Drains for SLNDs;2015-12-01T00:00:00Z;2017-01-11T00:00:00Z;2017-01-03T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2017;2015;2017;2017;UCSF;;Emmanuel
565;494;NCT01942811;1;1;28844733;13.06.2017;;08.01.2015;06.09.2013;NA;Interventional;Not Applicable;134;Completed;BiNational Quit Using Drugs Intervention Trial;2013-02-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCLA;;Emmanuel
574;503;NCT02084316;1;1;28867267;31.08.2017;;16.08.2016;07.03.2014;NA;Interventional;Phase 2/Phase 3;360;Completed;Testing and Linkage to HIV Care in China;2014-03-01T00:00:00Z;2016-01-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2014;UCLA;;Samruddhi
1022;751;NCT02694731;1;1;28918456;16.09.2017;;05.05.2017;24.02.2016;NA;Interventional;Not Applicable;104;Completed;A Mindfulness Mobile Intervention Targeting Reductions in Food Cravings;2016-02-01T00:00:00Z;2016-11-30T00:00:00Z;2016-11-29T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2016;2016;UCSF;;Emmanuel
794;186;NCT01941927;1;1;28921907;02.11.2017;;31.01.2020;30.08.2013;28.02.2018;Interventional;Phase 2;20;Completed;Trametinib With GSK2141795 in BRAF Wild-type Melanoma;2013-09-10T00:00:00Z;2017-05-03T00:00:00Z;2014-10-14T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2014;UCSF;;Samruddhi
764;77;NCT01624948;1;3;28923623;01.10.2017;;01.07.2016;15.06.2012;12.04.2016;Interventional;Phase 4;40;Completed;Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients;2012-09-01T00:00:00Z;2015-11-01T00:00:00Z;2015-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCSF;;Stefanie
761;70;NCT01535235;1;3;28936485;02.08.2017;;12.05.2016;09.02.2012;01.03.2016;Interventional;Phase 4;31;Completed;ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study;2012-02-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSF;;Nicole
766;84;NCT01281475;1;2;28944563;25.09.2017;;04.07.2020;20.01.2011;06.08.2016;Interventional;Phase 2/Phase 3;67;Completed;A Trial of Levodopa in Angelman Syndrome;2011-01-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSF;;Stefanie
771;112;NCT01327651;1;1;28986029;03.10.2017;trial had 3 sites, this earliest publiation, but 2 other sties reported in: 29420695;08.08.2017;01.12.2010;05.01.2017;Interventional;Phase 2;622;Completed;The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP);2011-08-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2010;2011;2014;2014;UCSF;;Mario
801;203;NCT02040298;1;1;29029896;10.10.2017;;22.09.2021;10.01.2014;21.05.2018;Interventional;Phase 2;50;Completed;Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple Sclerosis;2014-01-01T00:00:00Z;2016-04-01T00:00:00Z;2015-09-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2015;UCSF;;Stefanie
920;653;NCT01728961;1;2;29065172;24.10.2017;;16.05.2014;12.09.2012;NA;Interventional;Phase 4;19;Terminated;Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy;2012-02-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);NETWORK;TRUE;IMPAACT/UCSF;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSF;;Nicole
470;162;NCT02819050;1;1;29072676;26.10.2017;;08.12.2021;24.05.2016;12.10.2017;Interventional;Not Applicable;80;Completed;Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants;2014-01-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2014;2016;2016;UCLA;;Stefanie
791;175;NCT02605304;1;1;29091342;05.12.2017;;02.04.2018;12.11.2015;10.01.2018;Interventional;Phase 2;7;Terminated;12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF;2016-02-17T00:00:00Z;2017-03-20T00:00:00Z;2017-01-20T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of California, San Francisco HIV/AIDS CRS;NA;NA;NA;NA;NA;2015;2016;2017;2017;UCSF;;Emmanuel
419;433;NCT02258425;1;1;29095374;01.11.2017;;16.06.2017;02.10.2014;NA;Interventional;Not Applicable;130;Completed;Homeless Female Offenders Returning to the Community;2015-01-01T00:00:00Z;2016-11-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCLA/UCI;UCLA/UCI;NA;NA;NA;NA;NA;NA;NA;2014;2015;2016;2016;UCI, UCLA;;Stefanie
934;666;NCT01835665;1;2;29124108;12.09.2017;;12.05.2016;27.03.2013;NA;Interventional;Phase 1;8;Completed;Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations;2013-03-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCSF;;Susanne
204;351;NCT01911039;1;3;29128554;08.11.2017;;20.09.2021;15.07.2013;NA;Interventional;Phase 1;14;Completed;Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD;2013-07-01T00:00:00Z;2018-07-31T00:00:00Z;2017-12-31T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2018;2017;Stanford;;Mario
532;463;NCT01409642;1;1;29173737;14.10.2017;;18.05.2021;12.10.2010;NA;Interventional;Not Applicable;62;Completed;Family Focused Treatment of Pediatric Obsessive Compulsive Disorder;2008-01-01T00:00:00Z;2016-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2010;2008;2016;2015;UCLA;;Susanne
632;113;NCT01116921;1;1;29174079;22.11.2017;;06.01.2017;03.05.2010;06.01.2017;Interventional;Not Applicable;103;Completed;Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates;2011-02-01T00:00:00Z;2015-04-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2015;2015;UCSD;;Samruddhi
1008;737;NCT02494024;1;3;29181488;29.11.2017;not sure. One more dosing group. All other parameters seem to match;25.07.2017;30.06.2015;NA;Interventional;Phase 1;32;Completed;Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy;2015-07-01T00:00:00Z;2016-08-01T00:00:00Z;2016-08-01T00:00:00Z;FALSE;Randomized;Quadruple;INDUSTRY;TRUE;UCSF Memory and Aging Center;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSF;;Samruddhi
442;78;NCT00355056;1;1;29191325;05.12.2017;;14.07.2020;19.07.2006;02.05.2016;Interventional;Not Applicable;230;Completed;PREMIUM Migraine Trial;2006-01-01T00:00:00Z;2015-12-01T00:00:00Z;2015-02-01T00:00:00Z;TRUE;Randomized;Triple;INDUSTRY;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2006;2006;2015;2015;UCLA;;Emmanuel
973;705;NCT02124252;1;1;29197067;03.01.2018;;09.04.2019;24.04.2014;NA;Interventional;Not Applicable;7200;Completed;Community-Driven Cervical Cancer Prevention in Western Kenya;2016-01-01T00:00:00Z;2019-03-01T00:00:00Z;2016-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2016;2019;2016;UCSF;;Mario
327;377;NCT01766674;1;1;29202732;04.12.2017;;12.11.2019;09.01.2013;NA;Interventional;Not Applicable;112;Completed;Specialized Centers of Research (SCOR)on Sex Differences - Kyphosis Study;2013-02-01T00:00:00Z;2016-05-31T00:00:00Z;2016-05-31T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UC Davis;NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2013;2013;2016;2016;UCD, UCSF;;Stefanie
736;591;NCT02501889;1;1;29202751;04.12.2017;;24.10.2017;09.07.2015;NA;Interventional;Not Applicable;100;Completed;The Lean Living Study;2015-08-01T00:00:00Z;2017-06-01T00:00:00Z;2017-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSD;;Nicole
268;67;NCT01828593;1;2;29210625;01.11.2017;;25.05.2017;08.04.2013;09.02.2016;Interventional;Not Applicable;103;Completed;Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy;2013-04-01T00:00:00Z;2014-09-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCD;;Mario
477;172;NCT01383161;1;3;29246725;27.10.2017;;28.02.2020;22.06.2011;04.01.2018;Interventional;Phase 2;46;Completed;18-Month Study of Memory Effects of Curcumin;2012-03-01T00:00:00Z;2017-04-01T00:00:00Z;2017-04-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;UCLA Longevity Center;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2017;2017;UCLA;;Samruddhi
661;271;NCT01062568;1;3;29264508;12.04.2017;;08.08.2019;03.02.2010;10.06.2019;Interventional;Phase 3;50;Completed;The Adrenal Contribution to Androgen Production in Girls During Puberty;2010-02-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;2014;UCSD;;Stefanie
490;242;NCT02026011;1;1;29265379;01.02.2018;;27.06.2019;30.12.2013;08.01.2019;Interventional;Phase 2;87;Completed;Naltrexone for Individuals of East Asian Descent;2013-12-01T00:00:00Z;2016-09-01T00:00:00Z;2016-09-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCLA;;Susanne
804;219;NCT02282293;1;1;29272443;05.03.2018;;11.02.2019;30.10.2014;19.09.2018;Interventional;Phase 3;200;Completed;Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2);2014-12-09T00:00:00Z;2016-05-26T00:00:00Z;2016-05-26T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSF;;Nicole
272;89;NCT01576055;1;3;29285955;29.12.2017;no NCT-ID;08.09.2017;29.03.2012;24.08.2016;Interventional;Not Applicable;267;Completed;Evaluation of the GORE TIGRIS Vascular Stent;2012-04-01T00:00:00Z;2017-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;Randomized;None (Open Label);INDUSTRY;TRUE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2017;2015;UCD;;Susanne
;808;NCT02424097;1;3;29299732;04.01.2018;;08.04.2020;15.04.2015;29.10.2018;Interventional;Phase 4;40;Completed;MI Varnish and MI Paste Plus in a Caries Prevention and Remineralization Study;2013-05-01T00:00:00Z;2016-10-01T00:00:00Z;2016-10-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2013;2016;2016;UCSF;1;
1012;741;NCT02535767;1;1;29342267;28.03.2018;;02.02.2017;07.08.2015;NA;Interventional;Phase 1/Phase 2;28;Completed;Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali;2015-08-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSF;;Samruddhi
970;702;NCT02106702;1;3;29345992;18.01.2018;;15.06.2015;01.04.2014;NA;Interventional;Not Applicable;271;Completed;The Navigator Project;2010-02-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2010;2014;2014;UCSF;;Samruddhi
879;614;NCT01176396;1;1;29355409;01.02.2018;;08.04.2020;04.08.2010;NA;Interventional;Not Applicable;460;Completed;CAMBRA - PBRN Caries Management By Risk Assessment In A Practice-Based Research Network;2012-04-01T00:00:00Z;2017-05-01T00:00:00Z;2017-01-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Francisco, School of Dentistry;NA;NA;NA;NA;NA;NA;NA;NA;2010;2012;2017;2017;UCSF;;Samruddhi
324;374;NCT01704105;1;1;29396219;29.01.2018;Many analyses on this dataset, it was difficult to select - comment SW would choose the same;10.07.2018;05.10.2012;NA;Interventional;Not Applicable;8246;Completed;WASH Benefits Kenya;2012-11-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2016;UCD;;Nicole
1027;755;NCT02831023;1;1;29422384;06.02.2018;;09.01.2017;06.07.2016;NA;Interventional;Phase 2;80;Completed;Phase 2 Efficacy Study of Primaquine and Methylene Blue;2016-07-01T00:00:00Z;2017-01-01T00:00:00Z;2017-01-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCSF;;Stefanie
657;266;NCT02662244;1;3;29436720;13.02.2018;;03.09.2019;25.01.2015;07.05.2019;Interventional;Not Applicable;33;Completed;Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma;2015-09-01T00:00:00Z;2016-09-01T00:00:00Z;2016-09-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSD;;Stefanie
1026;754;NCT02812914;1;1;29444650;14.02.2018;;25.10.2017;03.06.2016;NA;Interventional;Not Applicable;50;Completed;NACER II: Reducing Prenatal Exposures to Household Air Pollution in Rural Guatemala Through a Gas Stove/Behavior Intervention to Improve Neonatal Health;2016-04-01T00:00:00Z;2017-06-19T00:00:00Z;2017-06-19T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCSF;;Emmanuel
893;628;NCT01444183;1;1;29444968;14.02.2018;;17.04.2018;15.09.2011;NA;Interventional;Not Applicable;95;Completed;Stress Management Intervention for Living With Epilepsy (SMILE);2012-01-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2015;2015;UCSF;;Samruddhi
792;183;NCT02623855;1;1;29447248;15.02.2018;;20.11.2020;24.11.2015;15.02.2018;Interventional;Not Applicable;156;Completed;Stay Healthy In Nature Everyday: Family Nature Outings in a Low Income Population;2015-07-01T00:00:00Z;2017-01-01T00:00:00Z;2016-09-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2016;UCSF;;Mario
945;677;NCT01917994;1;1;29474546;16.08.2018;;06.02.2017;01.08.2013;NA;Interventional;Not Applicable;230;Completed;Text Messaging Intervention to Improve Retention in Care and Virologic Suppression in an Urban HIV-Infected Population;2013-08-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCSF;;Susanne
692;549;NCT00895258;1;1;29480043;25.02.2018;;18.06.2014;07.05.2009;NA;Interventional;Phase 2;163;Completed;Cognitive Training to Improve Work Outcomes in Severe Mental Illness;2008-04-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2009;2008;2014;2014;UCSD;;Stefanie
733;588;NCT02433691;1;1;29480182;27.02.2018;;30.04.2018;13.04.2015;NA;Interventional;Not Applicable;60;Completed;Memory and Exercise Training Study in Older Adults With Subjective Memory Complaints;2015-01-01T00:00:00Z;2017-06-01T00:00:00Z;2017-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSD;;Emmanuel
375;423;NCT03303456;1;3;29487044;27.02.2018;;02.10.2017;24.07.2017;NA;Interventional;Not Applicable;79;Completed;Using Mobile Technology to Enhance Early Psychosis Treatment Delivery;2014-12-14T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;UC Davis Dept of Psychiatry;NA;NA;NA;NA;NA;NA;NA;NA;2017;2014;2015;2015;UCD;;Mario
797;193;NCT02215161;1;1;29487219;27.02.2018;;29.05.2018;30.07.2014;26.04.2018;Interventional;Phase 2;14;Terminated;Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer;2014-09-02T00:00:00Z;2018-04-02T00:00:00Z;2017-02-15T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2018;2017;UCSF;;Samruddhi
1019;748;NCT02593253;1;1;29507124;05.03.2018;;05.05.2017;23.10.2015;NA;Interventional;Not Applicable;200;Completed;The Effect of a Novel Audit and Feedback Bundle on Inpatient Performance;2016-02-01T00:00:00Z;2017-05-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;2016;UCSF;;Emmanuel
286;131;NCT01811355;1;3;29510461;06.03.2018;;28.07.2017;06.03.2013;03.04.2017;Interventional;Phase 4;23;Completed;Mexiletine for the Treatment of Muscle Cramps in ALS;2013-05-01T00:00:00Z;2016-05-01T00:00:00Z;2016-03-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCD;;Samruddhi
310;361;NCT01008566;1;3;29520435;08.03.2018;;11.05.2016;05.11.2009;NA;Interventional;Phase 1;21;Completed;Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer;2009-08-01T00:00:00Z;NA;2016-05-01T00:00:00Z;FALSE;NA;None (Open Label);NIH;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;NA;2016;UCD;;Emmanuel
531;462;NCT01406626;1;1;29532059;01.04.2018;;16.11.2020;28.07.2011;NA;Interventional;Not Applicable;356;Completed;Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care;2012-12-01T00:00:00Z;2016-10-01T00:00:00Z;2016-10-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2016;2016;UCLA;;Stefanie
363;411;NCT02642666;1;3;29538185;01.04.2018;;24.05.2017;23.12.2015;NA;Interventional;Not Applicable;23;Completed;The Effects of Yoga on Attention, Impulsivity and Hyperactivity in Pre-school Age Children;2015-12-01T00:00:00Z;2016-08-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCD;;Mario
276;106;NCT00033631;1;1;29543933;14.06.2018;;02.07.2021;09.04.2002;16.12.2016;Interventional;Phase 3;1532;Active, not recruiting;Radiation Therapy in Treating Patients With Stage II Prostate Cancer;2002-03-01T00:00:00Z;NA;2014-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;UC Davis;NA;NA;NA;NA;NA;2002;2002;NA;2014;UCD;;Mario
990;719;NCT02313181;1;1;29550235;14.03.2018;;01.05.2018;05.12.2014;NA;Interventional;Not Applicable;328;Completed;Early Limited Formula for Treating Lactation Concerns;2015-01-07T00:00:00Z;2017-10-01T00:00:00Z;2017-03-30T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;2017;UCSF;;Emmanuel
640;197;NCT02516202;1;1;29554173;01.05.2018;;13.06.2018;03.08.2015;07.05.2018;Interventional;Phase 3;302;Completed;The Vaginal Health Trial;2016-04-01T00:00:00Z;2017-07-01T00:00:00Z;2017-05-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;2017;UCSD;;Susanne
638;177;NCT00766116;1;3;29572158;02.03.2018;;31.01.2019;02.10.2008;29.01.2018;Interventional;Phase 1/Phase 2;50;Completed;Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML);2005-07-01T00:00:00Z;2014-09-26T00:00:00Z;2014-09-26T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2008;2005;2014;2014;UCSD;;Samruddhi
691;548;NCT00860145;1;3;29600809;30.03.2018;reports trial identifier in full text but not found in Google via this ID. 31185129 is a health-economic publication;07.05.2018;11.03.2009;NA;Interventional;Not Applicable;61;Completed;Radiosurgery or Open Surgery for Epilepsy Trial;2009-09-01T00:00:00Z;2016-07-01T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;TRUE;University of California, San Diego;University of California, San Francisco;University of Southern California;University of California, San Francisco;NA;NA;NA;NA;NA;2009;2009;2016;2016;UCSD, UCSF, USC;;Emmanuel
634;133;NCT01155011;1;1;29609594;02.04.2018;;01.08.2017;30.06.2010;10.04.2017;Interventional;Not Applicable;307;Completed;Multilevel Intervention for Physical Activity in Retirement Communities;2011-01-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2014;2014;UCSD;;Susanne
481;202;NCT02488915;1;1;29643261;11.04.2018;;13.06.2018;30.06.2015;17.05.2018;Interventional;Not Applicable;228;Completed;Analysis of Revascularization in Ischemic Stroke With EmboTrap;2015-11-01T00:00:00Z;2017-09-01T00:00:00Z;2017-05-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;NA;NA;NA;NA;NA;UCLA, CA, USA.;NA;NA;NA;2015;2015;2017;2017;UCLA;;Mario
323;373;NCT01674231;1;1;29649425;09.04.2018;;25.05.2017;23.08.2012;NA;Interventional;Not Applicable;20;Completed;The Effects Grapes on Health Indices;2012-08-01T00:00:00Z;2015-04-01T00:00:00Z;2014-10-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2014;UCD;;Nicole
562;491;NCT01906424;1;2;29649928;15.09.2018;1 group instead of 3;20.01.2017;16.07.2013;NA;Interventional;Not Applicable;7;Completed;Restoring Arm and Hand Function With Non-invasive Spinal Stimulation;2016-04-01T00:00:00Z;2016-12-31T00:00:00Z;2016-12-31T00:00:00Z;FALSE;Randomized;Single;INDUSTRY;TRUE;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;NA;NA;2013;2016;2016;2016;UCLA;;Susanne
542;471;NCT01630434;1;1;29650408;09.04.2018;;10.09.2018;25.06.2012;NA;Interventional;Not Applicable;316;Completed;International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation;2011-11-01T00:00:00Z;2016-04-01T00:00:00Z;2014-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);INDUSTRY;TRUE;NA;NA;NA;NA;NA;Ronald Reagan Medical Center, UCLA;NA;NA;NA;2012;2011;2016;2014;UCLA;;Nicole
806;227;NCT03043885;1;2;29683498;01.04.2018;;14.11.2018;01.02.2017;17.10.2018;Interventional;Not Applicable;40;Completed;Ridge Preservation With Platelet Rich Fibrin Augmented With Freeze Dried Bone Allograft;2015-01-05T00:00:00Z;2017-03-01T00:00:00Z;2016-05-09T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2017;2015;2017;2016;UCSF;;Mario
668;279;NCT02384200;1;2;29684391;22.04.2018;;07.08.2019;22.02.2015;14.07.2019;Interventional;Phase 4;86;Completed;A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL]);2015-03-01T00:00:00Z;2019-06-01T00:00:00Z;2017-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;University of California, San Diego;NA;NA;NA;2015;2015;2019;2017;UCSD;;Susanne
730;585;NCT02303626;1;1;29688579;17.06.2018;;15.02.2016;24.11.2014;NA;Interventional;Phase 2/Phase 3;110;Completed;12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks;2014-11-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;FALSE;Randomized;Quadruple;INDUSTRY;TRUE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSD;;Mario
500;317;NCT00998010;1;2;29722661;06.01.2018;;26.08.2020;17.10.2009;19.06.2020;Interventional;Phase 2;24;Completed;Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma;2011-10-03T00:00:00Z;2018-04-20T00:00:00Z;2016-03-29T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Ronald Reagan UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2009;2011;2018;2016;UCLA;;Emmanuel
568;497;NCT01957748;1;2;29725790;01.08.2018;;08.12.2021;09.09.2013;NA;Interventional;Not Applicable;117;Completed;CCTG 594: Engagement and Retention in Care for HIV+;2013-10-08T00:00:00Z;2020-11-24T00:00:00Z;2017-12-15T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;CCTG, UCSD AVRC, UCSD Owen Clinic;NA;NA;CCTG, Harbor-UCLA;NA;NA;NA;NA;NA;2013;2013;2020;2017;UCLA, UCSD;;Nicole
471;167;NCT02539797;1;1;29734347;07.05.2018;;06.02.2018;26.08.2015;05.11.2017;Interventional;Not Applicable;37;Completed;Improving Cognition in Schizophrenia Using tDCS;2014-10-01T00:00:00Z;2016-10-01T00:00:00Z;2016-10-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2016;2016;UCLA;;Emmanuel
1039;767;NCT03457545;1;3;29742287;20.06.2018;;28.02.2018;20.02.2018;NA;Interventional;Not Applicable;26;Completed;Treating Frailty in Lung Transplant Candidates (PREHAB);2015-12-11T00:00:00Z;2017-12-14T00:00:00Z;2017-12-14T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2018;2015;2017;2017;UCSF;;Mario
535;466;NCT01470794;1;1;29762717;03.09.2018;;16.05.2018;04.11.2011;NA;Interventional;Phase 1;58;Completed;Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor;2012-02-01T00:00:00Z;2016-04-12T00:00:00Z;2016-04-12T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2016;2016;UCLA;;Susanne
1021;750;NCT02654743;1;1;29854372;30.05.2018;;04.03.2019;11.01.2016;NA;Interventional;Phase 3;21;Completed;Open Label of Clinical Trial of Sulforaphane in Children With Autism;2016-01-01T00:00:00Z;2016-09-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2016;2016;UCSF;;Samruddhi
885;620;NCT01307683;1;1;29859038;01.06.2018;;22.01.2021;19.01.2011;NA;Interventional;Not Applicable;202;Completed;Maternal, Adiposity, Metabolism, and Stress Study;2011-08-01T00:00:00Z;2015-12-01T00:00:00Z;2015-08-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSF;;Emmanuel
453;111;NCT01365819;1;1;29860057;25.05.2018;;17.01.2018;31.05.2011;05.01.2017;Interventional;Phase 2;52;Completed;Varenicline for Methamphetamine Dependence;2012-02-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;UCLA DGSOM Dept Of Family Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2014;2014;UCLA;;Mario
951;683;NCT01964820;1;1;29871853;05.06.2018;;29.12.2017;10.10.2013;NA;Interventional;Not Applicable;95;Completed;Online Positive Emotion Skills Intervention for Symptoms of Depression;2014-07-01T00:00:00Z;2016-08-01T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2016;2016;UCSF;;Emmanuel
298;218;NCT02012491;1;1;29874535;07.06.2018;;03.07.2019;10.12.2013;28.08.2018;Interventional;Phase 3;300;Completed;Comparative Effectiveness of Pregnancy Failure Management Regimens;2014-01-01T00:00:00Z;2019-06-15T00:00:00Z;2017-05-15T00:00:00Z;TRUE;Randomized;Double;OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2019;2017;UCD;;Nicole
503;325;NCT02879994;1;1;29874546;01.06.2018;;24.06.2021;23.08.2016;11.09.2020;Interventional;Phase 2;11;Completed;Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer;2016-09-15T00:00:00Z;2019-01-03T00:00:00Z;2017-11-30T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCLA / Jonsson Comprehensive Cancer Center;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2019;2017;UCLA;;Emmanuel
516;447;NCT01051037;1;3;29893274;21.03.2018;outcome: less follow-up but median follow up smaller than planned follow up time (2 vs. 3 years);03.05.2019;15.01.2010;NA;Interventional;Not Applicable;17;Completed;Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways;2010-02-08T00:00:00Z;2017-12-20T00:00:00Z;2017-12-20T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2017;2017;UCLA;;Nicole
292;188;NCT01365793;1;3;29897851;14.06.2018;;19.06.2018;01.06.2011;05.03.2018;Interventional;Phase 3;1389;Completed;Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis;2010-11-01T00:00:00Z;2017-01-01T00:00:00Z;2016-09-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2011;2010;2017;2016;UCD;;Stefanie
297;212;NCT02902913;1;1;29904393;03.07.2017;;31.03.2021;07.09.2016;26.07.2018;Interventional;Not Applicable;9;Completed;Impact of Extra Virgin Olive Oil Oleocanthal Content on Platelet Reactivity;2015-01-01T00:00:00Z;2015-09-01T00:00:00Z;2015-09-01T00:00:00Z;TRUE;Randomized;Double;OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2015;2015;UCD;;Emmanuel
983;713;NCT02233582;1;3;29924642;20.06.2018;This randomized and double-blind placebo controlled clinical trial consisted of two cohorts (in 2014 and 2016) using the same study protocol except determination of gene expression for some specific cytokines in the 2014 study and the addition of leg muscle oximetry in the 2016 study;02.04.2021;03.09.2014;NA;Interventional;Phase 1;20;Completed;Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDS) on Acclimatization to High Altitude;2014-09-01T00:00:00Z;2017-06-01T00:00:00Z;2016-10-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2016;UCSF;;Samruddhi
538;468;NCT01528020;1;1;29926087;01.08.2018;;16.05.2016;02.02.2012;NA;Interventional;Not Applicable;173;Completed;Collaborative Adolescent Research on Emotions and Suicide;2012-01-01T00:00:00Z;2016-05-01T00:00:00Z;2015-08-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;"University of California, Los Angeles; Harbor UCLA";NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2015;UCLA;;Nicole
370;418;NCT03194620;1;2;29959422;29.06.2018;;31.10.2017;19.06.2017;NA;Interventional;Not Applicable;12;Completed;Absorption, Metabolism and Excretion of Dietary Polyphenolic Bioactives in Humans;2016-08-01T00:00:00Z;2017-01-12T00:00:00Z;2017-01-12T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2017;2016;2017;2017;UCD;;Samruddhi
547;476;NCT01720641;1;1;29970355;03.07.2018;;04.08.2014;29.10.2012;NA;Interventional;Not Applicable;370;Completed;Partner Notification Strategies for MSM in Peru;2012-08-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCLA;;Susanne
905;640;NCT01542918;1;1;29986852;10.07.2018;;07.08.2020;27.02.2012;NA;Interventional;Phase 1;14;Completed;Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma;2012-12-17T00:00:00Z;2016-08-30T00:00:00Z;2016-04-07T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2016;UCSF;;Stefanie
590;518;NCT02277327;1;2;29997169;11.07.2018;;24.10.2017;24.10.2014;NA;Interventional;Phase 2;200;Completed;Trial to Reduce Hospitalizations in Children With Medical Complexity;2014-11-01T00:00:00Z;2016-11-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCLA;;Stefanie
1015;744;NCT02569060;1;1;30024798;19.07.2018;;14.05.2020;02.10.2015;NA;Interventional;Not Applicable;568;Completed;Feeding America Intervention Trial for Health--Diabetes Mellitus;2015-10-01T00:00:00Z;2017-10-31T00:00:00Z;2017-10-31T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Samruddhi
999;728;NCT02423720;1;1;30036361;23.07.2018;;22.02.2018;17.04.2015;NA;Interventional;Not Applicable;53;Completed;Mindfulness Meditation Intervention for Colorectal Cancer Patients and Caregivers;2015-04-28T00:00:00Z;2017-01-01T00:00:00Z;2016-05-03T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2016;UCSF;;Stefanie
924;656;NCT01771705;1;2;30046659;27.06.2018;;15.05.2020;16.01.2013;NA;Interventional;Not Applicable;40;Completed;NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients;2013-05-02T00:00:00Z;2017-04-17T00:00:00Z;2016-08-13T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2016;UCSF;;Stefanie
783;149;NCT02040805;1;2;30083381;20.07.2018;;04.02.2020;16.01.2014;09.06.2017;Interventional;Not Applicable;323;Completed;Comparison of Treatment for Hoarding Disorder;2014-02-01T00:00:00Z;2016-12-31T00:00:00Z;2016-12-31T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSF;;Susanne
660;270;NCT02219308;1;1;30095776;01.09.2018;;10.10.2019;11.08.2014;06.06.2019;Interventional;Not Applicable;67;Completed;Pain Control for Intrauterine Device Placement Using Paracervical Block;2014-10-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSD;;Nicole
815;236;NCT01982968;1;1;30100404;09.08.2018;;27.09.2021;06.11.2013;07.12.2018;Interventional;Not Applicable;58;Completed;Treatment of IPF With Laparoscopic Anti-Reflux Surgery;2013-12-01T00:00:00Z;2017-11-01T00:00:00Z;2017-11-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCSF;;Nicole
793;184;NCT02234284;1;1;30130430;01.10.2018;;08.03.2019;12.08.2014;20.02.2018;Interventional;Not Applicable;192;Completed;Aides in Respiration Health Coaching for COPD;2014-11-12T00:00:00Z;2017-05-04T00:00:00Z;2017-05-04T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSF;;Susanne
134;247;NCT02690948;1;2;30145186;24.08.2018;;06.03.2019;12.02.2016;31.01.2019;Interventional;Phase 1/Phase 2;16;Completed;Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer;2016-02-01T00:00:00Z;2018-08-29T00:00:00Z;2017-11-30T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2018;2017;Stanford;;Mario
;90;NCT01975090;1;1;30177423;01.09.2018;;25.10.2021;28.10.2013;14.09.2017;Interventional;Not Applicable;129;Completed;The SENTRY Clinical Study;2014-09-01T00:00:00Z;2018-12-01T00:00:00Z;2016-08-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2018;2016;Stanford;1;
291;185;NCT02116621;1;1;30193253;01.10.2018;;27.04.2018;15.04.2014;27.02.2018;Interventional;Not Applicable;215;Completed;N-of-1 Trials Using mHealth in Chronic Pain;2014-07-01T00:00:00Z;2017-05-01T00:00:00Z;2017-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCD;;Stefanie
704;561;NCT01465607;1;1;30204761;11.09.2018;;26.05.2015;02.11.2011;NA;Interventional;Not Applicable;1228;Completed;Implementation of an Efficacious Intervention for High Risk Women in Mexico;2011-11-01T00:00:00Z;2015-04-01T00:00:00Z;2015-04-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSD;;Mario
473;169;NCT01949116;1;1;30219823;17.05.2019;;28.10.2021;19.09.2013;04.12.2017;Interventional;Phase 2;176;Completed;Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications;2014-01-31T00:00:00Z;2016-12-08T00:00:00Z;2016-12-08T00:00:00Z;TRUE;Randomized;Quadruple;NIH;TRUE;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;NA;NA;2013;2014;2016;2016;UCLA;;Samruddhi
995;724;NCT02371525;1;1;30239620;30.05.2019;;24.10.2017;19.02.2015;NA;Interventional;Not Applicable;121;Completed;Enhancing PrEP in Community Settings (EPIC);2015-04-01T00:00:00Z;2017-01-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2016;UCSF;;Mario
911;645;NCT01627392;1;1;30242831;25.10.2018;;01.12.2015;14.06.2012;NA;Interventional;Not Applicable;305;Completed;Mechanisms of the Nicotine Metabolism Effect on Tobacco Dependence;2012-07-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCSF;;Susanne
;677;NCT01429454;1;3;30249470;22.09.2018;10.1093/schbul/sbx021.042 is earlier but not a full publication (conference abstract);03.02.2021;29.08.2011;15.11.2019;Interventional;Phase 1;127;Completed;NAPLS Omega-3 Fatty Acid Versus Placebo Study;2011-08-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2016;2016;UCSD;1;
835;292;NCT02428309;1;2;30277008;24.01.2019;;22.10.2019;23.04.2015;03.10.2019;Interventional;Phase 1;1;Terminated;Autologous Polyclonal Tregs for Lupus;2015-08-27T00:00:00Z;2018-10-03T00:00:00Z;2016-09-02T00:00:00Z;TRUE;Non-Randomized;None (Open Label);NIH;FALSE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2015;2015;2018;2016;UCSF;;Susanne
810;230;NCT02482233;1;1;30280019;28.09.2018;;23.01.2019;17.06.2015;09.11.2018;Interventional;Phase 4;30;Completed;The END Perioperative Smoking Pilot Study;2015-08-01T00:00:00Z;2016-09-01T00:00:00Z;2016-05-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;UCSF / SFVAMC;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSF;;Samruddhi
650;224;NCT02035202;1;2;30281086;18.06.2019;;22.07.2019;09.10.2013;04.10.2018;Interventional;Not Applicable;255;Completed;Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness;2013-10-01T00:00:00Z;2017-05-01T00:00:00Z;2017-05-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCSD;;Mario
798;195;NCT02278939;1;1;30294699;20.09.2018;;31.08.2018;28.10.2014;30.04.2018;Interventional;Not Applicable;67;Completed;Fit and Trim for Diabetes Prevention;2014-11-01T00:00:00Z;2017-02-28T00:00:00Z;2016-07-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2016;UCSF;;Emmanuel
;803;NCT01787331;1;3;30327180;24.09.2018;;22.01.2020;06.02.2013;01.06.2018;Interventional;Phase 2;21;Completed;Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer;2013-10-29T00:00:00Z;2018-09-30T00:00:00Z;2017-05-30T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2018;2017;UCSF;1;
462;150;NCT02670343;1;2;30345711;21.10.2018;;23.02.2018;28.01.2016;27.06.2017;Interventional;Phase 1/Phase 2;8;Completed;Phlebotomy Study of Testosterone Undecanoate;2016-01-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;FALSE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2016;2016;UCLA;;Stefanie
343;393;NCT02077998;1;3;30381944;19.11.2018;;05.01.2018;28.02.2014;NA;Interventional;Early Phase 1;1;Completed;Oxaliplatin in Treating Patients With Metastatic Breast Cancer;2015-05-01T00:00:00Z;2015-12-01T00:00:00Z;2015-05-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UC Davis Cancer Center;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2015;2015;UCD;;Nicole
795;191;NCT02072941;1;1;30383086;01.12.2018;;22.04.2019;24.02.2014;02.04.2018;Interventional;Not Applicable;445;Completed;Preparing Spanish-speaking Older Adults for Advance Care Planning and Medical Decision Making (PREPARE);2014-09-01T00:00:00Z;2017-03-01T00:00:00Z;2017-03-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSF;;Nicole
958;690;NCT01990235;1;1;30383086;01.12.2018;published together with a second trial;15.10.2018;04.11.2013;NA;Interventional;Not Applicable;541;Completed;Improving Advance Care Planning by Preparing Diverse Seniors for Decision Making;2013-01-01T00:00:00Z;2017-11-01T00:00:00Z;2017-11-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCSF;;Susanne
714;570;NCT01867177;1;3;30398952;01.11.2018;;27.07.2018;29.05.2013;NA;Interventional;Not Applicable;583;Completed;Community-based Interventions to Increase HIV Testing and HIV Care Utilization;2013-06-01T00:00:00Z;2017-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2016;UCSD;;Samruddhi
480;194;NCT02178800;1;1;30408115;08.11.2018;;14.10.2021;27.06.2014;30.04.2018;Interventional;Phase 2;199;Completed;Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults;2015-02-01T00:00:00Z;2018-07-13T00:00:00Z;2017-04-05T00:00:00Z;TRUE;Randomized;Quadruple;NIH;TRUE;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;NA;NA;2014;2015;2018;2017;UCLA;;Samruddhi
937;669;NCT01869179;1;1;30412233;14.02.2020;;13.01.2020;09.01.2013;NA;Interventional;Not Applicable;390;Completed;"Community Choirs To Promote Healthy Aging; Community of Voices Chorus";2013-02-01T00:00:00Z;2018-08-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2018;2016;UCSF;;Emmanuel
1034;762;NCT03064724;1;3;30413543;01.11.2018;;22.02.2017;20.02.2017;NA;Interventional;Not Applicable;47;Completed;Practice-based Intervention for Vietnamese and Korean Patients;2012-08-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2017;2012;2015;2015;UCSF;;Mario
722;577;NCT02125773;1;3;30422909;01.02.2019;for discussion: https://pubmed.ncbi.nlm.nih.gov/25017425/ different outcome - I added another one found by the trial acronym;08.05.2020;25.04.2014;NA;Interventional;Not Applicable;150;Completed;Pre-exposure Prophylaxis Accessibility Research and Evaluation 2;2014-02-19T00:00:00Z;2019-11-08T00:00:00Z;2017-10-09T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;CCTG, UCSD AVRC;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2019;2017;UCSD;;Stefanie
;643;NCT02217436;1;1;30422942;01.08.2021;;03.07.2019;08.08.2014;28.06.2018;Interventional;Not Applicable;80;Completed;iPad as a Distraction Tool During Facial Laceration Repair;2014-04-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego and Rady Children's Hospital San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCSD;1;
664;275;NCT01502306;1;1;30454668;01.12.2018;;11.02.2020;23.12.2011;27.06.2019;Interventional;Phase 3;3816;Completed;A Randomized Trial of Medi-Cal Beneficiaries Calling the California Smokers' Helpline;2012-06-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2014;2014;UCSD;;Emmanuel
821;244;NCT02097641;1;1;30455077;16.11.2018;;18.03.2019;19.03.2014;15.01.2019;Interventional;Phase 2;60;Completed;Human Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome (START);2014-03-15T00:00:00Z;2018-02-09T00:00:00Z;2017-03-09T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2018;2017;UCSF;;Stefanie
488;226;NCT02008773;1;1;30478008;23.11.2018;;08.01.2019;07.12.2013;11.10.2018;Interventional;Phase 2;170;Completed;A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia;2014-03-26T00:00:00Z;2017-06-20T00:00:00Z;2017-06-20T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2017;2017;UCLA;;Samruddhi
884;619;NCT01270230;1;1;30478804;01.01.2019;;25.10.2016;02.12.2010;NA;Interventional;Phase 2;396;Completed;A Randomized Controlled Trial of the Bruthas Project;2011-02-01T00:00:00Z;2016-08-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2016;2015;UCSF;;Emmanuel
789;168;NCT02230566;1;1;30515718;01.05.2019;;16.07.2020;22.08.2014;29.11.2017;Interventional;Phase 3;12;Completed;A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7);2014-12-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSF;;Stefanie
368;416;NCT03065504;1;1;30527287;22.11.2018;;18.12.2018;01.11.2016;NA;Interventional;Not Applicable;30;Completed;Turmeric and Turmeric-containing Tablets and Sebum Production;2016-11-01T00:00:00Z;2017-08-28T00:00:00Z;2017-08-28T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCD;;Stefanie
609;537;NCT02752646;1;3;30527440;07.12.2018;TRN not mentioned, but similar PICO;03.03.2017;25.04.2016;NA;Interventional;Not Applicable;200;Completed;Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%;2016-04-01T00:00:00Z;2017-03-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;UCLA Jules Stein Eye Institute;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCLA;;Samruddhi
1010;739;NCT02529176;1;1;30535345;01.01.2019;;13.11.2019;18.08.2015;NA;Interventional;Not Applicable;1021;Completed;Trial of a Best-Practice Alert in the Electronic Medical Record to Reduce Unnecessary Telemetry Monitoring;2016-12-01T00:00:00Z;2017-06-01T00:00:00Z;2017-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;2017;UCSF;;Susanne
614;541;NCT02994602;1;1;30556332;16.12.2018;;22.02.2018;18.11.2016;NA;Interventional;Phase 1;12;Completed;Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ? (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males;2017-01-01T00:00:00Z;2017-10-01T00:00:00Z;2017-06-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2016;2017;2017;2017;UCLA;;Susanne
;688;NCT00598169;1;1;30573564;26.12.2018;;07.08.2020;09.01.2008;NA;Interventional;Phase 1;23;Completed;Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma;2007-11-01T00:00:00Z;2014-11-01T00:00:00Z;2014-10-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);NETWORK;TRUE;University of California, San Diego;NA;NA;University of California, San Diego;NA;NA;NA;NA;NA;2008;2007;2014;2014;UCSD;1;
354;404;NCT02428647;1;1;30580974;21.12.2018;;04.01.2022;09.02.2015;NA;Interventional;Not Applicable;3433;Completed;Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation;2015-09-01T00:00:00Z;2017-07-01T00:00:00Z;2017-05-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCD;;Susanne
807;228;NCT02342678;1;1;30595143;26.10.2018;;28.11.2018;15.01.2015;25.10.2018;Interventional;Not Applicable;56;Completed;Lessening Incontinence Through Low-impact Activity;2015-01-01T00:00:00Z;2017-04-01T00:00:00Z;2017-04-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Susanne
555;484;NCT01808352;1;1;30615169;15.10.2019;;20.01.2016;05.03.2013;NA;Interventional;Phase 4;225;Completed;HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP);2013-08-01T00:00:00Z;2015-09-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;NA;None (Open Label);NETWORK;TRUE;UCLA Vice Street Clinic;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCLA;;Samruddhi
;301;NCT02086110;1;2;30625189;09.01.2019;;31.05.2019;07.03.2014;31.05.2019;Interventional;Not Applicable;11;Completed;Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism;2014-06-06T00:00:00Z;2015-11-16T00:00:00Z;2015-11-16T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;UC Davis MIND Institute;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCD;1;
1005;734;NCT02470936;1;1;30638635;10.01.2019;;20.02.2019;10.06.2015;NA;Interventional;Not Applicable;76;Completed;Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8;2015-06-01T00:00:00Z;2018-03-01T00:00:00Z;2017-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2018;2017;UCSF;;Samruddhi
1000;729;NCT02447159;1;1;30651080;16.01.2019;;02.05.2017;07.05.2015;NA;Interventional;Not Applicable;554;Completed;Evaluation of Conditional Cash Transfers to Increase Retention in PMTCT Services in Akwa Ibom State, Nigeria;2015-08-01T00:00:00Z;2017-04-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Mario
844;309;NCT01209325;1;1;30658128;15.01.2019;;06.08.2020;24.09.2010;29.04.2020;Interventional;Phase 2;149;Completed;Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males;2011-06-28T00:00:00Z;2017-12-12T00:00:00Z;2017-12-12T00:00:00Z;TRUE;NA;None (Open Label);NETWORK;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2017;2017;UCSF;;Nicole
663;274;NCT02513121;1;1;30667502;22.01.2019;;16.01.2020;29.07.2015;26.06.2019;Interventional;Not Applicable;40;Completed;Dietary Treatment Study of Pediatric NAFLD;2015-07-01T00:00:00Z;2017-08-31T00:00:00Z;2017-08-31T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSD;;Samruddhi
263;354;NCT03513965;1;3;30682576;23.01.2019;;06.08.2018;12.04.2018;NA;Interventional;Not Applicable;50;Completed;Allergy Experience Study;2017-01-05T00:00:00Z;2018-07-01T00:00:00Z;2017-08-03T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2018;2017;2018;2017;Stanford;;Mario
981;711;NCT02207036;1;1;30684432;04.09.2018;;05.05.2017;13.05.2014;NA;Interventional;Not Applicable;501;Completed;Tobacco Status Project: Social Media Intervention for Young Adult Smokers;2014-10-01T00:00:00Z;2016-11-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSF;;Nicole
982;712;NCT02221167;1;1;30688082;28.01.2019;;14.03.2018;18.08.2014;NA;Interventional;Not Applicable;60;Completed;Rx Milk Study of Donor Milk Supplementation to Improve Breastfeeding Outcomes;2014-07-01T00:00:00Z;2016-09-01T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;NA;NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2014;2014;2016;2016;UCSF;;Stefanie
959;691;NCT01997008;1;2;30701389;01.03.2019;;30.04.2020;21.11.2013;NA;Interventional;Not Applicable;22;Completed;Optimizing Resilience and Coping in HIV Via Internet Delivery;2014-05-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2015;2015;UCSF;;Emmanuel
1032;760;NCT02976220;1;1;30724735;06.02.2019;;26.10.2017;28.09.2016;NA;Interventional;Not Applicable;25;Completed;Health Outcomes Patient Education;2016-11-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCSF;;Samruddhi
456;119;NCT01982643;1;1;30724759;01.09.2019;;09.03.2020;04.11.2013;08.02.2017;Interventional;Phase 1/Phase 2;49;Completed;Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder;2013-11-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;UCLA Integrated Substance Abuse Programs;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCLA;;Nicole
384;92;NCT02048826;1;1;30728310;06.02.2019;;23.03.2021;27.01.2014;25.10.2016;Interventional;Not Applicable;31;Completed;FINGER Robot Therapy Study;2013-11-01T00:00:00Z;2016-02-01T00:00:00Z;2015-05-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2016;2015;UCI;;Samruddhi
785;155;NCT02078713;1;3;30763545;11.02.2019;sample size deviation, similar outcome analysed;30.04.2018;25.02.2014;07.07.2017;Interventional;Not Applicable;786;Completed;Patient-Centered Support for Contraceptive Decision-Making;2014-10-01T00:00:00Z;2016-10-01T00:00:00Z;2016-10-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSF;;Samruddhi
595;523;NCT02396576;1;1;30770523;15.02.2019;primary outcome changed?;08.08.2017;04.03.2015;NA;Interventional;Not Applicable;359;Completed;Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas;2015-04-07T00:00:00Z;2017-06-15T00:00:00Z;2017-06-15T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCLA;;Susanne
954;686;NCT01979874;1;2;30771686;13.02.2019;;18.07.2019;01.11.2013;NA;Interventional;Phase 2;26;Completed;The Effects of Omega-3 Fatty Acids on Peripheral Arterial Disease II;2014-02-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;UCSF & SFVAMC;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2017;2017;UCSF;;Emmanuel
374;422;NCT03303027;1;3;30797848;21.02.2019;trial ID - confirmed;29.04.2019;02.10.2017;NA;Interventional;Not Applicable;50;Completed;6-0 Fast Absorbing Gut Versus 5-0 Fast Absorbing Gut for Linear Wound Closure;2016-04-27T00:00:00Z;2019-04-16T00:00:00Z;2017-03-21T00:00:00Z;FALSE;Non-Randomized;Single;OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2017;2016;2019;2017;UCD;;Nicole
486;220;NCT02970162;1;2;30801481;01.03.2019;30801481 cites the trial ID and intervention suits the registration;20.12.2018;16.11.2016;24.09.2018;Interventional;Phase 3;26;Completed;Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS);2016-11-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCLA;;Emmanuel
940;672;NCT01882998;1;1;30802277;25.02.2019;;20.05.2016;17.06.2013;NA;Interventional;Not Applicable;1230;Completed;Primary HIV Prevention in Pregnant and Lactating Ugandan Women;2013-02-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCSF;;Samruddhi
427;437;NCT03327831;1;3;30807390;01.04.2019;;13.12.2017;23.10.2015;NA;Interventional;Phase 4;31;Completed;Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses;2015-04-01T00:00:00Z;2017-07-01T00:00:00Z;2017-02-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCI;;Samruddhi
581;510;NCT02181062;1;1;30836804;19.03.2019;;06.12.2019;30.06.2014;NA;Interventional;Not Applicable;240;Completed;Culturally Tailoring a Stroke Intervention in Community Senior Centers;2014-10-01T00:00:00Z;2018-01-01T00:00:00Z;2016-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2018;2016;UCLA;;Nicole
897;632;NCT01468753;1;2;30840672;06.03.2019;;13.05.2015;07.11.2011;NA;Interventional;Not Applicable;40;Completed;Pilot Study: Acceptability, Feasibility and Efficacy of Vaginal Insemination in HIV Discordant Couples (Female Positive, Male Negative) Desiring Conception in Kisumu, Kenya;2012-03-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2011;2012;2014;2014;UCSF;;Susanne
1038;766;NCT03354000;1;3;30850461;01.03.2019;;17.04.2019;09.11.2017;NA;Interventional;Not Applicable;93;Completed;An RCT of an Online Training for Vulnerable Patients to Use an Online Patient Portal Website;2015-08-01T00:00:00Z;2018-07-31T00:00:00Z;2017-07-31T00:00:00Z;FALSE;Randomized;Double;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2017;2015;2018;2017;UCSF;;Nicole
1031;759;NCT02966054;1;1;30866859;11.03.2019;;05.04.2018;09.11.2016;NA;Interventional;Not Applicable;42;Completed;Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer: a Pilot Randomized Controlled Trial;2014-08-01T00:00:00Z;2017-06-20T00:00:00Z;2017-06-20T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2014;2017;2017;UCSF;;Samruddhi
786;158;NCT02094664;1;2;30887708;18.03.2019;;05.01.2018;18.03.2014;30.07.2017;Interventional;Not Applicable;32;Completed;Heated Humidified Oxygen Compared to Dry Oxygen Therapy in Children With Bronchiolitis;2014-01-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCSF;;Emmanuel
1033;761;NCT03048786;1;3;30892616;16.03.2020;;01.10.2018;06.02.2017;NA;Interventional;Not Applicable;200;Completed;Mobile-based Peer Mentoring for Smoking Cessation;2017-02-06T00:00:00Z;2017-08-14T00:00:00Z;2017-08-14T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2017;2017;2017;2017;UCSF;;Stefanie
615;542;NCT03253874;1;2;30907922;01.05.2019;;15.08.2017;15.11.2016;NA;Interventional;Not Applicable;1798;Completed;Pre-Operative Testing for Cataract Surgery Among Adults in LA County;2014-10-01T00:00:00Z;2016-04-01T00:00:00Z;2016-04-01T00:00:00Z;FALSE;Non-Randomized;Single;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2014;2016;2016;UCLA;;Stefanie
743;598;NCT02715115;1;2;30918097;27.03.2019;;06.08.2020;21.02.2016;NA;Interventional;Phase 2;82;Completed;A Safety Study of NNZ-2566 in Pediatric Rett Syndrome;2016-03-01T00:00:00Z;2017-01-05T00:00:00Z;2017-01-05T00:00:00Z;FALSE;Randomized;Quadruple;INDUSTRY;TRUE;University of California, San Diego;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCSD, UCSF;;Samruddhi
653;257;NCT02145247;1;2;30918916;07.02.2019;;08.08.2019;20.05.2014;28.03.2019;Interventional;Not Applicable;39;Completed;Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS);2014-05-01T00:00:00Z;2018-01-01T00:00:00Z;2017-02-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2018;2017;UCSD;;Mario
927;659;NCT01792648;1;1;30943980;03.04.2019;;31.10.2017;26.04.2012;NA;Interventional;Not Applicable;24;Completed;Effects of Almond Intake on Atherogenic Lipoprotein Particles;2013-04-01T00:00:00Z;2016-04-01T00:00:00Z;2016-02-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2016;2016;UCSF;;Mario
979;710;NCT02183909;1;3;30973542;01.08.2019;can be argued;17.11.2017;06.05.2014;NA;Interventional;Not Applicable;380;Completed;Connecting Resources for Urban Sexual Health;2013-05-01T00:00:00Z;2017-08-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UCSF Center for AIDS Prevention;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2017;2017;UCSF;;Samruddhi
485;213;NCT02090075;1;1;31002997;13.03.2019;;29.03.2019;16.03.2014;06.08.2018;Interventional;Phase 4;66;Completed;Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque;2014-09-01T00:00:00Z;2017-04-05T00:00:00Z;2016-12-27T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2016;UCLA;;Nicole
932;664;NCT01825681;1;1;31045422;01.05.2019;;01.08.2019;25.03.2013;NA;Interventional;Not Applicable;175;Completed;Life Enhancing Activities for Family Caregivers;2013-10-01T00:00:00Z;2019-06-30T00:00:00Z;2017-08-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2019;2017;UCSF;;Susanne
829;268;NCT02202031;1;2;31075059;06.09.2019;;17.07.2019;24.07.2014;31.05.2019;Interventional;Not Applicable;161;Completed;Controlling Urgency Through Relaxation Exercises;2014-09-01T00:00:00Z;2018-03-01T00:00:00Z;2017-12-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2018;2017;UCSF;;Nicole
819;240;NCT01116661;1;1;31075771;10.05.2019;;07.05.2019;03.05.2010;27.12.2018;Interventional;Phase 2;199;Terminated;Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the Brain;2010-08-01T00:00:00Z;2019-02-28T00:00:00Z;2017-12-28T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCSF Department of Neurosurgery;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2019;2017;UCSF;;Stefanie
426;436;NCT03191929;1;1;31095060;01.06.2019;;16.04.2019;09.06.2017;NA;Interventional;Not Applicable;410;Completed;Depression Screening in Primary Care: Using HIT for Patients With Limited English;2011-08-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2017;2011;2015;2015;UCI;;Nicole
334;384;NCT01900613;1;1;31096944;16.05.2019;;17.07.2017;11.07.2013;NA;Interventional;Not Applicable;800;Completed;Ni??os Sanos, Familia Sana - A Multi-Intervention Program to Prevent Childhood Obesity in Mexican-Heritage Children in Rural California;2011-04-01T00:00:00Z;2016-09-01T00:00:00Z;2016-09-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;Center for Transnational Health, UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2011;2016;2016;UCD;;Samruddhi
1013;742;NCT02566356;1;3;31103018;18.05.2019;;17.05.2019;30.09.2015;NA;Interventional;Early Phase 1;59;Completed;Adult Study Oxytocin - fMRI;2012-09-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;Randomized;Double;OTHER;TRUE;University of California San Francisco, San Francisco Veterans Affairs Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2015;2012;2017;2017;UCSF;;Nicole
968;700;NCT02104466;1;1;31127837;01.11.2019;;30.05.2017;27.03.2014;NA;Interventional;Not Applicable;40;Completed;Group Acupuncture Treatment Effects for Painful Diabetic Neuropathy (GATE-PDN);2015-03-01T00:00:00Z;2016-03-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2016;2015;UCSF;;Emmanuel
593;521;NCT02393456;1;3;31128568;29.04.2019;Similar PICO in three studies mentioned , can be argued;08.08.2017;22.01.2015;NA;Interventional;Early Phase 1;161;Completed;Oxytocin and the Social Brain;2015-01-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCLA;;Samruddhi
895;630;NCT01463046;1;3;31152020;31.05.2019;;19.04.2019;27.10.2011;NA;Interventional;Phase 1;29;Completed;Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome;2012-01-01T00:00:00Z;2018-12-01T00:00:00Z;2015-11-14T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2018;2015;UCSF;;Emmanuel
891;626;NCT01427855;1;1;31161217;01.07.2019;;20.11.2020;31.08.2011;NA;Interventional;Not Applicable;113;Completed;Dietary Protein Sources and Atherogenic Dyslipidemia;2012-01-01T00:00:00Z;2017-05-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2017;2016;UCSF;;Samruddhi
861;344;NCT01009918;1;1;31171092;11.06.2019;;29.03.2021;06.11.2009;12.01.2021;Interventional;Phase 2;468;Completed;Lisinopril or Coreg CR? in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab;2010-03-01T00:00:00Z;2018-11-01T00:00:00Z;2017-08-01T00:00:00Z;TRUE;Randomized;Double;OTHER;TRUE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2009;2010;2018;2017;UCSF;;Samruddhi
356;406;NCT02445638;1;1;31172172;01.09.2019;;22.01.2019;11.05.2015;NA;Interventional;Not Applicable;20;Completed;HDL Lipidomic, Proteomic and Functional Changes in Women After Eating Eggs;2015-05-01T00:00:00Z;2017-09-06T00:00:00Z;2017-09-06T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCD;;Nicole
561;490;NCT01900301;1;1;31174846;19.04.2019;;03.10.2019;08.07.2013;NA;Interventional;Phase 1;60;Completed;Generalization of Extinction Learning;2013-08-01T00:00:00Z;2017-08-01T00:00:00Z;2017-08-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;Department of Psychology, UCLA;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCLA;;Stefanie
;915;NCT01671501;1;1;31187344;11.06.2019;;08.10.2018;20.08.2012;NA;Interventional;Not Applicable;614;Completed;Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients;2013-03-01T00:00:00Z;2017-08-01T00:00:00Z;2016-08-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Associate Professor, University of California, San Francisco and Adjunct Investigator, Division of Research, Kaiser Permanente, Northern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2017;2016;UCSF;1;
830;273;NCT02910037;1;1;31189036;13.06.2019;;07.05.2021;13.09.2016;21.06.2019;Interventional;Not Applicable;214;Completed;"Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort";2016-06-01T00:00:00Z;2017-07-31T00:00:00Z;2017-07-31T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2016;2016;2017;2017;UCSF;;Mario
496;295;NCT03676803;1;2;31242596;25.06.2019;;01.11.2019;17.09.2018;15.10.2019;Interventional;Not Applicable;31;Completed;Effect of Spice Consumption on the Microbiome;2017-08-03T00:00:00Z;2018-05-30T00:00:00Z;2017-11-17T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;Center for Human Nutrition, UCLA David Geffen School of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2018;2017;2018;2017;UCLA;;Susanne
805;225;NCT01958320;1;1;31255386;27.06.2019;;28.11.2018;04.10.2013;09.10.2018;Interventional;Phase 2;202;Completed;Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus;2013-12-01T00:00:00Z;2017-06-01T00:00:00Z;2017-06-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCSF;;Stefanie
;431;NCT03681171;1;1;31294009;25.06.2019;;20.09.2018;30.08.2018;NA;Interventional;Not Applicable;9;Completed;Therapeutic Dance Intervention for Children With Cerebral Palsy;2016-06-25T00:00:00Z;2016-09-01T00:00:00Z;2016-08-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;NA;NA;NA;NA;NA;University of California, Irvine;NA;NA;NA;2018;2016;2016;2016;UCI;1;
1041;769;NCT03713840;1;2;31303190;15.07.2019;;18.10.2018;17.10.2018;NA;Interventional;Not Applicable;154;Completed;Community Partnering to Encourage Healthy Beverage Intake Through Child Care;2013-08-15T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2018;2013;2014;2014;UCSF;;Nicole
827;260;NCT02147301;1;2;31355158;17.06.2019;;21.08.2019;19.05.2014;03.04.2019;Interventional;Not Applicable;17;Terminated;TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve;2014-12-17T00:00:00Z;2017-04-05T00:00:00Z;2017-01-27T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSF;;Emmanuel
612;540;NCT02953158;1;1;31367691;12.06.2019;;30.12.2019;06.10.2016;NA;Interventional;Not Applicable;60;Completed;Effectiveness of Changing Dietary Fat on Weight Loss;2017-01-03T00:00:00Z;2017-12-20T00:00:00Z;2017-12-20T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCLA Center for Human Nutrition;NA;NA;NA;NA;NA;NA;NA;NA;2016;2017;2017;2017;UCLA;;Emmanuel
569;498;NCT01963780;1;1;31378427;01.08.2019;;07.12.2018;04.09.2013;NA;Interventional;Not Applicable;79;Completed;International EXPAND Lung Pivotal Trial;2013-11-01T00:00:00Z;2018-04-01T00:00:00Z;2017-10-30T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2018;2017;UCLA;;Stefanie
13;60;NCT00499616;1;1;31386611;06.08.2019;;01.07.2021;10.07.2007;01.12.2015;Interventional;Phase 3;464;Completed;Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma;2007-10-08T00:00:00Z;2021-06-30T00:00:00Z;2014-06-30T00:00:00Z;TRUE;Non-Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;Lucile Packard Children's Hospital at Stanford University Medical Center;NA;NA;NA;NA;NA;2007;2007;2021;2014;Stanford;;Samruddhi
706;563;NCT01625819;1;3;31397771;01.11.2019;linked is substudy;07.01.2016;18.04.2012;NA;Interventional;Not Applicable;135;Completed;Exploring Behavioral Interventions to Improve Heart Failure;2010-08-01T00:00:00Z;2015-08-01T00:00:00Z;2014-04-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2012;2010;2015;2014;UCSD;;Samruddhi
;359;NCT02547077;1;1;31403536;01.05.2020;;24.05.2017;09.09.2015;NA;Interventional;Not Applicable;50;Completed;Use of 2-octylcyanoacrylate (Dermabond) Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure;2015-07-01T00:00:00Z;2016-05-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2015;UCD;1;
300;256;NCT02143024;1;3;31414506;25.08.2019;;06.01.2020;19.06.2013;25.03.2019;Interventional;Not Applicable;23;Completed;A Family-based Primary Care Intervention to Enhance Older Men's Depression Care;2015-11-01T00:00:00Z;2016-12-31T00:00:00Z;2016-12-31T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2015;2016;2016;UCD;;Stefanie
578;507;NCT02129153;1;1;31415193;15.08.2019;;06.02.2017;30.04.2014;NA;Interventional;Not Applicable;318;Completed;Linking Families Together Study- A Randomized Trial to Raise Parental Monitoring;2014-09-01T00:00:00Z;2016-08-01T00:00:00Z;2016-06-30T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCLA;;Susanne
651;231;NCT01694121;1;3;31434541;01.07.2019;primary and secondary outcome changed, time frame of primary outcome changed;04.12.2018;22.09.2012;14.11.2018;Interventional;Not Applicable;455;Completed;Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men;2013-03-01T00:00:00Z;2018-05-01T00:00:00Z;2017-04-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2018;2017;UCSD;;Emmanuel
734;589;NCT02467036;1;3;31436494;22.08.2019;for discussion: https://escholarship.org/content/qt2zj757f4/qt2zj757f4_noSplash_f7b6d9a220fef370ed2e3fdcf2716728.pdf?t=q1mul7  no date, no pmdi;16.10.2017;28.10.2014;NA;Interventional;Not Applicable;66;Completed;Family Based Treatment for Weight Loss With Breakfast Prescription;2014-01-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSD;;Stefanie
353;403;NCT02383186;1;3;31442535;21.08.2019;trial ID - confirmed;17.07.2017;10.11.2014;NA;Interventional;Not Applicable;50;Completed;Dermal Suturing Only Versus Layered Cutaneous Closure;2014-05-28T00:00:00Z;2016-04-01T00:00:00Z;2016-04-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCD;;Nicole
112;206;NCT01977677;1;3;31537527;19.09.2019;;27.09.2018;31.10.2013;05.06.2018;Interventional;Phase 1/Phase 2;30;Completed;Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma;2014-11-01T00:00:00Z;2018-09-01T00:00:00Z;2017-11-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2018;2017;Stanford;;Stefanie
;414;NCT02034071;1;2;31545799;23.09.2019;;30.08.2016;08.01.2014;NA;Interventional;Phase 1/Phase 2;13;Completed;Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome;2014-04-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;FALSE;Randomized;Quadruple;INDUSTRY;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCI;1;
60;117;NCT01364727;1;2;31557562;18.09.2019;;05.04.2019;31.05.2011;23.01.2017;Interventional;Phase 2;33;Completed;A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies;2011-06-01T00:00:00Z;2018-12-31T00:00:00Z;2014-07-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2018;2014;Stanford;;Samruddhi
676;294;NCT02251236;1;1;31560741;14.08.2020;;08.10.2019;24.09.2014;08.10.2019;Interventional;Not Applicable;14;Completed;Elvitegravir (EVG) Cerebrospinal Fluid (CSF) Pharmacokinetics in HIV-Infected Individuals;2016-01-01T00:00:00Z;2017-01-18T00:00:00Z;2017-01-18T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2014;2016;2017;2017;UCSD;;Mario
502;321;NCT01890265;1;1;31575509;28.09.2019;;19.08.2020;24.06.2013;24.07.2020;Interventional;Phase 2;160;Completed;Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF);2013-07-30T00:00:00Z;2017-11-16T00:00:00Z;2017-11-16T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;David Geffen School of Medicine at UCLA, USA;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCLA;;Emmanuel
616;543;NCT03828604;1;1;31580931;30.09.2019;;01.02.2019;31.01.2019;NA;Interventional;Not Applicable;57;Completed;Stress-Induced Inflammation and Reward Processing;2017-05-12T00:00:00Z;2018-05-09T00:00:00Z;2017-12-08T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2019;2017;2018;2017;UCLA;;Stefanie
681;312;NCT01960257;1;1;31584944;04.10.2019;;10.05.2021;08.10.2013;12.05.2020;Interventional;Phase 4;92;Completed;Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis;2013-10-25T00:00:00Z;2017-01-31T00:00:00Z;2017-01-31T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;NA;NA;NA;University of California, San Diego;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCSD;;Emmanuel
586;514;NCT02258776;1;2;31601842;10.10.2019;;27.02.2017;26.09.2014;NA;Interventional;Not Applicable;75;Completed;The Effect of Pomegranate on Aging and Inflammation of the Skin;2015-10-01T00:00:00Z;2017-02-27T00:00:00Z;2017-02-27T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UCLA Department of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;2017;UCLA;;Emmanuel
974;706;NCT02126007;1;1;31612533;14.10.2019;;01.06.2016;25.04.2014;NA;Interventional;Not Applicable;53;Completed;Fatigue Management in HIV;2014-10-01T00:00:00Z;2015-12-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCSF;;Nicole
1002;731;NCT02451345;1;3;31714037;12.11.2019;;21.07.2020;19.05.2015;NA;Interventional;Not Applicable;58;Completed;Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model;2015-03-25T00:00:00Z;2020-04-30T00:00:00Z;2017-06-30T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2020;2017;UCSF;;Samruddhi
373;421;NCT03303014;1;3;31724097;13.11.2019;;20.04.2021;02.10.2017;NA;Interventional;Not Applicable;50;Completed;5-0 Prolene Versus 5-0 Fast Absorbing Gut;2015-10-13T00:00:00Z;2019-10-01T00:00:00Z;2016-03-15T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2017;2015;2019;2016;UCD;;Samruddhi
598;526;NCT02472379;1;2;31759092;20.11.2019;;01.05.2017;10.06.2015;NA;Interventional;Not Applicable;78;Completed;Writing About Experiences and Health in Older Adults;2015-10-01T00:00:00Z;2017-03-01T00:00:00Z;2017-01-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCLA;;Mario
649;223;NCT02444793;1;1;31801624;04.12.2019;;13.02.2019;12.05.2015;26.09.2018;Interventional;Phase 1;24;Terminated;A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors;2015-05-01T00:00:00Z;2017-10-01T00:00:00Z;2017-09-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSD;;Mario
505;347;NCT02120781;1;3;31804729;05.12.2019;;10.05.2021;21.03.2014;02.03.2021;Interventional;Phase 2;21;Completed;Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia;2014-03-01T00:00:00Z;2016-12-21T00:00:00Z;2016-04-01T00:00:00Z;TRUE;Randomized;Triple;INDUSTRY;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCLA;;Stefanie
489;241;NCT01860807;1;3;31820289;09.12.2019;;06.01.2019;20.05.2013;06.01.2019;Interventional;Phase 2;125;Completed;Trial of Ibudilast for Methamphetamine Dependence;2013-07-01T00:00:00Z;2017-12-31T00:00:00Z;2017-12-31T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCLA;;Samruddhi
941;673;NCT01888835;1;1;31825466;01.03.2020;;09.03.2018;25.06.2013;NA;Interventional;Phase 2;120;Completed;Mirtazapine for the Treatment of Methamphetamine Dependence Among MSM (M2.0);2013-08-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;Triple;OTHER_GOV;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCSF;;Susanne
652;251;NCT01238172;1;1;31935026;14.01.2020;;20.02.2019;09.11.2010;20.02.2019;Interventional;Phase 3;478;Completed;Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance;2011-01-01T00:00:00Z;2019-01-15T00:00:00Z;2017-11-18T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;NA;NA;NA;University of California, San Diego;NA;NA;NA;NA;NA;2010;2011;2019;2017;UCSD;;Stefanie
;181;NCT01483391;1;1;31940011;01.05.2020;27227701 does not report the primary outcomes;26.09.2021;26.11.2011;NA;Interventional;Not Applicable;150;Completed;Early Intervention for Youth at Risk for Bipolar Disorder;2011-10-06T00:00:00Z;2020-09-15T00:00:00Z;2016-09-15T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;Stanford University;UCLA Department of Psychiatry;NA;NA;NA;NA;NA;NA;NA;2011;2011;2020;2016;Stanford, UCLA;1;
1045;772;NCT04155229;1;1;31961377;01.04.2020;;04.11.2019;28.10.2019;NA;Interventional;Not Applicable;104;Completed;EMR Defaults to Nudge Opioid Prescribing;2016-10-03T00:00:00Z;2017-09-03T00:00:00Z;2017-09-03T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2019;2016;2017;2017;UCSF;;Nicole
537;467;NCT01495780;1;3;32009781;13.11.2019;;29.04.2020;16.12.2011;NA;Interventional;Not Applicable;17;Completed;eRT Remote Health Monitoring;2012-01-01T00:00:00Z;2014-08-20T00:00:00Z;2014-08-20T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2014;2014;UCLA;;Stefanie
602;530;NCT02640079;1;3;32022890;07.11.2020;;11.04.2018;17.12.2015;NA;Interventional;Not Applicable;24;Completed;A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea;2016-01-01T00:00:00Z;2017-11-01T00:00:00Z;2017-11-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;2017;UCLA;;Mario
491;245;NCT02321930;1;1;32025629;03.02.2020;;27.02.2019;23.09.2014;18.01.2019;Interventional;Phase 4;37;Completed;Musculoskeletal Ultrasound Assessment of Therapeutic Response of Tofacitinib in Rheumatoid Arthritis Patients;2016-02-16T00:00:00Z;2017-09-29T00:00:00Z;2017-09-29T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCLA David Geffen School of Medicine, Division of Rheumatology;NA;NA;NA;NA;NA;NA;NA;NA;2014;2016;2017;2017;UCLA;;Stefanie
1042;770;NCT03861624;1;2;32028315;20.05.2020;;27.02.2019;25.02.2019;NA;Interventional;Not Applicable;240;Completed;Intramedullary Nailing Versus External Fixation in Open Tibia Fractures in Tanzania;2015-12-17T00:00:00Z;2017-03-25T00:00:00Z;2017-03-25T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2019;2015;2017;2017;UCSF;;Nicole
811;232;NCT02279043;1;2;32032641;04.02.2020;;11.03.2019;27.10.2014;15.11.2018;Interventional;Not Applicable;630;Completed;Online Peer Influence on IUD Behaviors and Attitudes;2015-10-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2016;2016;UCSF;;Stefanie
966;698;NCT02094768;1;2;32033078;04.02.2020;;31.10.2017;20.03.2014;NA;Interventional;Not Applicable;30;Completed;Soda and Milk Study;2014-04-01T00:00:00Z;2017-05-01T00:00:00Z;2016-09-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2016;UCSF;;Samruddhi
293;196;NCT01213082;1;3;32055016;13.02.2020;automatically indexed: meta analysis. ;19.06.2018;29.09.2010;07.05.2018;Interventional;Phase 1/Phase 2;34;Completed;ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD);2010-09-01T00:00:00Z;2017-01-31T00:00:00Z;2017-01-31T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2017;2017;UCD;;Stefanie
295;208;NCT02672176;1;1;32130184;02.03.2020;There is published pilot data for this study at PMID: 29439942. Not sure if that should be use over final results because it was published first. Comment SW no since it comprises a different patient group COPD instead of diabetes;14.10.2019;20.01.2016;28.06.2018;Interventional;Not Applicable;319;Completed;Improving Health in Diabetes Project;2016-02-01T00:00:00Z;2017-12-31T00:00:00Z;2017-12-31T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCD;;Nicole
599;527;NCT02603471;1;1;32163431;12.03.2020;;22.04.2022;15.07.2014;NA;Interventional;Not Applicable;35;Completed;Cell Phone Technology Targeting ART and Naltrexone Adherence and Alcohol Use;2014-07-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCLA Integrated Substance Abuse Programs;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCLA;;Mario
596;524;NCT02446821;1;1;32168217;01.04.2020;;04.04.2022;24.04.2015;NA;Interventional;Phase 2;286;Completed;Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception;2015-06-01T00:00:00Z;2019-03-22T00:00:00Z;2017-05-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2019;2017;UCLA;;Mario
763;75;NCT01537133;1;1;32298699;13.04.2020;;17.11.2016;09.02.2012;11.03.2016;Interventional;Not Applicable;84;Completed;Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment;2012-10-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSF;;Stefanie
1020;749;NCT02610400;1;1;32334702;25.04.2020;;15.07.2020;18.09.2015;NA;Interventional;Phase 3;9845;Completed;Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in Namibia;2016-02-01T00:00:00Z;2017-12-01T00:00:00Z;2017-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;2017;UCSF;;Nicole
943;675;NCT01904890;1;3;32352912;30.04.2020;;29.12.2015;10.07.2013;NA;Interventional;Not Applicable;994;Completed;AANCART Research Project on Lay Health Workers and Asian Americans;2012-03-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2015;2015;UCSF;;Stefanie
1003;732;NCT02460731;1;2;32373661;10.04.2020;;07.08.2020;19.05.2015;NA;Interventional;Phase 1;6;Completed;Young Plasma Transfusions for Progressive Supranuclear Palsy;2015-05-01T00:00:00Z;2019-12-01T00:00:00Z;2017-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco Memory and Aging Center;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2019;2017;UCSF;;Stefanie
666;277;NCT01720667;1;2;32385134;08.05.2020;;12.08.2019;22.10.2012;03.07.2019;Interventional;Phase 1/Phase 2;280;Completed;Efficacy of Intravenous Levetiracetam in Neonatal Seizures;2013-03-01T00:00:00Z;2019-07-31T00:00:00Z;2017-10-31T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2019;2017;UCSD;;Mario
559;488;NCT01883791;1;2;32415721;05.07.2020;;31.10.2018;30.11.2012;NA;Interventional;Not Applicable;1080;Completed;Screening, Brief Intervention and Referral to Treatment for Substance Abuse in Mental Health Treatment Settings;2013-03-01T00:00:00Z;2018-06-30T00:00:00Z;2017-06-30T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2018;2017;UCLA;;Stefanie
986;715;NCT02244801;1;1;32446407;23.05.2020;for discussion: automatically indexed article summarizes different studies, but PI is author. No other article to the sudy is found. I would say it counts;10.10.2018;11.09.2014;NA;Interventional;Phase 1;6;Completed;Donor-Alloantigen-Reactive Regulatory T Cell (darTreg) Therapy in Renal Transplantation (The ONE Study );2015-04-01T00:00:00Z;2018-08-28T00:00:00Z;2017-09-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2018;2017;UCSF;;Stefanie
658;267;NCT02512419;1;1;32448552;21.05.2020;;21.06.2019;29.07.2015;30.05.2019;Interventional;Not Applicable;48;Completed;Developing a Text-Message Enhanced Physical Activity Intervention for Latino Men;2015-07-01T00:00:00Z;2017-12-31T00:00:00Z;2017-10-31T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSD;;Mario
348;398;NCT02238951;1;3;32452814;26.05.2020;not full study, but partial analysis - 32452814;15.11.2018;10.09.2014;NA;Interventional;Not Applicable;60;Completed;Cancer Care Coordination for Chemotherapy Patients;2013-12-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Davis Betty Irene Moore School of Nursing;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2017;2017;UCD;;Mario
603;531;NCT02687633;1;2;32467653;01.04.2020;;30.04.2018;10.02.2016;NA;Interventional;Not Applicable;8;Completed;Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex;2015-09-01T00:00:00Z;2017-08-01T00:00:00Z;2017-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2017;2017;UCLA;;Mario
882;617;NCT01235767;1;1;32469870;29.05.2020;;20.11.2020;04.11.2010;NA;Interventional;Not Applicable;291;Completed;Animal Source Food Supplement and Pregnancy in Vietnam;2011-01-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2016;2016;UCSF;;Susanne
926;658;NCT01772680;1;2;32488893;02.06.2020;;20.11.2020;17.01.2013;NA;Interventional;Not Applicable;40;Completed;Zinc and Diabetes in Patients With Thalassemia: a Pilot Study;2012-11-01T00:00:00Z;2015-05-01T00:00:00Z;2015-01-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2015;2015;UCSF;;Stefanie
372;420;NCT03302988;1;3;32531302;09.06.2020;Not OA, sample size deviation but mention of NCT, not a article;20.09.2018;02.10.2017;NA;Interventional;Not Applicable;33;Completed;Wound Eversion Versus Planar Closure for Face or Neck Wounds;2015-10-13T00:00:00Z;2017-07-25T00:00:00Z;2016-07-06T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2017;2015;2017;2016;UCD;;Samruddhi
358;408;NCT02464111;1;1;32649760;01.09.2020;;04.09.2015;22.04.2015;NA;Interventional;Not Applicable;30;Completed;Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women;2015-05-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);FED;FALSE;USDA WHNRC, UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2015;2015;UCD;;Nicole
493;254;NCT02582515;1;2;32653895;12.07.2020;;03.04.2019;16.10.2015;11.03.2019;Interventional;Not Applicable;20;Completed;Augmentation of Brief Habit Reversal Training With D-cycloserine or Placebo;2015-10-01T00:00:00Z;2017-08-01T00:00:00Z;2017-08-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCLA;;Stefanie
333;383;NCT01894958;1;1;32660869;23.05.2020;;31.01.2018;03.07.2013;NA;Interventional;Phase 2;72;Completed;A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome;2014-01-01T00:00:00Z;2015-10-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;Randomized;Quadruple;INDUSTRY;TRUE;UC Davis MIND Institute;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2015;2015;UCD;;Emmanuel
831;286;NCT01771731;1;1;32678452;01.07.2020;;05.08.2020;14.01.2013;03.09.2019;Interventional;Phase 1/Phase 2;27;Completed;Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease;2014-08-01T00:00:00Z;2017-05-19T00:00:00Z;2017-05-12T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2017;2017;UCSF;;Emmanuel
832;288;NCT01750268;1;1;32712569;02.07.2020;;18.09.2020;28.11.2012;26.09.2019;Interventional;Phase 4;32;Completed;Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI;2012-11-01T00:00:00Z;2015-10-01T00:00:00Z;2015-10-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCSF;;Stefanie
617;544;NCT03862443;1;1;32730310;30.07.2020;;01.03.2019;14.02.2019;NA;Interventional;Not Applicable;36;Completed;BEhavioral EConomics for Oral Health iNnovation Pilot Trial;2017-05-10T00:00:00Z;2018-03-19T00:00:00Z;2017-08-13T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;2019;2017;2018;2017;UCLA, UCSF;;Emmanuel
1004;733;NCT02465983;1;3;32730744;21.07.2020;;12.12.2019;28.05.2015;NA;Interventional;Phase 1;4;Terminated;Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer;2015-05-01T00:00:00Z;2017-11-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Stefanie
820;243;NCT01802216;1;1;32734226;02.12.2019;;11.04.2019;15.02.2013;08.01.2019;Interventional;Not Applicable;51;Completed;Kidney and Periodontal Disease Study;2014-02-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2017;2017;UCSF;;Nicole
675;291;NCT02010697;1;2;32753992;23.07.2020;direct results in an absstract conf. https://cdn.ymaws.com/www.srnt.org/resource/resmgr/conferences/2018_Annual_Meeting/65388_SRNT_2018_Abstract_fin.pdf;11.02.2020;02.12.2013;02.10.2019;Interventional;Not Applicable;3125;Completed;Nonsmokers Helping Smokers Quit;2013-12-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCSD;;Mario
1037;765;NCT03184337;1;1;32757824;06.08.2020;;24.10.2018;30.05.2017;NA;Interventional;Not Applicable;26;Completed;Women's Lifestyle Balance Study;2017-04-24T00:00:00Z;2017-12-31T00:00:00Z;2017-12-31T00:00:00Z;FALSE;Non-Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2017;2017;2017;2017;UCSF;;Samruddhi
777;141;NCT01638559;1;1;32786149;01.05.2021;;23.09.2019;09.07.2012;17.05.2017;Interventional;Phase 2;161;Completed;Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients;2012-08-14T00:00:00Z;2018-06-11T00:00:00Z;2016-03-31T00:00:00Z;TRUE;NA;None (Open Label);NIH;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2018;2016;UCSF;;Nicole
422;435;NCT02550561;1;3;32789810;13.08.2020;;19.03.2018;03.09.2015;NA;Interventional;Not Applicable;13;Completed;Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS;2015-06-01T00:00:00Z;2018-03-01T00:00:00Z;2017-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2018;2017;UCI;;Emmanuel
483;210;NCT01717859;1;1;32803573;15.08.2020;;06.05.2019;19.10.2012;09.07.2018;Interventional;Phase 4;74;Completed;Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab;2014-09-01T00:00:00Z;2017-04-01T00:00:00Z;2017-04-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCLA David Geffen School of Medicine, Division of Rheumatology;NA;NA;NA;NA;NA;NA;NA;NA;2012;2014;2017;2017;UCLA;;Samruddhi
727;582;NCT02241226;1;3;32850982;31.07.2020;outcome switching - but at least one primary outcome is reported;14.12.2015;09.09.2014;NA;Interventional;Not Applicable;115;Completed;Self-Directed Biological Transformation Initiative;2014-09-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Chopra Center for Wellbeing & University of California, San Diego;University of California, San Francisco;NA;Chopra Center for Wellbeing & University of California, San Diego;NA;University of California, San Diego;NA;NA;NA;2014;2014;2015;2015;UCSD, UCSF;;Susanne
955;687;NCT01983384;1;1;32925344;01.10.2020;;16.12.2019;29.10.2013;NA;Interventional;Not Applicable;205;Completed;Anesthetic Depth and Postoperative Delirium Trial - 2;2015-07-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2015;2017;2017;UCSF;;Nicole
1040;768;NCT03550144;1;2;32955293;21.09.2020;;10.10.2018;16.05.2018;NA;Interventional;Not Applicable;60;Completed;Improving Mental Health and Well-Being Via Awe Walks;2016-12-05T00:00:00Z;2018-05-26T00:00:00Z;2017-12-10T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2018;2016;2018;2017;UCSF;;Samruddhi
1044;771;NCT03982459;1;1;32997124;01.09.2020;;09.06.2019;27.05.2019;NA;Interventional;Not Applicable;76;Completed;National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC;2015-02-01T00:00:00Z;2018-09-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2019;2015;2018;2017;UCSF;;Mario
800;199;NCT02408965;1;3;33075332;17.10.2020;;15.08.2019;11.03.2015;09.05.2018;Interventional;Phase 4;284;Completed;Uterotonic Prophylaxis Trial;2015-03-01T00:00:00Z;2017-03-01T00:00:00Z;2017-03-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Susanne
591;519;NCT02290938;1;1;33231130;24.11.2020;;24.04.2019;10.07.2014;NA;Interventional;Not Applicable;185;Completed;Motivational Interviewing and Culture for Urban Native American Youth (MICUNAY);2014-07-01T00:00:00Z;2018-06-01T00:00:00Z;2017-04-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2018;2017;UCLA;;Emmanuel
582;511;NCT02181114;1;1;33245618;15.09.2020;sample size (802 vs 815 in registry);30.04.2018;27.06.2014;NA;Interventional;Not Applicable;815;Completed;Your Path to Transplant: A Randomized Control Trial of A Tailored Computer Education Intervention for Living Donor Kidney Transplant;2014-05-01T00:00:00Z;2017-12-01T00:00:00Z;2017-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCLA;;Samruddhi
824;252;NCT01555541;1;1;33288485;11.11.2020;outcome switching - but a primary outcome is reported;02.07.2021;09.03.2012;03.03.2019;Interventional;Phase 2;19;Completed;Study of Intensive Consolidation and Stem Cell Mobilization Therapy Followed by Autologous Stem Cell Transplantation in High-risk Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma;2012-05-25T00:00:00Z;2021-07-01T00:00:00Z;2017-07-06T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2021;2017;UCSF;;Susanne
961;693;NCT02026544;1;1;33313066;21.08.2020;combination of preclinical and clinical report;20.04.2021;19.12.2013;NA;Interventional;Not Applicable;10;Completed;Effect of Low Frequency Ultrasound on Kidney Function;2014-01-28T00:00:00Z;2014-10-06T00:00:00Z;2014-10-06T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2014;2014;UCSF;;Nicole
232;352;NCT02360449;1;1;33387236;02.01.2021;;06.01.2021;05.02.2015;NA;Interventional;Not Applicable;44;Completed;Social Motivation Intervention for Children With Autism Spectrum Disorder: Improving Peer Initiation;2015-01-01T00:00:00Z;2020-11-05T00:00:00Z;2017-07-19T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2020;2017;Stanford;;Nicole
745;600;NCT04522635;1;1;33407747;06.01.2021;;20.08.2020;18.08.2020;NA;Interventional;Phase 4;65;Completed;Fluid Mobilization in Hospitalized Patients With Acute Kidney Injury;2015-06-03T00:00:00Z;2019-12-31T00:00:00Z;2017-12-15T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2020;2015;2019;2017;UCSD;;Stefanie
407;427;NCT01423266;1;3;33502122;27.01.2021;;19.05.2016;15.08.2011;NA;Interventional;Not Applicable;78;Completed;Effects of a High Protein Diet on Clinical Outcomes in Heart Failure;2009-12-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2011;2009;2015;2015;UCI;;Stefanie
1007;736;NCT02491190;1;1;33504589;01.01.2021;sample size deviation, similar outcome analysed;12.05.2016;26.06.2015;NA;Interventional;Not Applicable;58;Completed;Using Multimedia Digital Health to Enable and Engage Pediatric Inpatients and Their Parents;2015-08-01T00:00:00Z;2016-03-01T00:00:00Z;2016-01-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSF;;Samruddhi
996;725;NCT02373657;1;2;33534742;01.02.2021;;23.06.2021;23.02.2015;NA;Interventional;Not Applicable;4068;Completed;Water Uptake for Health in Amhara Pilot;2014-04-01T00:00:00Z;2017-05-01T00:00:00Z;2017-05-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;F.I. Proctor Foundation, University of California San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2017;2017;UCSF;;Mario
939;671;NCT01877330;1;2;33600437;18.02.2021;;17.03.2020;12.12.2012;NA;Interventional;Not Applicable;208;Completed;Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block;2013-01-01T00:00:00Z;2016-04-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2016;2016;UCSF;;Susanne
347;397;NCT02224976;1;1;33651630;02.03.2021;Charite IP blocked from accessing complete article;26.01.2016;21.08.2014;NA;Interventional;Not Applicable;18;Completed;Effect of Intense Training on Ovarian Function and Bone Turnover;2014-01-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;NA;None (Open Label);FED;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCD;;Samruddhi
345;395;NCT02143011;0;3;33652807;26.02.2021;I found this one by searching for orange juice trial and PI;14.01.2019;16.05.2014;NA;Interventional;Not Applicable;23;Completed;Stress and Sugar Synergy;2014-04-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;University of California, Davis;NA;NA;NA;2014;2014;2016;2016;UCD;;Nicole
364;412;NCT02804490;1;1;33693468;08.05.2021;;16.08.2017;15.06.2016;NA;Interventional;Phase 3;255;Completed;Efficacy of Biofortified Maize to Improve Maternal and Infant Vitamin A Status;2016-03-01T00:00:00Z;2017-06-02T00:00:00Z;2017-06-02T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;NA;NA;NA;NA;NA;University of California, Davis;NA;NA;NA;2016;2016;2017;2017;UCD;;Mario
563;492;NCT01922206;1;1;33705165;01.02.2021;;14.01.2020;02.08.2013;NA;Interventional;Not Applicable;362;Completed;Maternal HIV: Trial to Assist Disclosure to Children;2013-03-01T00:00:00Z;2019-11-01T00:00:00Z;2017-11-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2019;2017;UCLA;;Stefanie
1017;746;NCT02585336;1;1;33778854;27.10.2021;;20.01.2021;21.10.2015;NA;Interventional;Not Applicable;214;Completed;Changes in Sugar-sweetened Beverage Intake and Metabolic Health: Improving Metabolic Profile Very Effortlessly;2015-07-28T00:00:00Z;2016-10-16T00:00:00Z;2016-10-16T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSF;;Stefanie
1011;740;NCT02535455;1;3;33790528;16.04.2019;;17.06.2020;20.08.2015;NA;Interventional;Not Applicable;10;Completed;Acceptance and Compassion to Enhance Self-care Pilot;2015-08-01T00:00:00Z;2016-12-31T00:00:00Z;2016-12-31T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSF;;Nicole
402;311;NCT02205307;1;1;33872284;01.08.2021;;22.06.2020;29.07.2014;11.05.2020;Interventional;Not Applicable;347;Terminated;A Study Assessing Perfusion Outcomes With PINPOINT Near Infrared Fluorescence Imaging in Low Anterior Resection;2015-01-01T00:00:00Z;2017-05-01T00:00:00Z;2017-05-01T00:00:00Z;TRUE;Randomized;None (Open Label);INDUSTRY;TRUE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;2017;UCI;;Susanne
971;703;NCT02106767;1;3;33880760;16.05.2021;;21.01.2020;03.04.2014;NA;Interventional;Phase 1;16;Completed;The Effects of Rifampin on the Pharmacokinetics of Rosuvastatin;2014-11-01T00:00:00Z;2016-08-07T00:00:00Z;2016-08-07T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSF;;Emmanuel
752;44;NCT01383174;1;1;33937611;26.04.2021;;03.01.2019;03.06.2011;05.05.2015;Interventional;Not Applicable;151;Completed;Nuevo Amanecer: Promoting the Psychosocial Health of Latinas;2011-02-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCSF;;Samruddhi
80;153;NCT02021812;1;3;33940079;30.04.2021;;15.09.2021;13.12.2013;07.07.2017;Interventional;Not Applicable;31;Active, not recruiting;Feasibility Study for GORE TAG Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms;2014-01-01T00:00:00Z;2022-04-01T00:00:00Z;2016-08-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2022;2016;Stanford;;Susanne
618;545;NCT04598100;1;3;33963489;07.05.2021;;16.10.2020;01.10.2020;NA;Interventional;Not Applicable;199;Completed;Promoting Resiliency in Veteran Families With Young Children;2014-04-03T00:00:00Z;2018-06-30T00:00:00Z;2017-01-18T00:00:00Z;FALSE;Randomized;Double;OTHER;TRUE;University of California, Los Angeles, Semel Institute;NA;NA;NA;NA;University of California, Los Angeles, Semel Institute;NA;NA;NA;2020;2014;2018;2017;UCLA;;Samruddhi
344;394;NCT02084979;1;1;33993104;20.07.2021;;10.06.2019;10.03.2014;NA;Interventional;Not Applicable;185;Completed;A Controlled Trial of Patient Centered Telepsychiatry Interventions;2014-04-01T00:00:00Z;2019-04-29T00:00:00Z;2017-12-31T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Professor UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2019;2017;UCD;;Mario
335;385;NCT01923337;1;1;33993383;15.05.2021;;02.01.2019;13.08.2013;NA;Interventional;Phase 1;17;Completed;Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer;2013-08-01T00:00:00Z;2016-10-17T00:00:00Z;2016-10-17T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UC Davis Comprehensive Cancer Center;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCD;;Samruddhi
584;513;NCT02256865;1;1;34043794;18.08.2021;first reported trial has sample size deviation with different outcome than registry;11.03.2022;22.09.2014;NA;Interventional;Early Phase 1;40;Active, not recruiting;Hormonal Mechanisms of Sleep Restriction;2014-10-01T00:00:00Z;2023-10-01T00:00:00Z;2017-11-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2023;2017;UCLA;;Samruddhi
645;215;NCT03158012;1;1;34132739;16.06.2021;;18.10.2019;09.05.2017;21.08.2018;Interventional;Phase 1;15;Completed;Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients;2016-04-01T00:00:00Z;2018-08-01T00:00:00Z;2017-12-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;UCSD School of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2017;2016;2018;2017;UCSD;;Nicole
728;583;NCT02254902;1;3;34153979;15.09.2021;possiby this one - could not access full text - https://pubmed.ncbi.nlm.nih.gov/34153979/ - confirmed now after DC;11.05.2016;29.09.2014;NA;Interventional;Not Applicable;27;Terminated;Physical Activity and Education Program for Somali Women;2014-09-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCSD;;Mario
991;720;NCT02315690;1;1;34193475;01.06.2021;;30.08.2021;08.12.2014;NA;Interventional;Phase 3;4000;Completed;Evaluation of Reactive Focal Mass Drug Administration for Malaria Elimination in Swaziland;2015-09-01T00:00:00Z;2017-07-01T00:00:00Z;2017-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UTSW, UCSF;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;2017;UCSF;;Susanne
802;204;NCT01781975;1;1;34214479;29.06.2021;;10.02.2020;17.01.2013;25.05.2018;Interventional;Phase 2;67;Completed;Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus;2014-01-01T00:00:00Z;2018-05-01T00:00:00Z;2017-05-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2018;2017;UCSF;;Mario
320;370;NCT01592682;1;1;34300133;20.07.2021;;01.06.2015;26.04.2012;NA;Interventional;Not Applicable;410;Completed;Creating Smokefree Living Together for Chinese Household Pairs;2012-04-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCD;;Susanne
81;154;NCT02264977;1;2;34318189;16.01.2021;;07.02.2022;08.10.2014;07.07.2017;Interventional;Not Applicable;9;Active, not recruiting;Early Feasibility of the Branched TAG Device in the Treatment of Aortic Arch Aneurysms;2015-04-01T00:00:00Z;2022-04-01T00:00:00Z;2016-07-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2022;2016;Stanford;;Nicole
637;174;NCT01601626;1;2;34398956;16.08.2021;;07.02.2018;16.05.2012;10.01.2018;Interventional;Phase 2;71;Terminated;Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV;2013-07-13T00:00:00Z;2017-06-28T00:00:00Z;2017-01-19T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of California, San Diego;NA;NA;NA;NA;NA;2012;2013;2017;2017;UCSD;;Nicole
619;546;NCT04710095;1;1;34429151;24.08.2021;;20.01.2021;12.01.2021;NA;Interventional;Not Applicable;60;Completed;Perceived Alcohol Rewards and Risks Study;2015-11-13T00:00:00Z;2017-04-05T00:00:00Z;2017-04-05T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2021;2015;2017;2017;UCLA;;Mario
784;151;NCT02417233;1;1;34435440;01.08.2021;;17.11.2017;12.12.2014;27.06.2017;Interventional;Not Applicable;756;Completed;Engagement to Care South Africa;2014-10-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSF;;Nicole
576;505;NCT02122068;1;2;34498016;29.05.2021;comparison group changed (waiting list instead of relaxation cd);19.01.2021;16.04.2014;NA;Interventional;Not Applicable;26;Completed;Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers;2014-04-01T00:00:00Z;2015-09-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCLA;;Susanne
349;399;NCT02289859;1;1;34546436;21.09.2021;;17.07.2017;10.11.2014;NA;Interventional;Not Applicable;50;Completed;Undermining During Cutaneous Wound Closure;2014-05-01T00:00:00Z;2016-07-01T00:00:00Z;2016-04-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCD;;Samruddhi
732;587;NCT02330744;1;1;34643736;13.10.2021;;31.08.2017;24.12.2014;NA;Interventional;Not Applicable;40;Completed;The Neurobiology of Approach Avoidance Training in Depression;2014-07-01T00:00:00Z;2017-07-01T00:00:00Z;2017-04-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSD;;Emmanuel
398;187;NCT01882985;1;2;34649352;24.09.2021;;30.12.2020;18.06.2013;02.03.2018;Interventional;Phase 2;14;Completed;Docetaxel Plus Lycopene in Castration Resistant, Chemotherapy-Nave Prostate Cancer Patients;2010-12-01T00:00:00Z;2016-10-01T00:00:00Z;2016-10-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2013;2010;2016;2016;UCI;;Stefanie
150;299;NCT00928226;1;1;34670228;01.11.2021;;10.01.2020;23.06.2009;12.12.2019;Interventional;Not Applicable;56;Completed;Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases;2009-04-01T00:00:00Z;2019-12-01T00:00:00Z;2017-10-31T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2019;2017;Stanford;;Emmanuel
854;332;NCT01687673;1;1;34950179;06.09.2021;;12.11.2020;11.09.2012;21.10.2020;Interventional;Phase 2;29;Completed;Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma;2012-10-05T00:00:00Z;2020-01-09T00:00:00Z;2016-04-26T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2012;2012;2020;2016;UCSF;;Mario
560;489;NCT01884233;1;2;34979421;25.12.2021;;22.04.2022;24.05.2013;NA;Interventional;Not Applicable;62;Completed;Cell Phone Technology Targeting ART Adherence and Drug Use;2012-12-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2016;2016;UCLA;;Samruddhi
976;707;NCT02139722;1;1;34993863;06.01.2022;;17.07.2020;06.05.2014;NA;Interventional;Not Applicable;431;Completed;Patient-Centered Care and Asian Americans;2014-01-02T00:00:00Z;2017-07-30T00:00:00Z;2017-05-28T00:00:00Z;FALSE;Randomized;Double;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSF;;Mario
564;493;NCT01937936;1;1;35382758;05.04.2022;;26.10.2016;04.09.2013;NA;Interventional;Not Applicable;50;Completed;Heart Failure Caregiver Study;2013-09-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCLA;;Samruddhi
376;424;NCT03526081;1;1;35452808;01.04.2022;;21.05.2019;03.05.2018;NA;Interventional;Not Applicable;17;Completed;Absorption, Metabolism and Excretion of Apigenin and Apigenin Glycosides;2015-01-20T00:00:00Z;2016-07-30T00:00:00Z;2016-07-30T00:00:00Z;FALSE;Non-Randomized;Single;OTHER;TRUE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2018;2015;2016;2016;UCD;;Stefanie
1016;745;NCT02577575;1;2;35755629;19.09.2020;;17.05.2019;29.09.2015;NA;Interventional;Early Phase 1;120;Completed;Adult Oxytocin Study;2010-08-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;Randomized;Double;OTHER;TRUE;University of California San Francisco, San Francisco Veterans Affairs Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2015;2010;2015;2015;UCSF;;Mario
862;346;NCT00905060;1;1;28193626;13.02.2017;;23.03.2021;18.05.2009;25.02.2021;Interventional;Phase 2;70;Completed;HSPPC-96 Vaccine With Temozolomide in Patients With Newly Diagnosed GBM;2009-06-29T00:00:00Z;2014-06-03T00:00:00Z;2014-06-03T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;2014;UCSF;;Stefanie
158;345;NCT01970007;2;3;10.1016/j.jvir.2021.03.097;01.05.2021;section snippet, abstract with matching PICO. And Trial-ID. Slides found by susanne no permanent link.;12.03.2021;22.10.2013;03.02.2021;Interventional;Not Applicable;243;Completed;VIVO Clinical Study;2013-12-13T00:00:00Z;2019-11-20T00:00:00Z;2017-11-20T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2019;2017;Stanford;;Susanne
918;651;NCT01709773;2;3;10.1016/j.ygyno.2017.07.055;01.10.2017;"only this one found; https://www.gynecologiconcology-online.net/article/S0090-8258(17)31072-7/fulltext, is a conference abstract and unsure whether it fits. It compares 3 treatment (registry: only one), maybe combines different trials, anywhay not a full publication to count";16.02.2018;15.10.2012;NA;Interventional;Not Applicable;20;Completed;Focal Ablation of Cervical Precancer;2013-01-17T00:00:00Z;2014-05-26T00:00:00Z;2014-04-11T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2014;2014;UCSF;;Susanne
594;522;NCT02394054;1;2;10.1017/S0033291721004104;15.10.2021;publication combines 3 trial;08.08.2017;22.01.2015;NA;Interventional;Early Phase 1;84;Completed;Vasopressin and the Social Brain;2015-01-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCLA;;Nicole
977;708;NCT02141828;1;2;10.1182/blood.V128.22.2780.2780;;is a poster abstract but exceeding 500 words;07.05.2020;11.05.2014;NA;Interventional;Phase 1;18;Completed;A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene;2014-05-01T00:00:00Z;2016-06-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSF;;Susanne
680;310;NCT01098422;2;3;10.1200/jco.2012.30.15_suppl.e14079;20.05.2012;;02.08.2021;01.04.2010;06.05.2020;Interventional;Not Applicable;10;Terminated;A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver;2010-01-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;2015;UCSD;;Mario
870;606;NCT00734682;2;3;10.1200/jco.2015.33.15_suppl.2029;20.05.2015;Not available on pubmed & only able to access the abstract;05.01.2015;13.08.2008;NA;Interventional;Phase 1;34;Completed;A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas;2008-08-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2014;2014;UCSF;;Nicole
845;315;NCT01466972;2;2;10.1200/jco.2015.33.15_suppl.529;20.05.2015;;07.07.2020;25.10.2011;27.05.2020;Interventional;Phase 2;30;Completed;Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib;2012-04-27T00:00:00Z;2019-10-02T00:00:00Z;2015-12-07T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2011;2012;2019;2015;UCSF;;Samruddhi
899;634;NCT01478178;2;3;10.1200/JCO.2016.34.15_suppl.2063;20.05.2016;Not available on pubmed & only able to access the abstract;19.01.2017;14.11.2011;NA;Interventional;Phase 1/Phase 2;55;Completed;Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma;2011-10-01T00:00:00Z;2016-10-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of California, San Francisco, 94143, USA;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2016;2015;UCSF;;Nicole
465;156;NCT02093962;2;2;10.1200/JCO.2016.34.15_suppl.9075;20.05.2016;abstrACT CONFERENCE,TRIAL DISCONTINUES;23.03.2021;18.03.2014;13.07.2017;Interventional;Phase 2;265;Terminated;Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer;2014-06-01T00:00:00Z;2016-05-01T00:00:00Z;2016-04-01T00:00:00Z;TRUE;Randomized;Triple;INDUSTRY;TRUE;UCLA-Dept of Medicine a Div of Hem/Onc;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCLA;;Mario
1009;738;NCT02508441;2;2;10.1200/JCO.2018.36.15_suppl.2557;01.06.2018;Not available on pubmed & only able to access the abstract;16.10.2018;15.07.2015;NA;Interventional;Phase 1;22;Terminated;Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors;2015-12-08T00:00:00Z;2017-11-13T00:00:00Z;2017-11-13T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Nicole
834;290;NCT02918357;2;2;10.1200/JCO.2018.36.6_suppl.236;26.02.2018;only conference abstract: 10.1200/JCO.2018.36.6_suppl.236;27.11.2019;27.09.2016;30.09.2019;Interventional;Phase 2/Phase 3;385;Completed;Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence;2016-09-15T00:00:00Z;2017-09-21T00:00:00Z;2017-09-21T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCSF;;Susanne
339;389;NCT02022345;2;3;"Bommer W. The percutaneous coronary intervention California audit monitored pilot with offsite surgery (PCI-CAMPOS) outcomes in 153,950 patients in hospitals with and without onsite cardiac surgery. Presented at: American College of Cardiology Annual Scientific Session; March 29, 2014; Washington, DC.";29.03.2014;slides;24.05.2017;17.12.2013;NA;Interventional;Not Applicable;5609;Completed;Safety and Efficacy of PCI at California Hospitals Without Onsite Cardiac Surgery;2010-08-01T00:00:00Z;2015-02-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;TRUE;UC Davis Health System;NA;NA;NA;NA;NA;NA;NA;NA;2013;2010;2015;2014;UCD;;Emmanuel
931;663;NCT01823978;2;3;https://ascopubs.org/doi/10.1200/jco.2014.32.15_suppl.tps3132;20.05.2014;meeting abstract, less than 500 words;04.10.2019;21.03.2013;NA;Interventional;Phase 1;19;Completed;Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer;2013-04-01T00:00:00Z;2017-09-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2016;UCSF;;Emmanuel
936;668;NCT01841463;2;2;https://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.9076;20.05.2015;conference abstract;03.09.2014;17.04.2013;NA;Interventional;Phase 1;100;Suspended;Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation;2013-08-01T00:00:00Z;2016-03-01T00:00:00Z;2015-03-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;UCSF Medical Center at Mount Zion;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2015;UCSF;;Nicole
336;386;NCT01924260;2;3;https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.3589;20.05.2020;;06.04.2021;13.08.2013;NA;Interventional;Phase 1;26;Completed;Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer;2013-08-09T00:00:00Z;2017-02-08T00:00:00Z;2017-02-08T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UC Davis Comprehensive Cancer Center;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCD;;Emmanuel
319;369;NCT01564381;1;3;https://doi.org/10.1016/j.phanu.2016.05.002;01.07.2016;;13.07.2017;22.02.2012;NA;Interventional;Phase 1/Phase 2;64;Completed;Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women;2012-03-01T00:00:00Z;2015-03-01T00:00:00Z;2015-03-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCD;;Mario
858;338;NCT01292252;2;3;https://doi.org/10.1016/j.spinee.2019.05.184;01.09.2019;;29.04.2021;07.02.2011;08.12.2020;Interventional;Phase 4;36;Completed;Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion;2011-08-01T00:00:00Z;2016-12-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2011;2011;2016;2015;UCSF;;Mario
499;316;NCT02589067;2;3;https://doi.org/10.1093%2Fofid%2Fofy210.1973;26.11.2018;conference abstract;03.12.2020;20.10.2015;15.06.2020;Interventional;Phase 2;67;Completed;Decolonization of the Oropharynx, an Important and Neglected Reservoir of S. Aureus Colonization;2015-10-01T00:00:00Z;2017-11-01T00:00:00Z;2017-10-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCLA;;Samruddhi
719;574;NCT02067156;2;3;https://doi.org/10.1093/neuonc/nov206.18;09.11.2015;;22.02.2017;16.02.2014;NA;Interventional;Phase 2;26;Completed;Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma;2014-02-01T00:00:00Z;2017-02-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;FALSE;University of California, San Diego Moores Cancer Center;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2016;UCSD;;Mario
400;214;NCT02320812;2;2;https://iovs.arvojournals.org/article.aspx?articleid=2690954;Jul 18;abstract: https://iovs.arvojournals.org/article.aspx?articleid=2690954;04.03.2019;16.12.2014;07.08.2018;Interventional;Phase 1/Phase 2;28;Completed;Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa;2015-06-01T00:00:00Z;2017-07-19T00:00:00Z;2017-07-19T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;Gavin Herbert Eye Institute, UCI, Irvine, CA;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;2017;UCI;;Samruddhi
756;54;NCT01562132;2;3;https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.12196;15.05.2014;poster - https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.12196;01.09.2021;21.03.2012;31.07.2015;Interventional;Phase 2;6;Terminated;Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection;2013-09-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2014;2014;UCSF;;Nicole
935;667;NCT01841307;2;3;https://patents.google.com/patent/US20140194503;;Terminated with interim analysis;12.02.2019;23.04.2013;NA;Interventional;Phase 1;16;Terminated;Cromolyn Detection of Silent Aspiration;2015-07-01T00:00:00Z;2017-09-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2015;2017;2017;UCSF;;Samruddhi
355;405;NCT02438878;2;3;https://www.bcm.edu/sites/default/files/2014/cc/heinig-uc-davis-abstract-press-release.pdf;;;25.09.2018;06.05.2015;NA;Interventional;Not Applicable;423;Completed;Supporting Baby Behavior Through Pediatric Offices;2015-03-01T00:00:00Z;2017-02-16T00:00:00Z;2016-12-07T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2016;UCD;;Samruddhi
687;350;NCT02001064;2;3;https://www.researchgate.net/publication/335313774_Pilot_Randomized_Controlled_Trial_of_Care4TodayR_Mobile_Health_Manager_for_Improving_Antiretroviral_Adherence_among_Persons_Living_with_HIV;14.10.2016;;08.07.2021;27.11.2013;03.06.2021;Interventional;Not Applicable;60;Completed;Care4Today v2.0 Application for Improving Adherence to HIV Medications;2013-10-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCSD;;Emmanuel
659;269;NCT01505179;2;3;https://www.sciencedirect.com/science/article/pii/S1071916415005084?via%3Dihub ;01.08.2016;Behind paywall, cannot access and confirm(scihub fail);09.01.2020;08.12.2011;05.06.2019;Interventional;Not Applicable;10;Completed;The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction;2011-02-01T00:00:00Z;2015-01-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2014;UCSD;;Samruddhi
378;36;NCT01313923;0;;;;;08.05.2017;10.03.2011;17.12.2014;Interventional;Early Phase 1;3;Terminated;Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus;2011-02-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCI;;Emmanuel
625;55;NCT01510756;0;;;;terminated early;16.12.2015;11.01.2012;21.08.2015;Interventional;Phase 2;4;Terminated;Sorafenib for the Treatment of Chronic Lymphocytic Leukemia (CLL);2011-12-01T00:00:00Z;2014-12-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCSD Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2014;2014;UCSD;;Emmanuel
626;58;NCT01838499;0;;;;industry sponsored trial;21.07.2016;19.04.2013;13.10.2015;Interventional;Phase 2;224;Terminated;Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa;2013-05-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCSD;;Emmanuel
443;79;NCT00777049;0;;;;;14.07.2016;21.10.2008;26.05.2016;Interventional;Phase 2;54;Completed;Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer;2009-02-01T00:00:00Z;2015-04-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;NA;NA;2008;2009;2015;2015;UCLA;;Emmanuel
283;125;NCT01673828;0;;;;;25.05.2017;20.08.2012;20.03.2017;Interventional;Phase 2;13;Completed;Allopregnanolone for the Treatment of Traumatic Brain Injury;2013-04-01T00:00:00Z;2016-07-01T00:00:00Z;2015-05-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;University of California, Davis;NA;NA;NA;2012;2013;2016;2015;UCD;;Emmanuel
390;142;NCT00915031;0;;;;here I find papers in the main investigators name about the same subject but no mention of nctid or a match in sample size for that matter (i.e. 19698020). ;06.03.2019;03.06.2009;22.05.2017;Interventional;Not Applicable;738;Completed;Use of Hypothermia During Robotic Prostatectomy;2009-08-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;2015;UCI;;Emmanuel
302;297;NCT01110174;0;;;;;13.11.2019;22.04.2010;24.10.2019;Interventional;Not Applicable;8;Completed;Assessing Response to Neoadjuvant Chemotherapy With HD PET/CT, Serum Glycomic Markers and Tissue Muc-1 Isoforms;2010-03-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2016;2016;UCD;;Emmanuel
683;314;NCT02495883;0;;;;;01.12.2020;26.09.2013;27.05.2020;Interventional;Phase 4;56;Completed;Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response;2013-12-01T00:00:00Z;2017-04-01T00:00:00Z;2017-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCSD;;Emmanuel
366;414;NCT03002883;0;;;;;29.03.2017;19.12.2016;NA;Interventional;Not Applicable;113;Completed;STAND Community College Tobacco Cessation Trial;2014-09-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2016;2014;2016;2016;UCD;;Emmanuel
513;444;NCT01002417;0;;;;;01.03.2015;25.10.2009;NA;Interventional;Phase 2/Phase 3;274;Completed;MCS in the Treatment of Lower Urinary Tract Symptoms;2010-07-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;Randomized;Quadruple;INDUSTRY;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2009;2010;2014;2014;UCLA;;Emmanuel
520;451;NCT01122329;0;;;;;19.03.2015;11.05.2010;NA;Interventional;Phase 4;17;Completed;A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease;2010-10-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;TRUE;Mary S. Easton Center for Alzheimer's Disease Research at UCLA;NA;NA;"Mary S. Easton Center for Alzheimer's Disease Research at UCLA; UCLA Department of Molecular and Medical Pharmacology";NA;NA;NA;NA;NA;2010;2010;2015;2015;UCLA;;Emmanuel
522;453;NCT01219647;0;;;;;05.12.2014;08.10.2010;NA;Interventional;Phase 1/Phase 2;35;Completed;Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis;2010-07-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;2014;UCLA;;Emmanuel
529;460;NCT01391949;0;;;;;29.04.2019;11.07.2011;NA;Interventional;Phase 2/Phase 3;1;Terminated;Pedaling Exercises for Disability and Activity Limitations;2011-07-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCLA;;Emmanuel
550;479;NCT01724047;0;;;;;22.09.2014;05.11.2012;NA;Interventional;Not Applicable;250;Completed;Autism Intervention Research Network for Behavioral Health (AIR-B II): Deployment Into Elementary Schools;2012-11-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;Double;FED;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCLA;;Emmanuel
551;480;NCT01751698;0;;;; there are two papers written close to the date of registration (which was 2012): 22744141 and 22490620. But neither report nctid and neither have a matching sample size to the estimated sample size of 192. I don?t feel confident enough to add them as publications.;09.10.2018;14.12.2012;NA;Interventional;Not Applicable;192;Completed;Adaptive Interventions for Minimally Verbal Children With ASD in the Community;2013-01-01T00:00:00Z;2017-12-01T00:00:00Z;2017-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2017;2017;UCLA;;Emmanuel
552;481;NCT01755962;0;;;;;12.11.2020;11.10.2012;NA;Interventional;Not Applicable;88;Completed;Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity;2012-04-01T00:00:00Z;2017-12-14T00:00:00Z;2017-12-14T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2017;2017;UCLA;;Emmanuel
553;482;NCT01756651;0;;;;no studies have his name in them;10.05.2017;20.12.2012;NA;Interventional;Phase 1;20;Completed;Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures;2013-02-01T00:00:00Z;2016-05-10T00:00:00Z;2016-05-10T00:00:00Z;FALSE;Non-Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2016;2016;UCLA;;Emmanuel
717;572;NCT02021214;0;;;;;26.02.2020;09.12.2013;NA;Interventional;Early Phase 1;24;Completed;Effects of Methylphenidate (Ritalin) on the Neural Basis of Anxiety;2014-03-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;FALSE;NA;Double;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2014;2014;UCSD;;Emmanuel
718;573;NCT02046928;0;;;;;11.07.2016;20.01.2014;NA;Interventional;Phase 2;5;Terminated;Safety, Tolerability and Efficacy of A6 in Patients With Chronic Lymphocytic Leukemia (CLL);2014-02-01T00:00:00Z;2016-03-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;FALSE;Moores Cancer Center, UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2015;UCSD;;Emmanuel
731;586;NCT02327637;0;;;;;04.06.2019;19.12.2014;NA;Interventional;Not Applicable;5;Terminated;A Comparison of Bed Rest Versus Moderate Activity in Preterm Premature Rupture of Membranes (PPROM);2014-12-01T00:00:00Z;2016-12-12T00:00:00Z;2016-12-12T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSD;;Emmanuel
689;547;NCT00771862;0;;;;23489466 cites another registration, 33021563 as well;15.03.2018;14.10.2008;NA;Interventional;Phase 4;16;Terminated;Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study;2008-10-01T00:00:00Z;2017-05-30T00:00:00Z;2017-05-30T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2017;2017;UCSD;;Emmanuel
630;85;NCT01696214;0;;;;;02.01.2019;25.06.2012;08.08.2016;Interventional;Phase 4;20;Completed;A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial;2012-10-01T00:00:00Z;2016-11-01T00:00:00Z;2015-05-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2015;UCSD;;Mario
641;200;NCT02644122;0;;;;1 PERSON ENROLLED;13.06.2018;07.12.2015;11.05.2018;Interventional;Phase 2;1;Terminated;SF1126 in Recurrent or Progressive SCCHN and Mutations in PIK3CA Gene and/or PI-3 Kinase Pathway Genes;2016-11-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2016;2016;UCSD;;Mario
296;209;NCT00795665;0;;;;;04.05.2020;20.11.2008;03.07.2018;Interventional;Phase 2;7;Completed;Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma;2008-06-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2015;2015;UCD;;Mario
494;255;NCT01694433;0;;;;;18.04.2019;24.09.2012;15.03.2019;Interventional;Phase 2/Phase 3;66;Completed;"""Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy""";2013-02-01T00:00:00Z;2014-01-09T00:00:00Z;2014-01-09T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;UCLA Department of Medicine/Division of Dermatology and Nutrition;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2014;2014;UCLA;;Mario
833;289;NCT02177773;0;;;;TERMINATED;21.10.2019;25.06.2014;26.09.2019;Interventional;Phase 1/Phase 2;300;Terminated;GA-68 DOTA-TOC of Somatostatin Positive Malignancies;2014-06-23T00:00:00Z;2017-08-07T00:00:00Z;2017-08-07T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSF;;Mario
860;340;NCT01276236;0;;;;;03.03.2021;20.12.2010;16.12.2020;Interventional;Phase 2;13;Completed;Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS);2011-03-09T00:00:00Z;2015-04-30T00:00:00Z;2015-01-31T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;"University of California, San Francisco; San Francisco General Hospital (SFGH)";NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2015;2015;UCSF;;Mario
331;381;NCT01869543;0;;;;;19.03.2019;03.04.2013;NA;Interventional;Not Applicable;219;Completed;Asthma and Indoor-air: Reducing Exposures;2012-07-01T00:00:00Z;2017-02-08T00:00:00Z;2017-02-08T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2017;2017;UCD;;Mario
362;410;NCT02597777;0;;;;in vitro studyfound;03.04.2017;31.10.2015;NA;Interventional;Not Applicable;14;Completed;Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin;2016-01-01T00:00:00Z;2016-02-01T00:00:00Z;2016-02-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, Davis, Dermatology;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2016;2016;UCD;;Mario
415;431;NCT02078895;0;;;;Terminated;21.08.2018;26.02.2014;NA;Interventional;Phase 3;15;Terminated;Randomization of Botox for Stent Pain and Irritative Voiding Symptoms;2014-02-01T00:00:00Z;2017-02-01T00:00:00Z;2017-02-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Irvine Department of Urology;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCI;;Mario
539;469;NCT01581996;0;;;;;08.05.2017;09.04.2012;NA;Interventional;Not Applicable;9;Completed;Fosrenol and Phosphorus Balance - Lanthanum Carbonate;2012-03-01T00:00:00Z;2017-05-01T00:00:00Z;2017-05-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2017;2017;UCLA;;Mario
579;508;NCT02129790;0;;;;several similar, but none one arm or 10 patients, others much larger;16.04.2019;25.04.2014;NA;Interventional;Not Applicable;10;Completed;Mentalization-Based Therapy to Prevent Suicidal Behavior in Adolescents With Bipolar Disorder;2014-01-01T00:00:00Z;2018-09-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UCLA Department of Psychiatry;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2018;2017;UCLA;;Mario
597;525;NCT02457988;0;;;;;24.10.2017;25.02.2015;NA;Interventional;Early Phase 1;120;Terminated;The Cirrhosis Outpatient Optimization, Readmission & Safety Study;2015-04-01T00:00:00Z;2018-03-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2018;2017;UCLA;;Mario
606;534;NCT02723318;0;;;;;24.10.2017;25.03.2016;NA;Interventional;Not Applicable;150;Completed;The Impact of Family Financial Support on Cognition;2016-03-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCLA;;Mario
746;601;NCT04626219;0;;;;;10.11.2020;23.02.2009;NA;Interventional;Not Applicable;150;Completed;Neurobiology of Anorexia and Bulimia Nervosa;2009-02-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;2014;UCSD;;Mario
901;636;NCT01488123;0;;;;;24.10.2016;05.12.2011;NA;Interventional;Not Applicable;32;Completed;Integrative Approaches for Cancer Survivorship;2012-01-01T00:00:00Z;2015-10-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2015;2014;UCSF;;Mario
1018;747;NCT02591381;0;;;;failed enrollment;01.05.2018;20.10.2015;NA;Interventional;Not Applicable;3;Terminated;Transcorporal Versus Standard Artificial Urinary Sphincter Placement;2015-10-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Mario
1024;752;NCT02719730;0;;;;terminated;09.02.2018;15.03.2016;NA;Interventional;Not Applicable;5;Terminated;Upgrade the Grains Study: Increasing Whole Grain Consumption in Low-income Children With Obesity;2016-06-22T00:00:00Z;2016-08-02T00:00:00Z;2016-08-02T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCSF Benioff Children's Hospital Oakland;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2016;2016;UCSF;;Mario
1028;756;NCT02852226;0;;;;;09.09.2019;10.05.2016;NA;Interventional;Not Applicable;30;Completed;CRUSH-PrEP for Women Project;2016-05-01T00:00:00Z;2017-08-01T00:00:00Z;2017-08-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UCSF Center for AIDS Prevention;NA;NA;NA;NA;UCSF Center for AIDS Prevention;NA;NA;NA;2016;2016;2017;2017;UCSF;;Mario
1030;758;NCT02947477;0;;;;;14.01.2020;24.10.2016;NA;Interventional;Not Applicable;100;Completed;Emotion Tracking Study for Residents;2016-10-01T00:00:00Z;2017-12-17T00:00:00Z;2017-12-17T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCSF;;Mario
684;320;NCT02699125;0;;;;could not access full text to confirm 28557555 - after DC not confirmed, publications compares not the registered intervention (other second drug, nebivolol);10.11.2020;26.02.2016;15.07.2020;Interventional;Phase 4;41;Completed;Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic;2015-01-01T00:00:00Z;2016-08-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2016;2016;UCSD;;Mario
624;53;NCT00991302;0;;;;;21.02.2018;07.10.2009;29.07.2015;Interventional;Not Applicable;172;Completed;Durability of Adherence in Self-Management of HIV;2010-01-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of California, San Diego;NA;NA;NA;NA;NA;2009;2010;2015;2015;UCSD;;Nicole
444;80;NCT01871090;0;;;;;31.01.2019;04.06.2013;02.06.2016;Interventional;Not Applicable;99;Completed;Remote Device Interrogation In The Emergency Department;2013-09-01T00:00:00Z;2015-07-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);INDUSTRY;FALSE;Los Angeles Biomedical Research Institute at Harbor - UCLA;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCLA;;Nicole
475;170;NCT02227316;0;;;;;05.06.2018;26.08.2014;13.12.2017;Interventional;Phase 4;40;Completed;Effectiveness of IV Acetaminophen and IV Ibuprofen in Reducing Post Procedural Pain in the UFE Procedure;2014-08-01T00:00:00Z;2016-09-01T00:00:00Z;2016-09-01T00:00:00Z;TRUE;Randomized;Double;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCLA;;Nicole
796;192;NCT02988193;0;;;;;16.09.2019;02.12.2016;03.04.2018;Interventional;Not Applicable;28;Completed;Piloting Healthcare Coordination in Hypertension;2015-12-01T00:00:00Z;2017-02-28T00:00:00Z;2017-01-01T00:00:00Z;TRUE;Randomized;None (Open Label);INDUSTRY;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2017;2017;UCSF;;Nicole
484;211;NCT01699178;0;;;;;25.06.2021;05.09.2012;16.07.2018;Interventional;Phase 3;182;Completed;Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men;2012-08-01T00:00:00Z;2014-04-01T00:00:00Z;2014-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);INDUSTRY;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCLA;;Nicole
646;216;NCT01987609;0;;;;;28.12.2018;12.11.2013;22.08.2018;Interventional;Phase 2;7;Completed;Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques;2015-07-01T00:00:00Z;2018-02-01T00:00:00Z;2017-03-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;UCSD Division of Dermatology;NA;NA;NA;NA;NA;NA;NA;NA;2013;2015;2018;2017;UCSD;;Nicole
812;233;NCT02317276;0;;;;;15.01.2019;03.12.2014;26.11.2018;Interventional;Phase 4;11;Terminated;A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal;2014-12-01T00:00:00Z;2017-04-06T00:00:00Z;2017-04-06T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSF;;Nicole
492;246;NCT02634606;0;;;;;23.01.2019;26.09.2014;23.01.2019;Interventional;Phase 3;13;Terminated;Effects of a Supplement Derived From Palm Oil on Cholesterol Levels in the Blood;2011-03-22T00:00:00Z;2015-11-13T00:00:00Z;2015-11-13T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;UCLA Department of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2011;2015;2015;UCLA;;Nicole
825;253;NCT02436889;0;;;;;28.03.2019;30.04.2015;05.03.2019;Interventional;Phase 4;23;Completed;Treatment of Incontinence Without Memory Problems;2016-02-01T00:00:00Z;2018-07-01T00:00:00Z;2017-12-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2018;2017;UCSF;;Nicole
655;262;NCT02745353;0;;;;;05.12.2019;15.04.2016;19.04.2019;Interventional;Phase 2;7;Terminated;Naloxegol in Cancer Opioid-Induced Constipation;2016-05-01T00:00:00Z;2017-06-22T00:00:00Z;2017-06-22T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCSD;;Nicole
141;265;NCT01336803;0;;;;;30.05.2019;12.04.2011;03.05.2019;Interventional;Phase 2;21;Completed;Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI;2011-08-01T00:00:00Z;2018-10-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2018;2014;Stanford;;Nicole
665;276;NCT01736085;0;;;;;06.02.2020;15.11.2012;28.06.2019;Interventional;Phase 3;3706;Completed;Providing Free Nicotine Patches to Quitline Smokers;2013-04-01T00:00:00Z;2014-11-01T00:00:00Z;2014-11-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2014;2014;UCSD;;Nicole
837;300;NCT02440789;0;;;;;30.07.2021;06.04.2015;12.12.2019;Interventional;Phase 1/Phase 2;32;Completed;Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART);2015-12-21T00:00:00Z;2018-02-01T00:00:00Z;2017-11-02T00:00:00Z;TRUE;NA;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2015;2015;2018;2017;UCSF;;Nicole
839;302;NCT01625013;0;;;;;14.04.2021;11.06.2012;02.01.2020;Interventional;Not Applicable;51;Completed;Synvisc-One for Younger, Active Patients With Osteoarthritis;2011-11-01T00:00:00Z;2019-08-07T00:00:00Z;2017-10-02T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2019;2017;UCSF;;Nicole
682;313;NCT02244957;0;;;;;13.07.2020;15.09.2014;14.05.2020;Interventional;Not Applicable;23;Completed;Right Ventricular Hemodynamics Using Cardiac MRI in Patients COPD and OSA;2014-09-01T00:00:00Z;2020-02-01T00:00:00Z;2017-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2020;2017;UCSD;;Nicole
850;327;NCT02368691;0;;;;;29.10.2020;10.02.2015;13.09.2020;Interventional;Phase 2;32;Terminated;Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC);2015-06-01T00:00:00Z;2017-09-22T00:00:00Z;2017-09-22T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Nicole
853;331;NCT01162239;0;;;;;19.10.2020;14.06.2010;19.10.2020;Interventional;Phase 3;216;Completed;Maintaining Nonsmoking;2010-05-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2016;2016;UCSF;;Nicole
155;335;NCT01390584;0;;;;;01.12.2020;07.07.2011;30.10.2020;Interventional;Phase 2;6;Terminated;Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma;2012-04-02T00:00:00Z;2018-05-18T00:00:00Z;2015-04-09T00:00:00Z;TRUE;Non-Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;Stanford University;NA;NA;NA;NA;NA;2011;2012;2018;2015;Stanford;;Nicole
156;337;NCT03125629;0;;;;;08.04.2021;24.03.2017;06.11.2020;Interventional;Phase 2;53;Completed;Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals;2014-05-27T00:00:00Z;2020-02-05T00:00:00Z;2016-11-30T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2017;2014;2020;2016;Stanford;;Nicole
305;356;NCT00593931;0;;;;;25.05.2017;03.01.2008;NA;Interventional;Not Applicable;215;Terminated;Development Of New Techniques For Functional Magnetic Resonance Imaging Of The Brain;1999-05-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;UC Davis Dept. of Radiology;NA;NA;NA;NA;NA;NA;NA;NA;2008;1999;2014;2014;UCD;;Nicole
317;367;NCT01426542;0;;;;;07.02.2019;05.08.2011;NA;Interventional;Phase 1;24;Completed;Preventing Brain Injury in Infants With Congenital Heart Disease;2011-03-01T00:00:00Z;2017-07-28T00:00:00Z;2017-07-28T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2017;2017;UCD;;Nicole
360;409;NCT02550574;0;;;;;19.06.2017;09.09.2015;NA;Interventional;Not Applicable;50;Completed;Use of 2-octylcyanoacrylate With Full-thickness Skin Grafts;2015-08-01T00:00:00Z;2017-05-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2016;UCD;;Nicole
371;419;NCT03199716;0;;;;;10.06.2019;19.02.2015;NA;Interventional;Not Applicable;27;Completed;Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents;2014-09-01T00:00:00Z;2017-03-23T00:00:00Z;2017-03-23T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UC Davis Pediatrics Endocrinology;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2017;2017;UCD;;Nicole
406;426;NCT00830466;0;;;;;08.02.2017;27.01.2009;NA;Interventional;Phase 1;22;Completed;A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.;2008-12-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Beckman Laser Institute and Medical Clinic, University of California Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2009;2008;2016;2016;UCI;;Nicole
506;438;NCT00329706;0;;;;;01.05.2017;24.05.2006;NA;Interventional;Not Applicable;710;Completed;Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID);2006-06-01T00:00:00Z;2017-01-01T00:00:00Z;2017-01-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2006;2006;2017;2017;UCLA;;Nicole
530;461;NCT01404247;0;;;;;10.07.2017;10.05.2011;NA;Interventional;Phase 1;20;Completed;Spectral Domain Optical Coherence Tomography Imaging of the Eyes of Neonates;2011-01-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCLA;;Nicole
534;465;NCT01457066;0;;;;;26.05.2015;19.10.2011;NA;Interventional;Phase 1/Phase 2;118;Completed;Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM;2012-12-01T00:00:00Z;2014-09-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2014;2014;UCLA;;Nicole
546;475;NCT01698047;0;;;;;04.05.2017;26.09.2012;NA;Interventional;Not Applicable;168;Completed;Building Resiliency and Increasing Community Hope;2012-10-01T00:00:00Z;2014-06-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCLA;;Nicole
549;478;NCT01723410;0;;;;;10.12.2015;01.11.2012;NA;Interventional;Not Applicable;70;Completed;Neural and Physiological Responses to Real-World Experiences;2013-01-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2015;2015;UCLA;;Nicole
567;496;NCT01949285;0;;;;;20.01.2017;19.09.2013;NA;Interventional;Not Applicable;10;Completed;Transcutaneous Electrical Spinal Cord Stimulation for Lower Limbs;2015-06-01T00:00:00Z;2016-12-31T00:00:00Z;2016-12-31T00:00:00Z;FALSE;Randomized;Double;INDUSTRY;FALSE;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;NA;NA;2013;2015;2016;2016;UCLA;;Nicole
570;499;NCT01966679;0;;;;;21.10.2015;08.10.2013;NA;Interventional;Phase 2;40;Completed;Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial;2013-10-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCLA;;Nicole
575;504;NCT02114918;0;;;;;13.01.2017;11.04.2014;NA;Interventional;Not Applicable;47;Completed;Attention Training for Childhood Obsessive Compulsive Disorder;2013-04-01T00:00:00Z;2016-05-01T00:00:00Z;2016-01-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2016;2016;UCLA;;Nicole
605;533;NCT02723227;0;;;;;24.10.2017;25.03.2016;NA;Interventional;Not Applicable;150;Completed;The Impact of Family Financial Support on Parental Stress;2016-03-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCLA;;Nicole
708;565;NCT01683747;0;;;;;16.11.2015;09.09.2012;NA;Interventional;Phase 2;4;Terminated;Single Dose Enteral Tranexamic Acid in Critically Ill Patients;2012-06-01T00:00:00Z;2014-11-01T00:00:00Z;2014-11-01T00:00:00Z;FALSE;Randomized;Quadruple;FED;FALSE;VA San Diego Healthcare/University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSD;;Nicole
721;576;NCT02120989;0;;;;;28.04.2015;11.04.2014;NA;Interventional;Not Applicable;8;Completed;Researching Effective Sleep Treatments (Project REST);2014-05-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;VA San Diego Healthcare System and University of California San Diego;NA;NA;NA;NA;VA San Diego Healthcare System and University of California San Diego;NA;NA;NA;2014;2014;2015;2015;UCSD;;Nicole
725;580;NCT02166762;0;;;;;06.06.2019;16.06.2014;NA;Interventional;Not Applicable;20;Completed;Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy.;2013-05-01T00:00:00Z;2015-09-01T00:00:00Z;2014-09-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UCSD Electrophysiology;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2015;2014;UCSD;;Nicole
742;597;NCT02675101;0;;;;;02.07.2019;28.01.2016;NA;Interventional;Not Applicable;45;Completed;Nuts and Olestra for Persistent Organic Pollutant Reduction (NO-POPs) Trial;2016-03-01T00:00:00Z;2019-04-01T00:00:00Z;2017-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2019;2017;UCSD;;Nicole
912;646;NCT01639079;0;;;;;13.11.2018;10.07.2012;NA;Interventional;Not Applicable;146;Completed;Comparison of Internet Stop Smoking Intervention to Usual Care on Smoking Cessation at 6 Months;2012-06-01T00:00:00Z;2016-04-01T00:00:00Z;2016-04-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2016;UCSF;;Nicole
942;674;NCT01893996;0;;;;;07.04.2021;02.07.2013;NA;Interventional;Phase 4;63;Completed;Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease;2013-07-01T00:00:00Z;2017-07-01T00:00:00Z;2017-07-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCSF;;Nicole
950;682;NCT01959126;0;;;;;22.01.2021;10.07.2013;NA;Interventional;Not Applicable;70;Completed;Health Enhancement And Resilience Training;2013-05-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCSF;;Nicole
316;366;NCT01410838;0;;;;28257040 is a substudy, even mentions the parental study but cannot find a link;19.05.2015;03.08.2011;NA;Interventional;Not Applicable;44;Completed;Effects of Monosodium Glutamate on Energy Balance and Eating Behavior;2011-08-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;Double;FED;FALSE;WHNRC, ARS, University of California Davis;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;UCD;;Nicole
274;103;NCT00288080;0;;;;16425991 is study protocol;08.02.2022;06.02.2006;28.11.2016;Interventional;Phase 3;612;Active, not recruiting;Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer;2005-12-01T00:00:00Z;NA;2014-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of California, Davis;NA;NA;NA;NA;NA;2006;2005;NA;2014;UCD;;Nicole
287;134;NCT00931489;2;3;https://iovs.arvojournals.org/article.aspx?articleid=2272178;01.04.2014;abstract: https://iovs.arvojournals.org/article.aspx?articleid=2272178;26.06.2017;29.06.2009;14.04.2017;Interventional;Phase 2;131;Completed;Retinal and Retinal Pigment Epithelium (RPE) Autoimmunity in Age-related Macular Degeneration (AMD);2009-08-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;2014;UCD;;Samruddhi
642;201;NCT01829347;0;;;;(Due to results from the VTI-208 study, the ELAD plan is being re-evaluated;12.02.2019;08.04.2013;15.05.2018;Interventional;Phase 3;18;Terminated;To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure;2014-04-01T00:00:00Z;2018-09-01T00:00:00Z;2015-10-01T00:00:00Z;TRUE;Randomized;None (Open Label);INDUSTRY;TRUE;CA - University of California San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2018;2015;UCSD;;Samruddhi
648;221;NCT02354092;0;;;;;21.05.2019;29.01.2015;24.09.2018;Interventional;Not Applicable;14;Terminated;Paracervical Block for Pain Control With Osmotic Dilator Placement;2015-04-02T00:00:00Z;2015-08-25T00:00:00Z;2015-08-25T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;UCSD Department of Reproductive Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2015;2015;UCSD;;Samruddhi
823;250;NCT02605824;0;;;;1 participant, cross over, study closedas drug associated with bronchoconstriction;29.07.2019;12.11.2015;11.02.2019;Interventional;Phase 4;1;Terminated;Clinical Trial of NAC in Asthma;2016-03-01T00:00:00Z;2017-12-01T00:00:00Z;2017-12-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;2017;UCSF;;Samruddhi
495;263;NCT02489279;0;;;;;19.06.2019;30.06.2015;29.04.2019;Interventional;Not Applicable;107;Completed;Training Attentional Awareness and Control in ADHD;2015-06-01T00:00:00Z;2017-04-01T00:00:00Z;2016-12-01T00:00:00Z;TRUE;Randomized;Double;INDUSTRY;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2016;UCLA;;Samruddhi
662;272;NCT02141555;0;;;;;23.07.2019;10.05.2014;12.06.2019;Interventional;Phase 2/Phase 3;4;Completed;Comparing Buccal and Vaginal Misoprostol in Management of Early Pregnancy Loss;2014-08-01T00:00:00Z;2016-06-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;University of California, San Diego;NA;NA;NA;2014;2014;2016;2015;UCSD;;Samruddhi
678;298;NCT01472692;0;;;;;26.11.2019;13.11.2011;26.11.2019;Interventional;Phase 4;47;Completed;Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure;2011-10-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;UCSD;NA;NA;NA;NA;University of California, San Diego;NA;NA;NA;2011;2011;2014;2014;UCSD;;Samruddhi
838;301;NCT01545648;0;;;;4 participant/ Terminated d/t low accrual;13.12.2019;27.02.2012;13.12.2019;Interventional;Phase 2;4;Terminated;Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer;2012-11-01T00:00:00Z;2016-06-09T00:00:00Z;2015-06-09T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2015;UCSF;;Samruddhi
842;307;NCT00632827;0;;;;Terminated d/t manufacturing shortage;14.04.2020;28.02.2008;30.03.2020;Interventional;Phase 2;21;Terminated;Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak);2008-07-01T00:00:00Z;2016-06-23T00:00:00Z;2014-06-23T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2016;2014;UCSF;;Samruddhi
847;322;NCT01641601;0;;;;Terminated d/t inadequate enrollment;27.07.2020;03.07.2012;27.07.2020;Interventional;Not Applicable;8;Terminated;Prehospital Cervical Ripening Before Induction and the Maternal Experience;2012-07-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCSF;;Samruddhi
404;343;NCT01297959;0;;;;linked article not relevant;21.01.2021;11.02.2011;22.12.2020;Interventional;Phase 3;503;Completed;Study to Evaluate Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery;2013-01-10T00:00:00Z;2015-10-14T00:00:00Z;2015-10-14T00:00:00Z;TRUE;Randomized;Double;INDUSTRY;TRUE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2011;2013;2015;2015;UCI;;Samruddhi
332;382;NCT01889368;0;;;;;26.06.2017;10.10.2012;NA;Interventional;Not Applicable;19;Completed;Effect of a Grape Seed Extract (GSE) on Insulin Resistance;2012-11-01T00:00:00Z;2015-03-01T00:00:00Z;2015-03-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;UCD;;Samruddhi
346;396;NCT02194049;0;;;;"The pan-class I PI3K inhibitor buparlisib has been tested in SCLC in combination with cisplatin and etoposide in a phase I clinical study; however, no study results are available (NCT02194049).?";05.01.2018;10.07.2014;NA;Interventional;Phase 1;3;Completed;Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer;2014-07-01T00:00:00Z;2016-06-01T00:00:00Z;2016-04-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCD;;Samruddhi
410;429;NCT01684657;0;;;;Study suspended, transferring to other facility;19.05.2014;24.07.2012;NA;Interventional;Phase 3;32;Suspended;A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering;2012-09-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;UCIMC;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCI;;Samruddhi
508;439;NCT00748761;0;;;;;23.03.2020;08.09.2008;NA;Interventional;Not Applicable;119;Completed;Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder;2008-06-01T00:00:00Z;2016-12-31T00:00:00Z;2016-12-31T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;UCLA Child Psychiatry;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2016;2016;UCLA;;Samruddhi
512;443;NCT01002222;0;;;;;01.03.2015;25.10.2009;NA;Interventional;Phase 3;200;Completed;Open-Label Extension Study of MCS-2 in the Treatment of Lower Urinary Tract Symptoms (MCS-2-US-c);2011-01-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);INDUSTRY;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2009;2011;2014;2014;UCLA;;Samruddhi
514;445;NCT01018407;0;;;;;04.06.2015;20.11.2009;NA;Interventional;Not Applicable;192;Completed;Interventions for Communication in Autism Network;2009-12-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;2015;UCLA;;Samruddhi
558;487;NCT01873248;0;;;;Results status overdue, reporting of intial new drug trial with this TRN and secondary expanded access drug number was obtained;12.05.2021;03.06.2013;NA;Interventional;Phase 1/Phase 2;238;Completed;Investigation of 68Ga-DOTATATE, as a PET Imaging Agent in Neuroendocrine Tumor Patients;2013-08-26T00:00:00Z;2017-06-16T00:00:00Z;2017-06-16T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCLA;;Samruddhi
577;506;NCT02125942;0;;;;;11.01.2021;26.04.2014;NA;Interventional;Not Applicable;15;Completed;Central Meditation and Imagery Therapy for Augmentation of Borderline Personality Disorder Treatment;2014-04-01T00:00:00Z;2015-09-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCLA;;Samruddhi
583;512;NCT02183844;0;;;;;02.11.2017;30.06.2014;NA;Interventional;Not Applicable;61;Completed;A System for Preference Assessment in Mental Health;2014-06-16T00:00:00Z;2017-10-31T00:00:00Z;2017-10-31T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCLA;;Samruddhi
607;535;NCT02723357;0;;;;Behind paywall, cannot access and confirm;24.10.2017;24.03.2016;NA;Interventional;Not Applicable;150;Completed;The Impact of Family Financial Support on Parental Mental Health;2016-03-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCLA;;Samruddhi
610;538;NCT02770144;0;;;;Behind paywall, cannot access and confirm;24.10.2017;25.03.2016;NA;Interventional;Not Applicable;150;Completed;The Impact of Family Financial Support on Child Health;2016-03-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCLA;;Samruddhi
739;594;NCT02567448;0;;;;Terminated dlt failure to accrue/Behind Paywall;05.05.2020;27.09.2015;NA;Interventional;Not Applicable;24;Terminated;Pathophysiology of the Upper Airway in Patients With COPD and Concomitant OSA;2015-07-01T00:00:00Z;2016-08-11T00:00:00Z;2016-08-11T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCSD;;Samruddhi
744;599;NCT03446729;0;;;;;20.02.2018;08.02.2018;NA;Interventional;Not Applicable;50;Completed;Enhancing Memory to Facilitate Weight Loss: Tracking, Recording and Coaching;2014-01-02T00:00:00Z;2015-12-03T00:00:00Z;2015-12-03T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2018;2014;2015;2015;UCSD;;Samruddhi
883;618;NCT01264627;0;;;;;20.11.2020;15.12.2010;NA;Interventional;Not Applicable;99;Completed;A New Translational Tool for Studying the Role of Breathing in Meditation;2011-02-01T00:00:00Z;2017-08-31T00:00:00Z;2017-07-31T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2017;2017;UCSF;;Samruddhi
892;627;NCT01431885;0;;;;Behind paywall, scihub fail, Complete article could not be accessed;14.01.2020;24.08.2011;NA;Interventional;Not Applicable;82;Completed;Two Methods of Diagnosing Preterm Labor;2011-08-01T00:00:00Z;2015-02-13T00:00:00Z;2015-02-13T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSF;;Samruddhi
930;662;NCT01821443;0;;;;Terminated d/t loss of funding;19.01.2018;13.03.2013;NA;Interventional;Not Applicable;10;Terminated;A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS);2012-12-01T00:00:00Z;2015-10-22T00:00:00Z;2015-10-22T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2013;2012;2015;2015;UCSF;;Samruddhi
944;676;NCT01907945;0;;;;;30.07.2014;22.07.2013;NA;Interventional;Not Applicable;150;Completed;Healthy Networks Water Treatment Study;2012-10-01T00:00:00Z;2014-04-01T00:00:00Z;2014-04-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2014;2014;UCSF;;Samruddhi
957;689;NCT01988714;0;;;;Study found with subsample from this trial(27617637);03.04.2019;13.11.2013;NA;Interventional;Not Applicable;112;Completed;Cognitive Remediation of Schizophrenia in a Community Mental Health Setting;2009-09-01T00:00:00Z;2016-09-26T00:00:00Z;2016-09-26T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2009;2016;2016;UCSF;;Samruddhi
960;692;NCT02007707;0;;;;;05.08.2019;25.11.2013;NA;Interventional;Not Applicable;214;Completed;A Family-Based Approach To Reduce Smoking in Vietnamese Men;2014-04-01T00:00:00Z;2018-10-01T00:00:00Z;2016-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2018;2016;UCSF;;Samruddhi
978;709;NCT02181881;0;;;;;21.10.2014;02.07.2014;NA;Interventional;Not Applicable;60;Completed;DuoPACT Pilot Intervention;2014-05-01T00:00:00Z;2014-09-01T00:00:00Z;2014-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2014;2014;UCSF;;Samruddhi
997;726;NCT02410902;0;;;;;28.04.2021;19.03.2015;NA;Interventional;Phase 3;335;Completed;A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study);2015-05-01T00:00:00Z;2017-12-22T00:00:00Z;2017-12-22T00:00:00Z;FALSE;Randomized;Quadruple;INDUSTRY;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Samruddhi
671;283;NCT01397695;0;;;;https://doi.org/10.1002/lary.22501 reports other treatment;15.08.2019;18.07.2011;15.08.2019;Interventional;Phase 2;20;Completed;Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT);2009-06-01T00:00:00Z;2014-01-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2011;2009;2014;2014;UCSD;;Samruddhi
365;413;NCT02938650;0;;;;31257694 sounds similar but reports completely different outcomes;09.10.2017;17.10.2016;NA;Interventional;Phase 1;30;Completed;Nitrosomonas Eutropha on Nitrolipids in the Skin;2016-10-01T00:00:00Z;2017-05-01T00:00:00Z;2017-05-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;UC Davis;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCD;;Samruddhi
466;157;NCT02514889;0;0;;;only baseline characteristica etc. published (linked in registry);13.10.2017;18.04.2015;30.07.2017;Interventional;Not Applicable;261;Completed;Is MyPlate Approach to Helping Overweight Patients Lose Weight More Patient-centered?;2015-07-01T00:00:00Z;2017-07-31T00:00:00Z;2017-03-23T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;UCLA Fielding School of Public Health;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCLA;;Susanne
379;56;NCT01775722;0;;;;;09.03.2018;14.01.2013;27.08.2015;Interventional;Not Applicable;22;Completed;Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment;2012-12-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Beckman Laser Institute, UCI;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2015;2015;UCI;;Susanne
757;59;NCT01709474;0;;;;;15.12.2015;16.10.2012;20.10.2015;Interventional;Phase 2;7;Terminated;Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus;2013-06-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Randomized;None (Open Label);NIH;TRUE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2012;2013;2014;2014;UCSF;;Susanne
445;82;NCT02107196;0;;;;only publications of the preceeding trial (Iris-2) found;18.11.2016;04.04.2014;21.06.2016;Interventional;Phase 3;535;Completed;12-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D);2014-03-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;NA;NA;NA;Digestive Health and Nutrition Clinic. University of California, Los Angeles, CA, USA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCLA;;Susanne
387;105;NCT02307552;0;;;;;26.06.2017;28.08.2014;14.12.2016;Interventional;Not Applicable;1;Terminated;Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer;2013-06-01T00:00:00Z;2014-05-01T00:00:00Z;2014-04-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2014;2014;UCI;;Susanne
790;171;NCT01721603;0;;;;;19.12.2017;01.11.2012;19.12.2017;Interventional;Phase 2;2;Terminated;Dabrafenib and Trametinib With Radiosurgery in Melanoma Brain Mets;2013-04-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;NA;NA;NA;University of California, San Francisco;NA;NA;NA;NA;NA;2012;2013;2016;2016;UCSF;;Susanne
393;176;NCT01564485;0;;;;25262111 does not report the primary outcome;07.06.2021;24.02.2012;11.01.2018;Interventional;Not Applicable;193;Completed;Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome;2008-07-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2012;2008;2016;2016;UCI;;Susanne
395;179;NCT01780636;0;;;;;05.10.2021;25.01.2013;05.02.2018;Interventional;Phase 2/Phase 3;7;Terminated;Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome;2013-01-01T00:00:00Z;2014-07-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCI;;Susanne
639;190;NCT01199575;0;;;;;02.09.2021;31.08.2010;26.03.2018;Interventional;Phase 2;30;Active, not recruiting;Phase II Trial of Revlimid and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL);2010-08-01T00:00:00Z;2024-12-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;NA;NA;NA;NA;NA;Director of the CLL Research Consortium and University of California San Diego;NA;NA;NA;2010;2010;2024;2015;UCSD;;Susanne
826;259;NCT02294981;0;;;;;08.06.2020;14.11.2014;01.04.2019;Interventional;Not Applicable;4;Terminated;Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis;2016-01-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2014;2016;2017;2017;UCSF;;Susanne
828;261;NCT02524106;0;;;;;17.06.2019;12.08.2015;05.04.2019;Interventional;Phase 3;11;Terminated;Bococizumab HIV Evaluation (B-HIVE) Study;2016-08-01T00:00:00Z;2017-11-01T00:00:00Z;2017-11-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;priscilla.hsue@ucsf.edu;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;2017;UCSF;;Susanne
673;285;NCT01211756;0;;;;;30.08.2019;28.09.2010;30.08.2019;Interventional;Not Applicable;1;Terminated;Oxytocin Add-on for Stable Depressed Patients;2010-10-01T00:00:00Z;2015-12-01T00:00:00Z;2015-02-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;2015;UCSD;;Susanne
497;305;NCT02672033;0;;;;;22.07.2020;02.11.2015;05.02.2020;Interventional;Not Applicable;2;Terminated;Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma;2015-09-01T00:00:00Z;2018-07-17T00:00:00Z;2016-05-24T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCLA / Jonsson Comprehensive Cancer Center;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2018;2016;UCLA;;Susanne
315;365;NCT01336842;0;;;;;05.01.2018;11.04.2011;NA;Interventional;Phase 1;23;Completed;Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors;2011-04-01T00:00:00Z;2017-06-01T00:00:00Z;2017-01-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2017;2017;UCD;;Susanne
367;415;NCT03041103;0;;;;;03.10.2017;31.01.2017;NA;Interventional;Not Applicable;20;Completed;Acceptability and Tolerance of a Protein and Micronutrient Fortified Food;2017-01-31T00:00:00Z;2017-06-30T00:00:00Z;2017-06-30T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2017;2017;2017;2017;UCD;;Susanne
369;417;NCT03066791;0;;;;30088420 does not report the primary outcome (effect on sebum);18.12.2018;01.11.2016;NA;Interventional;Not Applicable;30;Completed;Turmeric and Curcumin on Sebum Production;2016-11-30T00:00:00Z;2017-08-28T00:00:00Z;2017-08-28T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCD;;Susanne
510;441;NCT00926146;0;;;;21218306 does not report primary outcome (vaccination) - and also not the other linked publications;26.01.2017;22.06.2009;NA;Interventional;Not Applicable;451;Completed;Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV;2009-07-01T00:00:00Z;2015-02-01T00:00:00Z;2014-01-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;2014;UCLA;;Susanne
515;446;NCT01046773;0;;;;;05.02.2018;11.01.2010;NA;Interventional;Phase 1;3;Terminated;Vitamin D Supplementation as Non-toxic Immunomodulation in Children With Crohn's Disease;2010-01-01T00:00:00Z;2017-05-01T00:00:00Z;2017-05-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2017;2017;UCLA;;Susanne
527;458;NCT01368510;0;;;;both linked publications state that they report the primary outcome although it is the secondary;23.03.2020;06.06.2011;NA;Interventional;Not Applicable;75;Completed;Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder;2011-07-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;UCLA Child Psychiatry;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCLA;;Susanne
604;532;NCT02722005;0;;;;;24.10.2017;24.03.2016;NA;Interventional;Not Applicable;150;Completed;The Impact of Family Financial Support on Health Related Quality of Life;2016-03-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCLA;;Susanne
701;558;NCT01340950;0;;;;;31.03.2016;21.04.2011;NA;Interventional;Phase 4;250;Completed;Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China;2010-07-01T00:00:00Z;2015-07-01T00:00:00Z;2014-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2010;2015;2014;UCSD;;Susanne
711;568;NCT01773746;0;;;;;10.09.2018;10.01.2013;NA;Interventional;Not Applicable;80;Terminated;Study of Room Air Versus 60% Oxygen for Resuscitation of Premature Infants;2013-08-01T00:00:00Z;2017-03-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;UCSD Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;UCSD;;Susanne
910;644;NCT01617291;0;;;;;12.02.2014;27.05.2012;NA;Interventional;Not Applicable;46;Terminated;Therapeutic Hypothermia After the Return of Spontaneous Circulation;2013-03-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco Fresno;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2014;2014;UCSF;;Susanne
946;678;NCT01919736;0;;;;;14.11.2019;29.07.2013;NA;Interventional;Not Applicable;30;Completed;Loaded and Unloaded Magnetic Resonance (MR) Imaging of Meniscus-Cartilage-Trabecular Bone in Osteoarthritis;2013-09-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UCSF, Department of Radiology and Biomedical Imaging;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCSF;;Susanne
952;684;NCT01965743;0;;;;;09.09.2014;15.10.2013;NA;Interventional;Not Applicable;53;Completed;Pilot of Social Network Intrauterine Contraceptive (IUC) Intervention;2014-04-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2014;2014;UCSF;;Susanne
963;695;NCT02059382;0;;;;;29.07.2014;24.12.2013;NA;Interventional;Not Applicable;40;Completed;EXercise Continuation Incorporating Technology Enhancements (EXCITE) Study;2013-08-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCSF;;Susanne
967;699;NCT02096757;0;;;;;16.09.2020;22.03.2014;NA;Interventional;Not Applicable;8;Completed;The Use of Fish Oil to Reduce Inflammation Caused by a Peripheral Vascular Intervention;2014-06-01T00:00:00Z;2017-03-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;UCSF & SFVAMC;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCSF;;Susanne
437;47;NCT01737593;2;2;https://www.uclahealth.org/anes/workfiles/poster-presentation-large.pdf - interim results, not enough words to count as publication;;https://www.uclahealth.org/anes/workfiles/poster-presentation-large.pdf - interim results, not enough words to count as publication;30.08.2016;13.11.2012;11.06.2015;Interventional;Phase 4;108;Terminated;Can Acetaminophen Given 1-2 Hours to Children Before Ear Tube Surgery Reduce Agitation After Anesthesia?;2012-11-01T00:00:00Z;2014-04-01T00:00:00Z;2014-04-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCLA;;Susanne
;206;NCT01943188;0;;;;;13.03.2017;11.09.2013;NA;Interventional;Phase 1;2;Terminated;Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer;2014-05-01T00:00:00Z;NA;2016-03-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;NA;2016;Stanford;1;
;385;NCT02473614;0;;;;;04.06.2021;12.06.2015;28.10.2016;Interventional;Not Applicable;11;Completed;Efficacy Study of the Music Glove Patients With Spinal Cord Injuries;2015-03-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCI;1;
;474;NCT01714310;0;;;;;26.01.2018;20.10.2012;07.12.2017;Interventional;Phase 2;34;Completed;Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation;2013-01-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2016;2016;UCLA;1;
;478;NCT02381392;0;;;;;22.03.2018;21.02.2015;11.02.2018;Interventional;Not Applicable;23;Terminated;A Comparison of Accuvein to Standard IV Access in Children 0 to 24 Months of Age in the Pediatric ED;2014-08-01T00:00:00Z;2016-11-19T00:00:00Z;2016-11-19T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Harbor-UCLA Department of Emergency Medicine;NA;NA;NA;NA;Harbor-UCLA Department of Emergency Medicine;NA;NA;NA;2015;2014;2016;2016;UCLA;1;
;540;NCT01602575;0;;;;;07.05.2018;17.05.2012;NA;Interventional;Not Applicable;119;Completed;Neuroimaging and Biomarkers in Chronic Visceral Pain;2013-01-01T00:00:00Z;2018-03-20T00:00:00Z;2016-03-20T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2018;2016;UCLA;1;
;613;NCT02986945;0;;;;PMID 30202203 no report of the primary outcomes, not the actual intervention;15.04.2019;01.12.2016;NA;Interventional;Not Applicable;30;Completed;Community-Partnered Participatory Development of Mobile Interventions;2016-12-01T00:00:00Z;2017-03-28T00:00:00Z;2017-03-28T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCLA;1;
;864;NCT00467220;0;;;;33512717 is only a review citing the trial (but therefore automatically indexed);17.01.2020;26.04.2007;NA;Interventional;Not Applicable;24;Completed;Effect of Daily Calorie or Alternate-day Calorie Reductions on Risk for Cardiovascular Disease and Cancer;2007-04-01T00:00:00Z;2015-12-17T00:00:00Z;2015-12-17T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;"University of California, Berkeley; University of California, San Francisco";NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2015;2015;UCSF;1;
;907;NCT01571817;0;;;;;02.10.2020;03.04.2012;NA;Interventional;Phase 1;1;Completed;Pancreatic Islet Transplantation Into the Gastric Submucosa;2012-04-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;2014;UCSF;1;
755;52;NCT01290523;0;;;;;18.04.2019;01.02.2011;28.07.2015;Interventional;Not Applicable;14;Terminated;Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma;2010-05-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2011;2010;2014;2014;UCSF;;Stefanie
382;66;NCT00556946;0;;;;;08.02.2017;09.11.2007;05.02.2016;Interventional;Not Applicable;17;Completed;Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains;2005-08-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Beckman Laser Institute University of California Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2007;2005;2014;2014;UCI;;Stefanie
454;115;NCT01778855;0;;;;;01.03.2017;23.01.2013;11.01.2017;Interventional;Phase 2/Phase 3;6;Terminated;Hypothermia in Acute Stroke With Thrombolysis Imaging Evaluation of Revascularization;2013-02-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCLA;;Stefanie
285;130;NCT02601105;0;;;;;02.05.2021;06.11.2015;30.03.2017;Interventional;Not Applicable;15;Completed;Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks;2014-10-01T00:00:00Z;2015-11-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;UC Davis Department of Dermatology;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2015;2015;UCD;;Stefanie
464;152;NCT01502761;0;;;;;26.07.2017;22.12.2011;30.06.2017;Interventional;Phase 1/Phase 2;4;Terminated;Intra-arterial Magnesium Administration for Acute Stroke;2012-03-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;University of Southern California;NA;NA;NA;NA;NA;NA;NA;2011;2012;2016;2016;UCLA, USC;;Stefanie
394;178;NCT00610467;0;;;;;15.04.2020;12.01.2008;01.02.2018;Interventional;Not Applicable;2;Terminated;Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis;2006-10-01T00:00:00Z;2017-10-30T00:00:00Z;2016-10-30T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2008;2006;2017;2016;UCI;;Stefanie
479;189;NCT02921386;0;;;;;18.04.2018;29.09.2016;05.03.2018;Interventional;Phase 2;18;Completed;The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate;2016-10-01T00:00:00Z;2017-01-21T00:00:00Z;2017-01-21T00:00:00Z;TRUE;Non-Randomized;None (Open Label);INDUSTRY;TRUE;Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCLA;;Stefanie
294;207;NCT02170298;0;;;;;10.12.2019;11.06.2014;28.06.2018;Interventional;Phase 4;6;Terminated;Lisdexamfetamine's Effect In ADHD in the Brain and Cognition;2014-02-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCD;;Stefanie
813;234;NCT02470741;0;;;;;04.11.2019;04.06.2015;30.11.2018;Interventional;Phase 4;12;Completed;Pilot of Letrozole for Uterine Myomas;2015-07-01T00:00:00Z;2017-12-01T00:00:00Z;2017-12-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;UCSF;;Stefanie
667;278;NCT02020408;0;;;;;07.04.2020;11.12.2013;10.07.2019;Interventional;Phase 4;88;Completed;Monoamine Contributions to Neurocircuitry in Eating Disorders;2011-05-01T00:00:00Z;2017-12-31T00:00:00Z;2017-12-31T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2013;2011;2017;2017;UCSD;;Stefanie
669;280;NCT01402544;0;;;;;23.08.2019;25.07.2011;05.08.2019;Interventional;Phase 2/Phase 3;20;Terminated;Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab;2011-07-01T00:00:00Z;2015-03-01T00:00:00Z;2015-03-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;NA;NA;NA;University of California, San Diego;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSD;;Stefanie
670;281;NCT01288807;0;;;;;04.09.2019;01.02.2011;07.08.2019;Interventional;Phase 4;8;Completed;Effect of Milnacipran on Pain in Fibromyalgia;2011-02-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;UCSD;;Stefanie
843;308;NCT01596751;0;;;;;02.07.2020;07.05.2012;01.04.2020;Interventional;Phase 1/Phase 2;67;Completed;Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer;2012-07-12T00:00:00Z;2019-07-05T00:00:00Z;2017-07-05T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2019;2017;UCSF;;Stefanie
501;318;NCT01734850;0;;;;;22.07.2020;19.11.2012;25.06.2020;Interventional;Phase 1/Phase 2;13;Completed;Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection;2013-04-01T00:00:00Z;2017-11-01T00:00:00Z;2017-09-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);INDUSTRY;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2017;2017;UCLA;;Stefanie
849;326;NCT00751101;0;;;;;11.09.2020;10.09.2008;11.09.2020;Interventional;Phase 2;24;Terminated;Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer;2007-08-20T00:00:00Z;2018-03-24T00:00:00Z;2014-03-24T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2008;2007;2018;2014;UCSF;;Stefanie
855;333;NCT01895959;0;;;;;26.10.2020;05.07.2013;26.10.2020;Interventional;Phase 4;12;Completed;To Look at the Characteristics of Synovial Fluid and Cartilage Matrix in Osteoarthritic Knee After Hyaluronic Acid Injection;2013-08-01T00:00:00Z;2017-01-01T00:00:00Z;2016-11-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2016;UCSF;;Stefanie
250;353;NCT02728700;0;;;;;10.09.2018;30.03.2016;NA;Interventional;Phase 1;1;Terminated;Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT;2016-02-01T00:00:00Z;2018-07-01T00:00:00Z;2017-04-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford Cancer Institute;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2018;2017;Stanford;;Stefanie
304;355;NCT00575679;0;;;;for discussion: https://pubmed.ncbi.nlm.nih.gov/24553532/ different sample size, publication seems to show one part of the study - other trial ID mentioned;02.01.2019;14.12.2007;NA;Interventional;Not Applicable;864;Completed;Behavior and Driving Safety Study;2008-01-01T00:00:00Z;2014-02-20T00:00:00Z;2014-02-20T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;University of California, Davis;NA;NA;NA;2007;2008;2014;2014;UCD;;Stefanie
321;371;NCT01615042;0;;;;;26.05.2020;06.06.2012;NA;Interventional;Phase 1;6;Terminated;Phase I Study of Lenalidomide in Patients With Acute Leukemia;2012-08-01T00:00:00Z;2017-05-01T00:00:00Z;2017-05-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2017;2017;UCD;;Stefanie
352;402;NCT02373254;0;;;;;11.07.2017;09.02.2015;NA;Interventional;Early Phase 1;1;Completed;NSAIDS Versus Opioids in Acute SER II Ankle Fractures;2015-01-01T00:00:00Z;2015-10-01T00:00:00Z;2015-10-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2015;2015;UCD;;Stefanie
405;425;NCT00800722;0;;;;;08.02.2017;01.12.2008;NA;Interventional;Phase 1;21;Completed;A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.;2008-11-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Beckman Laser Institute University of California Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2014;2014;UCI;;Stefanie
421;434;NCT02410980;0;;;;;03.03.2017;23.03.2015;NA;Interventional;Early Phase 1;15;Completed;Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies;2015-08-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Beckman Laser Institute, UCI;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCI;;Stefanie
523;454;NCT01221246;0;;;;;01.08.2019;11.10.2010;NA;Interventional;Phase 2;34;Completed;Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours;2011-03-08T00:00:00Z;2016-07-07T00:00:00Z;2016-07-07T00:00:00Z;FALSE;Randomized;Quadruple;INDUSTRY;TRUE;UCLA Stroke Center;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2016;2016;UCLA;;Stefanie
571;500;NCT01993069;0;;;;;01.05.2017;16.07.2013;NA;Interventional;Not Applicable;20;Terminated;Yoga Training for Returning Veterans With Headache;2013-10-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;2014;UCLA;;Stefanie
580;509;NCT02158390;0;;;;;10.07.2018;04.06.2014;NA;Interventional;Not Applicable;78;Completed;Phenotypic Specific Communication Intervention for Children With Down Syndrome;2014-06-01T00:00:00Z;2018-02-06T00:00:00Z;2017-08-30T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;NA;NA;NA;NA;NA;University of California, Los Angeles;NA;NA;NA;2014;2014;2018;2017;UCLA;;Stefanie
588;516;NCT02267070;0;;;;bi.nlm.nih.gov/pmc/articles/PMC4960434/#!po=59.5238 only pilot study with different duration, sample size, outcome;05.12.2017;19.11.2013;NA;Interventional;Not Applicable;48;Completed;Enhancing Cognitive Training Through Exercise After a First Schizophrenia Episode;2013-11-01T00:00:00Z;2017-07-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2016;UCLA;;Stefanie
592;520;NCT02393443;0;;;;;08.08.2017;22.01.2015;NA;Interventional;Early Phase 1;161;Completed;Oxytocin and Learning for Teaching;2015-01-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;UCLA;;Stefanie
600;528;NCT02605850;0;;;;registerd also on clincosm.com with study information;30.12.2019;12.10.2015;NA;Interventional;Not Applicable;32;Completed;Effects of Phytonutrients on Vascular Health;2016-01-01T00:00:00Z;2016-09-01T00:00:00Z;2016-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2016;2016;UCLA;;Stefanie
694;551;NCT01138553;0;;;;;03.07.2019;04.06.2010;NA;Interventional;Early Phase 1;4;Terminated;Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer;2010-06-01T00:00:00Z;2015-10-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;2014;UCSD;;Stefanie
710;567;NCT01708785;0;;;;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314468/?report=reader only design of the study, no outcomes;16.10.2017;11.10.2012;NA;Interventional;Not Applicable;230;Completed;Learning Theory to Improve Obesity Treatment;2012-10-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2017;2017;UCSD;;Stefanie
724;579;NCT02145884;0;;;;;09.02.2017;21.05.2014;NA;Interventional;Phase 2;26;Completed;Topical Timolol Gel for the Treatment of Infantile Hemangiomas;2014-05-01T00:00:00Z;2016-11-01T00:00:00Z;2016-10-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Rady Children's Hospital/ University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;UCSD;;Stefanie
729;584;NCT02280395;0;;;;;11.01.2021;26.10.2014;NA;Interventional;Phase 1/Phase 2;9;Terminated;A Phase I/II Double-Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of RUT058-60;2014-10-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;Randomized;Double;INDUSTRY;TRUE;University of California, San Diego;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;UCSD;;Stefanie
740;595;NCT02613052;0;;;;;23.09.2019;19.11.2015;NA;Interventional;Not Applicable;17;Completed;Agitated Saline, Albumin, or Propofol-albumin Mixture for Enhanced Contrast in TEE Examinations;2016-01-01T00:00:00Z;2017-09-01T00:00:00Z;2017-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of California, San Diego;NA;NA;NA;NA;University of California, San Diego;NA;NA;NA;2015;2016;2017;2017;UCSD;;Stefanie
865;602;NCT00472095;0;;;;;20.08.2021;09.05.2007;NA;Interventional;Not Applicable;200;Completed;Fotonovela for Type 2 Diabetes Mellitus;2007-06-01T00:00:00Z;2016-01-29T00:00:00Z;2016-01-29T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;UCSF-Fresno Medical Education Program, Department of Family Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2016;2016;UCSF;;Stefanie
871;607;NCT00739921;0;;;;;02.12.2019;19.08.2008;NA;Interventional;Not Applicable;260;Completed;The Polymerase Chain Reaction (PCR) Analysis of Nasal Polyps for Fungal DNA;2006-06-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2008;2006;2015;2015;UCSF;;Stefanie
875;610;NCT01010386;0;;;;;05.05.2017;06.11.2009;NA;Interventional;Phase 3;851;Completed;The Effects of Physiologic Oxygen Tension on Clinical In Vitro Fertilization Outcomes;2010-03-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;TRUE;NA;NA;NA;NA;NA;University of California, San Francisco;NA;NA;NA;2009;2010;2014;2014;UCSF;;Stefanie
904;639;NCT01536509;0;;;;;24.01.2020;16.02.2012;NA;Interventional;Not Applicable;140;Completed;Improving Medication Adherence in Pediatric Inflammatory Bowel Disease;2012-02-01T00:00:00Z;2016-05-31T00:00:00Z;2016-05-31T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;NA;NA;NA;University of California San Francisco Benioff Children's Hospital;NA;NA;NA;NA;NA;2012;2012;2016;2016;UCSF;;Stefanie
913;647;NCT01646463;0;;;;;13.02.2020;18.07.2012;NA;Interventional;Not Applicable;49;Completed;Pilot Trial of CenteringPregnancy With Mindfulness Skills;2011-01-01T00:00:00Z;2017-05-03T00:00:00Z;2017-05-03T00:00:00Z;FALSE;Non-Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2017;2017;UCSF;;Stefanie
928;660;NCT01804829;0;;;;;14.03.2017;04.03.2013;NA;Interventional;Phase 3;80;Completed;Civacir Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.;2013-06-01T00:00:00Z;2016-06-01T00:00:00Z;2016-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);INDUSTRY;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2016;UCSF;;Stefanie
933;665;NCT01826305;0;;;;;14.01.2020;03.04.2013;NA;Interventional;Not Applicable;23;Terminated;Independent Exercise Compared With Formal Rehabilitation Following Primary Total Knee Replacement;2014-07-01T00:00:00Z;2015-10-23T00:00:00Z;2015-10-23T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2015;2015;UCSF;;Stefanie
948;680;NCT01938807;0;;;;;22.01.2020;05.09.2013;NA;Interventional;Not Applicable;43;Completed;Audio Health Engagement Analysis in Diabetes: The AHEAD Study;2013-10-01T00:00:00Z;2015-09-29T00:00:00Z;2015-09-29T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;UCSF;;Stefanie
1001;730;NCT02450201;0;;;;https://pubmed.ncbi.nlm.nih.gov/31685983/  different NCT, similar outcome. But I would not take it.;19.10.2018;18.05.2015;NA;Interventional;Early Phase 1;5;Terminated;MRI With C13 Pilot Study Prostate Cancer;2016-10-12T00:00:00Z;2017-01-17T00:00:00Z;2017-01-17T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;2017;UCSF;;Stefanie
1014;743;NCT02568709;0;;;;;17.05.2019;29.09.2015;NA;Interventional;Early Phase 1;40;Completed;Oxytocin MEG Study;2012-02-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California San Francisco, San Francisco Veterans Affairs Medical Center;NA;NA;NA;NA;NA;NA;NA;NA;2015;2012;2016;2016;UCSF;;Stefanie
1025;753;NCT02753426;0;;;;;05.02.2020;24.04.2016;NA;Interventional;Phase 1;11;Completed;A Trial of Doxycycline in Renal Disease;2016-04-01T00:00:00Z;2018-01-01T00:00:00Z;2017-12-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2018;2017;UCSF;;Stefanie
397;181;NCT00928564;2;3;;Apr 16;Poster/abstract: https://www.ajog.org/article/S0002-9378(16)00033-8/pdf;22.01.2021;24.06.2009;09.02.2018;Interventional;Not Applicable;40;Completed;Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia;2009-04-01T00:00:00Z;2016-05-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2016;2015;UCI;;Stefanie
647;217;NCT02653456;2;3;https://www.jacc.org/doi/10.1016/j.jacc.2018.08.1381;Sep 18;abstract: https://www.jacc.org/doi/10.1016/j.jacc.2018.08.1381;23.10.2018;08.01.2016;27.08.2018;Interventional;Not Applicable;64;Completed;Evaluating Plaque Photoablation Using an Excimer Laser in Patients With Lower Extremity Vascular Disease;2016-04-07T00:00:00Z;2017-07-14T00:00:00Z;2017-05-03T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;UCSD;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;UCSD;;Stefanie
859;339;NCT01695473;2;3;;20.05.2016;abstract:https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.e14110;07.01.2021;26.09.2012;11.12.2020;Interventional;Phase 2;11;Terminated;Neoadjuvant BKM120 in High-risk Prostate Cancer;2013-04-23T00:00:00Z;2015-02-05T00:00:00Z;2015-02-05T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2015;2015;UCSF;;Stefanie
326;376;NCT01729416;2;3;;Okt 15;abstract:https://journals.lww.com/ajg/Fulltext/2015/10001/Randomized_Controlled_Trial_Comparing_Adenoma.1493.aspx;26.05.2017;02.11.2012;NA;Interventional;Not Applicable;178;Completed;Prospective Randomized Controlled Trial Comparing Water and Air Colonoscopy in a Community Based Setting;2014-02-01T00:00:00Z;2015-04-01T00:00:00Z;2015-04-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of California, Davis;NA;NA;NA;NA;NA;NA;NA;NA;2012;2014;2015;2015;UCD;;Stefanie
284;129;NCT01474746;1;2;10.15406/jpcpy.2017.07.00465;26.07.2017;;25.08.2017;10.11.2011;27.03.2017;Interventional;Phase 2;57;Completed;Trial of Sertraline to Treat Children With Fragile X Syndrome;2012-01-01T00:00:00Z;2015-09-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;UC Davis MIND Institute;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2015;2015;UCD;;Stefanie
417;432;NCT02199171;2;2;;01.06.2018;abstract:  https://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.5554;29.01.2020;16.07.2014;NA;Interventional;Phase 1;30;Completed;Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer;2014-07-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of California, Irvine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2017;UCI;;Stefanie
;11;NCT01245595;1;4;26669642;01.02.2017;;03.06.2015;19.11.2010;31.03.2015;Interventional;Not Applicable;144;Completed;Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery;2010-11-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;;Stanford;;First Stanford Sample
;12;NCT01216319;1;4;27622100;09.08.2016;;19.05.2016;05.10.2010;30.04.2015;Interventional;Not Applicable;50;Completed;Evaluation of the Cook Biodesign? Nipple Reconstruction Cylinder (NRC);2011-09-01T00:00:00Z;2014-04-01T00:00:00Z;2014-04-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2011;2014;;Stanford;;First Stanford Sample
;14;NCT01663012;1;4;25935109;03.05.2015;;25.01.2016;02.08.2012;28.05.2015;Interventional;Phase 2;20;Completed;Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma;2012-07-01T00:00:00Z;2015-02-01T00:00:00Z;2015-02-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;;Stanford;;First Stanford Sample
;16;NCT01846741;1;4;26663671;13.12.2015;;26.10.2015;15.04.2013;10.07.2015;Interventional;Not Applicable;20;Completed;VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37);2013-07-01T00:00:00Z;2015-08-01T00:00:00Z;2014-08-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;;Stanford;;First Stanford Sample
;17;NCT01270620;1;4;28494898;14.03.2017;;01.10.2015;14.12.2010;18.07.2015;Interventional;Phase 4;100;Completed;Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement;2010-12-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;Stanford University;NA;NA;NA;2010;2010;2015;;Stanford;;First Stanford Sample
;22;NCT01932060;1;4;28212181;01.03.2017;;07.12.2016;21.08.2013;03.02.2016;Interventional;Phase 3;51;Completed;Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.;2013-08-01T00:00:00Z;2015-09-01T00:00:00Z;2015-09-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;;Stanford;;First Stanford Sample
;41;NCT00572117;1;4;26894822;19.02.2016;;09.11.2016;10.12.2007;17.08.2016;Interventional;Phase 4;12;Completed;Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder;2007-08-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2014;;Stanford;;First Stanford Sample
;45;NCT01442714;1;4;26374199;13.10.2015;;04.12.2017;23.09.2011;17.10.2016;Interventional;Phase 2;33;Terminated;Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS;2011-08-01T00:00:00Z;2014-05-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;;Stanford;;First Stanford Sample
;56;NCT00505362;1;4;28840194;26.05.2017;no pubmed available;02.10.2017;19.07.2007;28.11.2016;Interventional;Not Applicable;63;Completed;Pain Study of Rectus Muscle Closure at Cesarean Delivery;2006-06-01T00:00:00Z;2017-10-01T00:00:00Z;2014-08-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2007;2006;2017;;Stanford;;First Stanford Sample
;60;NCT02445196;1;4;27046668;25.01.2016;25.01.2016;15.02.2017;11.05.2015;05.12.2016;Interventional;Not Applicable;120;Completed;PTSD Coach App Evaluation;2014-02-01T00:00:00Z;2016-09-01T00:00:00Z;2015-09-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2016;;Stanford;;First Stanford Sample
;68;NCT01055028;1;4;29760870;23.08.2018;;23.02.2018;21.01.2010;19.12.2016;Interventional;Phase 2;18;Terminated;Paclitaxel + Bevacizumab (Avastin) for the Treatment of Metastatic or Unresectable Angiosarcoma;2010-02-01T00:00:00Z;2016-06-24T00:00:00Z;2016-03-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2016;;Stanford;;First Stanford Sample
;71;NCT00981435;1;4;31444008;06.06.2019;;23.07.2019;21.09.2009;28.12.2016;Interventional;Phase 4;97;Completed;Steroids After Laser Trabeculoplasty for Glaucoma;2009-09-01T00:00:00Z;2015-09-01T00:00:00Z;2015-09-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;;Stanford;;First Stanford Sample
;73;NCT02206776;1;4;28448699;01.04.2017;;30.03.2017;31.07.2014;03.01.2017;Interventional;Phase 2;2;Terminated;Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD;2014-09-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;78;NCT01719861;1;4;32413603;20.04.2020;;02.03.2017;29.10.2012;12.01.2017;Interventional;Phase 2;6;Terminated;Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors;2012-10-01T00:00:00Z;2015-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;;Stanford;;First Stanford Sample
;81;NCT01108055;1;4;27068017;12.03.2016;;08.05.2017;15.04.2010;18.01.2017;Interventional;Phase 2;43;Completed;Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer;2010-04-01T00:00:00Z;2015-07-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;;Stanford;;First Stanford Sample
;90;NCT01862991;1;4;28834186;27.09.2017;;26.04.2017;22.05.2013;07.02.2017;Interventional;Not Applicable;80;Completed;Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services;2013-07-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;;Stanford;;First Stanford Sample
;91;NCT00747435;1;4;29342054;01.03.2018;;10.04.2017;04.09.2008;13.02.2017;Interventional;Not Applicable;73;Completed;Safety and Effectiveness of the MED-EL Electric-Acoustic System;2007-02-01T00:00:00Z;2016-02-01T00:00:00Z;2016-02-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2008;2007;2016;;Stanford;;First Stanford Sample
;94;NCT01898403;1;4;25124992;13.08.2014;;19.04.2017;03.07.2013;24.02.2017;Interventional;Not Applicable;50;Completed;Lymph Node Mapping Using Indocyanine Green Solution in Diagnosing Patients With Malignant Melanoma;2013-06-01T00:00:00Z;2015-04-01T00:00:00Z;2014-06-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;;Stanford;;First Stanford Sample
;100;NCT02006108;1;4;28411307;14.04.2017;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391060/ article shows results for persons age 10-24, study:10-40, part. Other;10.04.2018;28.10.2013;11.04.2017;Interventional;Not Applicable;21;Completed;Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance;2012-11-27T00:00:00Z;2017-04-11T00:00:00Z;2017-04-11T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2017;;Stanford;;First Stanford Sample
;104;NCT02597543;1;4;10.1016/j.healun.2017.01.1450;01.04.2017;no pubmed available;24.07.2017;30.10.2015;06.06.2017;Interventional;Phase 4;14;Completed;Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction;2015-11-01T00:00:00Z;2016-06-30T00:00:00Z;2016-06-30T00:00:00Z;TRUE;Non-Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;109;NCT02480166;1;4;29087397;31.10.2017;;21.08.2017;17.06.2015;17.07.2017;Interventional;Phase 4;60;Completed;Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6;2015-06-01T00:00:00Z;2016-10-01T00:00:00Z;2016-10-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;119;NCT01552213;1;4;26344009;07.09.2015;;25.07.2018;06.03.2012;13.10.2017;Interventional;Not Applicable;95;Completed;Early Screening and Treatment of Women With Prediabetes in Pregnancy;2012-03-01T00:00:00Z;2014-09-01T00:00:00Z;2014-09-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;;Stanford;;First Stanford Sample
;122;NCT02268994;1;4;28082519;12.01.2017;;22.02.2018;11.10.2014;30.11.2017;Interventional;Phase 3;234;Completed;KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD;2014-10-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;NA;NA;NA;Division of Nephrology at Stanford University School of Medicine;NA;NA;NA;NA;NA;2014;2014;2016;;Stanford;;First Stanford Sample
;129;NCT01050647;1;4;29298456;03.01.2018;;02.04.2019;13.01.2010;13.02.2018;Interventional;Phase 1/Phase 2;21;Completed;Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.;2010-02-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;;Stanford;;First Stanford Sample
;134;NCT01965002;1;4;26040967;01.03.2016;;28.04.2018;15.10.2013;26.03.2018;Interventional;Not Applicable;5;Terminated;Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors;2014-05-01T00:00:00Z;2015-03-24T00:00:00Z;2015-03-24T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2015;;Stanford;;First Stanford Sample
;135;NCT02844543;1;4;31445952;07.08.2019;;29.04.2018;30.06.2016;27.03.2018;Interventional;Not Applicable;155;Completed;EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1;2016-01-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2016;;Stanford;;First Stanford Sample
;137;NCT02855086;1;4;29623552;06.04.2018;;17.03.2020;01.08.2016;12.04.2018;Interventional;Phase 1/Phase 2;3;Terminated;Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery;2016-10-01T00:00:00Z;2016-11-22T00:00:00Z;2016-11-08T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2016;;Stanford;;First Stanford Sample
;142;NCT02108821;1;4;29361092;18.01.2018;18.01.2018;02.02.2021;21.03.2014;16.06.2018;Interventional;Phase 1;23;Completed;Fecal Microbiota Transplantation in Pediatric Patients;2014-03-01T00:00:00Z;2016-09-30T00:00:00Z;2016-09-30T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;;Stanford;;First Stanford Sample
;143;NCT02324075;1;4;28556458;29.06.2017;;15.12.2020;11.11.2014;26.06.2018;Interventional;Not Applicable;1226;Completed;Using Behaviour Change Messaging to Improve Communal Toilets in Dhaka, Bangladesh;2014-12-01T00:00:00Z;2015-11-01T00:00:00Z;2015-09-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;152;NCT01011218;1;4;32274500;13.10.2020;13.10.2020;01.11.2018;09.11.2009;13.09.2018;Interventional;Phase 2;70;Completed;Management of Insomnia in Breast Cancer Patients;2011-01-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2011;2016;;Stanford;;First Stanford Sample
;158;NCT02475837;1;4;31774037;27.11.2019;;11.01.2019;12.06.2015;04.12.2018;Interventional;Phase 2;17;Completed;Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access;2015-08-26T00:00:00Z;2017-10-23T00:00:00Z;2017-10-23T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;;Stanford;;First Stanford Sample
;159;NCT02736578;1;4;29667116;17.04.2018;;21.06.2019;04.04.2016;06.12.2018;Interventional;Phase 2;8;Terminated;Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery;2016-07-01T00:00:00Z;2017-05-22T00:00:00Z;2017-04-24T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;163;NCT02757547;1;4;29984172;18.04.2018;;07.07.2020;19.04.2016;04.02.2019;Interventional;Not Applicable;2;Terminated;Transcranial Magnetic Stimulation for Epilepsy;2015-09-01T00:00:00Z;2017-11-15T00:00:00Z;2017-11-15T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2017;;Stanford;;First Stanford Sample
;167;NCT02429778;1;4;30765288;17.12.2018;;24.01.2020;21.04.2015;18.03.2019;Interventional;Not Applicable;40;Completed;Relaxation Treatment for Anxiety in Adults Aged 60 or Older;2015-05-01T00:00:00Z;2017-06-01T00:00:00Z;2017-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;VA Palo Alto/Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;;Stanford;;First Stanford Sample
;168;NCT01962870;1;4;31043522;01.05.2019;;02.05.2019;08.10.2013;30.03.2019;Interventional;Phase 2;68;Completed;The Role of Vasopressin in the Social Deficits of Autism;2013-12-01T00:00:00Z;2017-05-30T00:00:00Z;2017-05-30T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;;Stanford;;First Stanford Sample
;183;NCT02085980;1;4;27404032;01.10.2016;;11.05.2021;10.03.2014;11.05.2021;Interventional;Not Applicable;30;Completed;Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal Atrophy;2014-03-01T00:00:00Z;2015-11-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;NA;NA;NA;NA;NA;Stanford University;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;187;NCT01856777;1;4;27067706;08.04.2016;;12.05.2014;03.05.2013;NA;Interventional;Not Applicable;600;Completed;Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy;2013-06-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;;Stanford;;First Stanford Sample
;188;NCT01729273;1;4;26154402;04.07.2015;not found in clinicla trials, ongoing?;02.10.2014;13.11.2012;NA;Interventional;Not Applicable;20;Completed;Vascular Health and Exercise Performance of Overweight Children;2012-07-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;NA;NA;NA;Stanford Prevention Research Center;NA;NA;NA;NA;NA;2012;2012;2014;;Stanford;;First Stanford Sample
;192;NCT01181245;1;4;https://www.hilarispublisher.com/abstract/fg3019-a-human-monoclonal-antibody-to-connective-tissue-growth-factor-combined-with-chemotherapy-in-patients-with-locall-26153.html;14.12.2016;;04.08.2014;04.05.2009;NA;Interventional;Phase 1;50;Completed;A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer;2008-12-01T00:00:00Z;2014-06-01T00:00:00Z;2014-05-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2008;2014;;Stanford;;First Stanford Sample
;195;NCT01034514;1;4;25104070;04.08.2014;21 instead of 35 participants. No trial ID.;03.05.2017;16.12.2009;NA;Interventional;Early Phase 1;35;Terminated;4D-CT-based Ventilation Imaging for Adaptive Functional Guidance in Radiotherapy;2009-12-01T00:00:00Z;2014-06-24T00:00:00Z;2014-06-24T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;;Stanford;;First Stanford Sample
;197;NCT01832064;1;4;25690615;17.02.2015;;29.07.2014;11.04.2013;NA;Interventional;Not Applicable;255;Completed;Active Living Tool Kit for Chronic Conditions;2013-06-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;;Stanford;;First Stanford Sample
;207;NCT01815814;1;4;26442234;10.09.2015;one publication linked, but only preliminary results;04.07.2015;19.03.2013;NA;Interventional;Not Applicable;38;Completed;Therapeutic Potential of Myofascial Structural Integration in Children With Cerebral Palsy;2011-11-01T00:00:00Z;2014-11-01T00:00:00Z;2014-11-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2011;2014;;Stanford;;First Stanford Sample
;210;NCT00352326;1;4;17894279;17.09.2007;unsure - publication is quite early and I have no access to full text;18.05.2017;12.07.2006;NA;Interventional;Not Applicable;29;Completed;Optimizing Assisted Communication Devices for Children With Motor Impairments Using a Model of Information Rate and Channel Capacity;2006-01-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2006;2006;2014;;Stanford;;First Stanford Sample
;214;NCT02147860;1;4;27271182;06.06.2016;;15.07.2016;21.05.2014;NA;Interventional;Not Applicable;44;Completed;Full Day and Night Closed-Loop With DiAs Platform;2014-05-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;215;NCT00185796;1;4;24607552;07.03.2014;;16.03.2015;12.09.2005;NA;Interventional;Phase 2;77;Completed;TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD;2004-07-01T00:00:00Z;2015-02-01T00:00:00Z;2014-04-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2005;2004;2015;;Stanford;;First Stanford Sample
;219;NCT01094587;1;4;28279777;06.03.2017;;12.10.2017;25.03.2010;NA;Interventional;Not Applicable;39;Terminated;Sutureless vs Sutured Gastroschisis Closure;2009-11-01T00:00:00Z;2015-06-24T00:00:00Z;2015-06-24T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2009;2015;;Stanford;;First Stanford Sample
;220;NCT00946673;1;4;28816142;06.05.2017;;04.10.2017;23.07.2009;NA;Interventional;Phase 1;17;Completed;Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer;2009-06-01T00:00:00Z;2015-07-01T00:00:00Z;2014-07-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;;Stanford;;First Stanford Sample
;226;NCT01123005;1;4;29859786;18.04.2018;;01.11.2017;27.07.2009;NA;Interventional;Phase 1;28;Terminated;Imaging and Biomarkers of Hypoxia in Solid Tumors;2010-12-01T00:00:00Z;2015-08-21T00:00:00Z;2015-08-21T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2010;2015;;Stanford;;First Stanford Sample
;232;NCT01579682;1;4;26276704;01.08.2015;paper found: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC4573312/ but: participants 45 instead of 90;12.04.2016;05.04.2012;NA;Interventional;Not Applicable;90;Completed;Adaptive Family Treatment for Adolescent Anorexia Nervosa;2011-09-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2015;;Stanford;;First Stanford Sample
;237;NCT01721668;1;4;29797585;24.05.2018;;03.08.2016;01.11.2012;NA;Interventional;Not Applicable;29;Completed;Improving Arm and Hand Functions in Chronic Stroke (CIHR 2012-2015);2012-11-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;;Stanford;;First Stanford Sample
;242;NCT01806701;1;4;33881197;21.04.2021;;12.10.2016;27.02.2013;NA;Interventional;Not Applicable;68;Completed;Brain Response to Treatment for Pediatric PTSD;2013-04-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;;Stanford;;First Stanford Sample
;246;NCT01885728;1;4;28794234;09.08.2017;;04.11.2016;18.06.2013;NA;Interventional;Not Applicable;22;Completed;Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients;2013-07-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University SOM;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;;Stanford;;First Stanford Sample
;250;NCT02104700;1;4;27704000;01.07.2016;;16.03.2021;01.04.2014;NA;Interventional;Phase 2/Phase 3;150;Completed;Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir;2014-04-01T00:00:00Z;2016-07-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;;Stanford;;First Stanford Sample
;251;NCT02536950;1;4;31470740;30.08.2019;;19.06.2018;18.07.2015;NA;Interventional;Not Applicable;16;Completed;An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas;2015-08-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;FALSE;Non-Randomized;Single;OTHER;FALSE;Stanford School of Medicine, Pediatric Endocrinology;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;256;NCT02613676;1;4;32657704;26.02.2020;;24.10.2016;17.11.2015;NA;Interventional;Not Applicable;1858;Completed;Transcutaneous Screening for Risk of Severe Hyperbilirubinemia in South African Newborns;2015-08-01T00:00:00Z;2016-10-01T00:00:00Z;2016-10-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;258;NCT02054364;1;4;29152825;20.11.2017;;26.04.2017;31.01.2014;NA;Interventional;Not Applicable;30;Completed;Feasibility of Combining Family and Cognitive Therapy to Prevent Chronic Anorexia;2013-11-01T00:00:00Z;2016-11-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2016;;Stanford;;First Stanford Sample
;259;NCT02400177;1;4;31002483;19.04.2019;found a trial, but no comparator https://doi.org/10.1002/aur.2108;30.05.2018;23.03.2015;NA;Interventional;Not Applicable;96;Completed;Parents Workgroup About Emotion Regulation;2015-03-01T00:00:00Z;2016-11-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;274;NCT02205671;1;4;29165000;14.11.2017;;24.04.2017;29.07.2014;NA;Interventional;Not Applicable;128;Completed;Building Better Caregivers: Development and Evaluation;2014-08-01T00:00:00Z;2017-03-01T00:00:00Z;2015-07-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford School of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;;Stanford;;First Stanford Sample
;277;NCT02897557;1;4;29431513;12.02.2018;also conference : https://www.businesswire.com/news/home/20170217005019/en/Insulet-Presents-Strong-Omnipod%C2%AE-Horizon%E2%84%A2-Hybrid-Closed-Loop/?feedref=JjAwJuNHiystnCoBq_hl-ZuHAZxVRaQvQ0qaekuSK9f3_P53wLuJwyFVA4-mOrLx7fxFuNFTHSunhvli30RlBNXya2izy9YOgHlBiZQk2LP6oD-t3eB0qV-nJQ-WeFyCN1Simk7pbS0xXPOT069Puw==;07.04.2021;01.09.2016;NA;Interventional;Not Applicable;59;Completed;Insulet Artificial Pancreas Early Feasibility Study;2016-09-01T00:00:00Z;2017-03-01T00:00:00Z;2017-02-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;279;NCT01893892;1;4;29405443;23.02.2018;;03.08.2017;02.07.2013;NA;Interventional;Not Applicable;12;Completed;Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms;2014-03-01T00:00:00Z;2017-03-15T00:00:00Z;2017-03-15T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2017;;Stanford;;First Stanford Sample
;280;NCT03064906;1;4;30925077;29.03.2019;;08.06.2018;22.02.2017;NA;Interventional;Not Applicable;24;Completed;Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2);2017-03-18T00:00:00Z;2017-04-07T00:00:00Z;2017-04-07T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2017;2017;2017;;Stanford;;First Stanford Sample
;282;NCT01987375;1;4;25904751;15.08.2016;;21.06.2019;08.10.2013;NA;Interventional;Phase 1;1;Terminated;Cetuximab IRDye800 Study as an Optical Imaging Agent to Detect Cancer During Surgical Procedures;2015-11-01T00:00:00Z;2017-04-19T00:00:00Z;2017-04-19T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2015;2017;;Stanford;;First Stanford Sample
;284;NCT02714972;1;4;29159870;20.11.2017;;09.05.2017;16.03.2016;NA;Interventional;Phase 2;35;Completed;Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young Adolescents;2016-05-01T00:00:00Z;2017-05-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;TRUE;NA;NA;NA;Stanford University;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;289;NCT04757935;1;4;30477870;11.09.2018;;16.02.2021;06.09.2018;NA;Interventional;Not Applicable;9;Completed;Yoga for Youth With IBD: a Pilot Feasibility Study;2017-01-01T00:00:00Z;2017-05-31T00:00:00Z;2017-05-31T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;"Clinician Educator at Stanford University; Stanford University";NA;NA;NA;NA;NA;NA;NA;NA;2018;2017;2017;;Stanford;;First Stanford Sample
;299;NCT03421158;1;4;32804876;10.12.2020;date unclear;29.01.2018;29.01.2018;NA;Interventional;Not Applicable;236;Completed;Non-pharmacological Analgesic Effects on Term Newborns;2014-11-07T00:00:00Z;2017-08-31T00:00:00Z;2015-09-30T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2018;2014;2017;;Stanford;;First Stanford Sample
;306;NCT02735356;1;4;31339515;01.09.2019;;10.04.2019;31.03.2016;NA;Interventional;Early Phase 1;9;Completed;Topical Itraconazole in Treating Patients With Basal Cell Cancer;2016-05-05T00:00:00Z;2017-10-10T00:00:00Z;2017-09-19T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford Cancer Institute;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;312;NCT02805075;1;4;34274493;16.07.2021;;18.03.2021;15.06.2016;NA;Interventional;Phase 1;15;Completed;Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant;2016-06-01T00:00:00Z;2017-11-17T00:00:00Z;2017-11-17T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;316;NCT02254356;1;4;30411151;08.11.2028;;29.03.2018;29.09.2014;NA;Interventional;Not Applicable;239;Completed;Zilver Flex Post-Market Study in Japan;2012-05-01T00:00:00Z;2017-12-26T00:00:00Z;2017-12-26T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;FALSE;Department of Cardiothoracic Surgery, Stanford University Medical Center, Stanford, CA;NA;NA;NA;NA;NA;NA;NA;NA;2014;2012;2017;;Stanford;;First Stanford Sample
;8;NCT01155141;1;1;24009220;05.09.2013;;20.08.2014;29.06.2010;01.08.2014;Interventional;Phase 4;15;Completed;Idiopathic Focal Segmental Glomerulosclerosis (FSGS) and Treatment With ACTH;2009-09-01T00:00:00Z;2014-01-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2009;2014;;Stanford;;First Stanford Sample
;15;NCT01823341;1;1;26049549;06.06.2015;;26.08.2016;29.03.2013;25.06.2015;Interventional;Phase 2;97;Completed;Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children;2013-05-01T00:00:00Z;2014-09-01T00:00:00Z;2014-09-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;NA;NA;NA;Stanford University;NA;NA;NA;NA;NA;2013;2013;2014;;Stanford;;First Stanford Sample
;21;NCT02366767;1;1;26049550;06.06.2015;;09.02.2017;26.06.2014;28.10.2015;Interventional;Not Applicable;21;Completed;Assessment of an Automatic Closed-loop Insulin Delivery System;2014-06-01T00:00:00Z;2014-09-01T00:00:00Z;2014-09-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2014;;Stanford;;First Stanford Sample
;27;NCT01330043;1;1;28239942;02.05.2017;;04.07.2017;07.10.2010;12.04.2016;Interventional;Phase 4;223;Completed;Extended Treatment for Smoking Cessation;2010-03-01T00:00:00Z;2015-03-01T00:00:00Z;2015-03-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;;Stanford;;First Stanford Sample
;28;NCT00850135;1;1;25262455;28.09.2014;;13.04.2016;20.02.2009;13.04.2016;Interventional;Phase 1/Phase 2;57;Completed;Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes;2009-02-01T00:00:00Z;2015-09-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;;Stanford;;First Stanford Sample
;32;NCT02178995;1;1;28031390;28.12.2016;;26.04.2017;24.06.2014;04.06.2016;Interventional;Phase 4;55;Completed;Methylphenidate Treatment of Attention Deficits in Epilepsy;2014-08-01T00:00:00Z;2015-12-01T00:00:00Z;2015-09-01T00:00:00Z;TRUE;Non-Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;Stanford University;NA;Stanford University;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;33;NCT01078363;1;1;28289008;14.03.2017;;02.12.2016;26.02.2010;17.06.2016;Interventional;Not Applicable;96;Completed;Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy;2009-06-01T00:00:00Z;2015-04-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2009;2015;;Stanford;;First Stanford Sample
;35;NCT01647945;1;1;28893866;11.09.2017;;11.08.2016;18.07.2012;24.06.2016;Interventional;Phase 2;23;Completed;FK506 (Tacrolimus) in Pulmonary Arterial Hypertension;2012-07-01T00:00:00Z;2014-08-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;;Stanford;;First Stanford Sample
;37;NCT01977690;1;1;26296190;21.08.2015;;21.07.2017;31.10.2013;16.07.2016;Interventional;Not Applicable;30;Completed;Clavicle Splint for Pain Reduction After Posterior Cervicothoracic Surgery;2013-10-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;;Stanford;;First Stanford Sample
;38;NCT01945112;1;1;27070112;01.09.2016;;21.11.2018;13.09.2013;23.07.2016;Interventional;Not Applicable;128;Completed;Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II);2014-02-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2015;;Stanford;;First Stanford Sample
;39;NCT00767624;1;1;27788313;01.10.2016;;10.10.2016;03.10.2008;05.08.2016;Interventional;Phase 2/Phase 3;150;Completed;TRIAD - Treatment of Insomnia and Depression;2008-12-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2015;;Stanford;;First Stanford Sample
;44;NCT00186069;1;1;26871905;12.02.2016;;01.12.2017;13.09.2005;12.10.2016;Interventional;Not Applicable;30;Completed;Magnesium Sulfate vs Placebo for Placental Abruption;2004-03-01T00:00:00Z;2017-11-01T00:00:00Z;2014-06-01T00:00:00Z;TRUE;Randomized;Double;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2005;2004;2017;;Stanford;;First Stanford Sample
;46;NCT01559857;1;1;26731446;01.01.2016;;30.03.2017;16.03.2012;19.10.2016;Interventional;Phase 4;37;Completed;Pioglitazone in Patients With Mood Disorders;2011-11-01T00:00:00Z;2014-06-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2014;;Stanford;;First Stanford Sample
;49;NCT02199028;1;1;27222506;23.05.2016;not the planned intervention (hyaluronidase treatment);24.09.2019;28.01.2014;03.11.2016;Interventional;Phase 1;30;Completed;Hyaluronidase Effect on Infusion Set Life;2014-07-01T00:00:00Z;2015-03-01T00:00:00Z;2015-03-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;51;NCT01549652;1;1;29278818;14.08.2017;;02.01.2019;13.02.2012;16.11.2016;Interventional;Not Applicable;133;Completed;5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence;2011-04-01T00:00:00Z;2016-10-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2016;;Stanford;;First Stanford Sample
;52;NCT02192684;1;1;27544837;21.06.2016;;14.03.2017;07.07.2014;18.11.2016;Interventional;Not Applicable;45;Completed;Obesity, Sleep Apnea, and Insulin Resistance;2010-09-01T00:00:00Z;2015-03-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2010;2015;;Stanford;;First Stanford Sample
;57;NCT00956085;1;1;27249077;01.05.2016;;20.06.2017;10.08.2009;29.11.2016;Interventional;Phase 2;12;Completed;Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder;2009-08-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2015;;Stanford;;First Stanford Sample
;59;NCT02037438;1;1;25409112;01.02.2015;;02.11.2018;14.01.2014;01.12.2016;Interventional;Not Applicable;1836;Completed;Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study;2014-01-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;;Stanford;;First Stanford Sample
;72;NCT01396070;1;1;26195720;20.07.2015;;17.02.2017;14.07.2011;28.12.2016;Interventional;Phase 2;36;Completed;Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level;2011-05-01T00:00:00Z;2016-05-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2016;;Stanford;;First Stanford Sample
;77;NCT01355705;1;1;29802551;25.05.2018;;17.09.2018;16.05.2011;11.01.2017;Interventional;Phase 1/Phase 2;14;Completed;Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma;2011-08-01T00:00:00Z;2017-07-01T00:00:00Z;2016-07-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2017;;Stanford;;First Stanford Sample
;85;NCT01449279;1;1;27681753;15.07.2016;;14.02.2020;05.10.2011;20.01.2017;Interventional;Phase 2;22;Completed;Pilot Ipilimumab in Stage IV Melanoma Receiving Palliative Radiation Therapy;2011-10-01T00:00:00Z;2016-12-01T00:00:00Z;2015-12-31T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2016;;Stanford;;First Stanford Sample
;86;NCT02488070;1;1;26659347;10.12.2015;;20.02.2018;26.06.2015;23.01.2017;Interventional;Phase 1/Phase 2;10;Completed;68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate Cancer;2015-06-01T00:00:00Z;2016-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford Cancer Institute;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;87;NCT02272725;1;1;28679502;05.07.2017;;21.11.2018;09.10.2014;24.01.2017;Interventional;Phase 3;91;Completed;Non-steroidal Anti-inflammatory Affect on Kidneys in Endurance Distances;2015-03-01T00:00:00Z;2017-01-01T00:00:00Z;2016-03-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;;Stanford;;First Stanford Sample
;89;NCT01631331;1;1;24929884;11.06.2014;;06.11.2017;25.06.2012;02.02.2017;Interventional;Early Phase 1;15;Completed;Vismodegib in Treating Patients With Basal Cell Carcinoma (BCC);2012-06-01T00:00:00Z;2016-05-31T00:00:00Z;2015-09-17T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;;Stanford;;First Stanford Sample
;95;NCT02440308;1;1;26659347;10.12.2015;;28.02.2017;01.05.2015;28.02.2017;Interventional;Phase 2;10;Completed;68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate Cancer;2015-04-01T00:00:00Z;2015-06-30T00:00:00Z;2015-06-30T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2015;;Stanford;;First Stanford Sample
;96;NCT02267629;1;1;27903098;01.12.2016;;20.06.2017;14.10.2014;30.03.2017;Interventional;Phase 2;7;Completed;Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder;2014-10-01T00:00:00Z;2016-02-01T00:00:00Z;2016-02-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;;Stanford;;First Stanford Sample
;97;NCT01827462;1;1;29410330;02.02.2018;;09.06.2017;04.04.2013;30.03.2017;Interventional;Phase 4;136;Completed;Comparison of Immune Responses to Influenza Vaccine In Adults of Different Ages (SLVP015 2007-2017);2007-10-01T00:00:00Z;2017-03-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2007;2017;;Stanford;;First Stanford Sample
;101;NCT02533726;1;1;27053145;06.04.2016;;13.09.2017;17.08.2015;21.04.2017;Interventional;Not Applicable;1312;Completed;Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers;2015-08-01T00:00:00Z;2016-02-01T00:00:00Z;2016-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford Health Care;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;105;NCT02643862;1;1;29242014;12.12.2017;;14.12.2017;24.11.2015;20.06.2017;Interventional;Phase 1/Phase 2;48;Completed;Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients;2015-03-18T00:00:00Z;2016-08-20T00:00:00Z;2016-08-20T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;NA;NA;NA;NA;NA;Stanford University;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;106;NCT01619982;1;1;30995208;01.05.2019;;16.04.2018;02.03.2012;21.06.2017;Interventional;Phase 4;32;Completed;Pre-operative Prophylaxis With Vancomycin and Cefazolin in Pediatric Cardiovascular Surgery Patients;2012-02-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;;Stanford;;First Stanford Sample
;115;NCT02312882;1;1;27699252;22.09.2016;;04.10.2017;05.12.2014;08.09.2017;Interventional;Not Applicable;40;Completed;Tofacitinib for the Treatment of Alopecia Areata and Its Variants;2014-12-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;116;NCT02626611;1;1;31193674;21.01.2019;;14.12.2017;24.11.2015;17.09.2017;Interventional;Phase 2;70;Completed;Multi Immunotherapy to Test Tolerance and Xolair;2015-12-01T00:00:00Z;2016-11-16T00:00:00Z;2016-11-16T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;117;NCT01624194;1;1;28696286;10.07.2017;;12.07.2019;18.06.2012;20.09.2017;Interventional;Phase 2;54;Completed;Intranasal Oxytocin Treatment for Social Deficits in Children With Autism;2012-06-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;;Stanford;;First Stanford Sample
;118;NCT02604173;1;1;28668540;28.06.2017;;21.11.2018;06.11.2015;23.09.2017;Interventional;Phase 3;103;Completed;Altitude Sickness Prevention and Efficacy of Comparative Treatments;2016-08-01T00:00:00Z;2016-09-01T00:00:00Z;2016-09-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2016;;Stanford;;First Stanford Sample
;123;NCT02933476;1;1;24976001;28.06.2014;;22.01.2018;08.07.2016;06.12.2017;Interventional;Not Applicable;6;Completed;Vibrotactile Stimulation in Parkinson's Disease;2016-05-01T00:00:00Z;2016-11-01T00:00:00Z;2016-11-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2016;;Stanford;;First Stanford Sample
;124;NCT02310789;1;1;30389955;02.11.2018;;21.12.2018;03.09.2014;12.12.2017;Interventional;Not Applicable;8;Completed;(Study: Vertex IIS) Does Ivacaftor Alter Wild Type CFTR-Open Probability In The Sweat Gland Secretory Coil?;2015-07-31T00:00:00Z;2017-08-23T00:00:00Z;2016-08-02T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;;Stanford;;First Stanford Sample
;125;NCT01990313;1;1;27553876;21.08.2016;;22.01.2018;06.11.2013;15.12.2017;Interventional;Not Applicable;15;Completed;Neural Signatures of Parkinson's Disease;2013-10-01T00:00:00Z;2016-11-01T00:00:00Z;2016-11-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;;Stanford;;First Stanford Sample
;130;NCT02280863;1;1;27191182;18.05.2016;;01.06.2018;09.07.2014;02.03.2018;Interventional;Not Applicable;24;Completed;Hybrid Closed-Loop Hotel Studies With Medtronic PID Controller;2014-07-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;133;NCT02852434;1;1;30500336;27.11.2018;;05.06.2019;20.06.2016;16.03.2018;Interventional;Phase 3;72;Completed;Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation;2016-07-01T00:00:00Z;2017-04-01T00:00:00Z;2017-04-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;138;NCT02605187;1;1;30867278;13.03.2019;;17.09.2018;10.11.2015;20.04.2018;Interventional;Not Applicable;160;Completed;Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management;2015-11-01T00:00:00Z;2017-05-22T00:00:00Z;2017-05-22T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;;Stanford;;First Stanford Sample
;140;NCT01067144;1;1;29238824;01.04.2018;;06.09.2018;09.02.2010;01.06.2018;Interventional;Phase 3;422;Terminated;Stanford Accelerated Recovery Trial (START);2010-05-01T00:00:00Z;2016-07-01T00:00:00Z;2016-07-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2016;;Stanford;;First Stanford Sample
;145;NCT02257970;1;1;30333315;18.10.2018;;15.08.2018;25.08.2014;19.07.2018;Interventional;Phase 4;117;Completed;Lymphedema Study for Arm or Leg Lymphedema;2009-03-01T00:00:00Z;2017-03-01T00:00:00Z;2016-12-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2009;2017;;Stanford;;First Stanford Sample
;146;NCT01802073;1;1;23054338;09.10.2012;;23.08.2018;21.02.2013;20.07.2018;Interventional;Phase 3;34;Completed;Primary Sclerosing Cholangitis With Oral Vancomycin by the Study of Its Antimicrobial and Immunomodulating Effects;2012-01-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2015;;Stanford;;First Stanford Sample
;148;NCT02738203;1;1;30444982;13.11.2018;;04.06.2019;04.04.2016;07.08.2018;Interventional;Phase 3;220;Completed;Self-Administered Lidocaine Gel for Pain Management With IUD Insertion;2016-06-01T00:00:00Z;2017-10-19T00:00:00Z;2017-10-19T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;150;NCT02586415;1;1;29364767;24.01.2018;;13.05.2019;21.10.2015;23.08.2018;Interventional;Not Applicable;182;Terminated;Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3;2016-04-01T00:00:00Z;2017-08-23T00:00:00Z;2017-08-23T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;;Stanford;;First Stanford Sample
;161;NCT01807598;1;1;31350306;13.08.2019;;09.01.2019;05.03.2013;14.12.2018;Interventional;Phase 2;10;Completed;Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia;2013-09-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;;Stanford;;First Stanford Sample
;162;NCT02303041;1;1;29175429;23.11.2017;;10.01.2019;25.11.2014;18.12.2018;Interventional;Phase 2;10;Terminated;Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma;2015-02-01T00:00:00Z;2017-06-01T00:00:00Z;2017-04-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;;Stanford;;First Stanford Sample
;166;NCT01392989;1;1;30951840;03.04.2019;;18.04.2019;21.06.2011;14.03.2019;Interventional;Phase 2;44;Completed;Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders;2011-03-01T00:00:00Z;2017-03-19T00:00:00Z;2016-06-07T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2017;;Stanford;;First Stanford Sample
;169;NCT03076190;1;1;31087093;01.11.2019;;19.03.2020;06.12.2016;06.06.2019;Interventional;Not Applicable;131;Completed;My Surgical Success: A Randomized Controlled Pilot Study of a Pre-surgical Psychological Intervention;2015-08-01T00:00:00Z;2017-06-01T00:00:00Z;2017-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2017;;Stanford;;First Stanford Sample
;173;NCT02047643;1;1;25231116;17.09.2014;;17.12.2019;17.01.2014;02.10.2019;Interventional;Not Applicable;18;Completed;Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol;2014-03-12T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2014;;Stanford;;First Stanford Sample
;174;NCT00490529;1;1;32558897;07.09.2020;;08.01.2020;20.06.2007;13.11.2019;Interventional;Phase 2;59;Completed;Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL;2009-08-01T00:00:00Z;2017-12-14T00:00:00Z;2017-12-14T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2007;2009;2017;;Stanford;;First Stanford Sample
;175;NCT02266576;1;1;32000738;30.01.2020;;09.12.2019;13.10.2014;09.12.2019;Interventional;Not Applicable;207;Completed;A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians;2015-06-01T00:00:00Z;2017-08-30T00:00:00Z;2017-08-30T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;;Stanford;;First Stanford Sample
;176;NCT02367430;1;1;31910750;08.01.2020;;04.02.2020;13.02.2015;27.01.2020;Interventional;Not Applicable;14;Completed;Critical Time Intervention for Individuals With Hoarding Disorder;2013-01-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2013;2015;;Stanford;;First Stanford Sample
;181;NCT03049280;1;1;31536129;01.11.2019;;15.09.2020;30.01.2017;28.07.2020;Interventional;Not Applicable;33;Completed;Prospective, Multicenter da Vinci? SP Surgical System TORS Study;2017-04-17T00:00:00Z;2017-12-26T00:00:00Z;2017-11-14T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2017;2017;2017;;Stanford;;First Stanford Sample
;185;NCT01400269;1;1;29775078;18.05.2018;22 instead of 48 participants;15.02.2022;31.05.2011;NA;Interventional;Not Applicable;48;Completed;An Evaluation of a Developmentally-Based Parent Training Program for Children With Autism;2010-09-01T00:00:00Z;2014-01-01T00:00:00Z;2014-01-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2010;2014;;Stanford;;First Stanford Sample
;191;NCT01919502;1;1;28830483;22.08.2017;;12.05.2014;05.08.2013;NA;Interventional;Not Applicable;51;Completed;Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility Treatment;2013-10-01T00:00:00Z;2014-04-01T00:00:00Z;2014-04-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;"Division of Reproductive Endocrinology and Infertility Stanford University School of Medicine; Dept of Obstetrics and Gynecology, Stanford University, Stanford University School of Medicine";NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;;Stanford;;First Stanford Sample
;198;NCT01899378;1;1;26832746;02.02.2016;;13.10.2016;10.07.2013;NA;Interventional;Phase 1;160;Completed;Safety and Efficacy of Probiotics in Bangladeshi Infants;2013-10-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;Stanford University;NA;NA;NA;2013;2013;2014;;Stanford;;First Stanford Sample
;199;NCT03868644;1;1;31361767;30.07.2019;;10.01.2020;06.03.2019;NA;Interventional;Not Applicable;10646;Completed;The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya;2009-02-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2019;2009;2014;;Stanford;;First Stanford Sample
;201;NCT00879151;1;1;26506579;02.09.2015;;21.05.2015;07.04.2009;NA;Interventional;Not Applicable;130;Completed;Study of Treatment for Adolescents With Bulimia Nervosa;2009-01-01T00:00:00Z;2014-09-01T00:00:00Z;2014-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;;Stanford;;First Stanford Sample
;202;NCT01040897;1;1;33911032;01.05.2021;publication selected since this was the first one to report the primary outcome;19.08.2018;28.12.2009;NA;Interventional;Not Applicable;865;Completed;Addressing Health Literacy and Numeracy to Prevent Childhood Obesity;2010-04-28T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2010;2014;;Stanford;;First Stanford Sample
;212;NCT01516411;1;1;27352250;28.06.2016;95 instead of 130 participants;08.12.2015;19.01.2012;NA;Interventional;Not Applicable;130;Completed;Promoting Healthy Lifestyles Using Mobile Phones;2010-10-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford Prevention Research Center;NA;NA;NA;NA;NA;NA;NA;NA;2012;2010;2014;;Stanford;;First Stanford Sample
;223;NCT01287936;1;1;30497166;23.11.2018;other publication not the primary outcomes;19.12.2016;27.01.2011;NA;Interventional;Phase 1/Phase 2;18;Completed;A Study of Modified Stem Cells in Stable Ischemic Stroke;2011-01-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;;Stanford;;First Stanford Sample
;227;NCT02036658;1;1;26950097;07.03.2016;;16.01.2018;10.01.2014;NA;Interventional;Not Applicable;108;Completed;Emotion Regulation During RCT of CBT vs. MBSR for Social Anxiety Disorder;2011-03-01T00:00:00Z;2015-09-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;Stanford University;NA;NA;NA;2014;2011;2015;;Stanford;;First Stanford Sample
;233;NCT01507948;1;1;28715908;18.07.2017;;19.01.2017;14.12.2011;NA;Interventional;Not Applicable;94;Completed;Brain Imaging of Psychotherapy for Posttraumatic Stress Disorder (PTSD);2010-09-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;Stanford University;NA;NA;NA;2011;2010;2016;;Stanford;;First Stanford Sample
;235;NCT02827630;1;1;28698169;11.07.2017;;05.07.2016;29.06.2016;NA;Interventional;Not Applicable;118;Completed;Proteus Discover in Subjects With Uncontrolled Hypertension and Type 2 Diabetes;2015-05-01T00:00:00Z;2016-01-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;Randomized;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2016;;Stanford;;First Stanford Sample
;240;NCT02438189;1;1;28100606;18.01.2017;;26.08.2016;01.05.2015;NA;Interventional;Phase 2;33;Completed;Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms;2015-06-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;NA;NA;NA;Stanford University;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;243;NCT01826591;1;1;29466592;20.02.2018;;06.08.2020;27.03.2013;NA;Interventional;Not Applicable;609;Completed;DIETFITS Study (Diet Intervention Examining the Factors Interacting With Treatment Success;2013-01-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;;Stanford;;First Stanford Sample
;244;NCT02155400;1;1;28800725;11.08.2017;;29.04.2017;27.05.2014;NA;Interventional;Not Applicable;37;Completed;Thermal Compression Device for Maintenance of Perioperative Normothermia;2014-08-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;;Stanford;;First Stanford Sample
;245;NCT02458898;1;1;28343658;23.03.2017;;26.05.2016;21.05.2015;NA;Interventional;Not Applicable;61;Completed;Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease;2015-02-01T00:00:00Z;2016-05-01T00:00:00Z;2016-05-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford Pediatric Gastroenterology;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;255;NCT01523223;1;1;29572391;27.03.2018;;16.03.2019;27.01.2012;NA;Interventional;Phase 1;16;Completed;Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies;2012-01-01T00:00:00Z;2016-10-01T00:00:00Z;2016-09-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;;Stanford;;First Stanford Sample
;262;NCT01642836;1;1;33933181;29.04.2021;;28.04.2021;10.07.2012;NA;Interventional;Not Applicable;241;Completed;Clinic, Family & Community Intervention for Children With Overweight and Obesity (Stanford GOALS);2012-07-13T00:00:00Z;2016-12-19T00:00:00Z;2016-12-19T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;;Stanford;;First Stanford Sample
;263;NCT02606981;1;1;31402005;01.09.2019;;10.05.2017;20.10.2015;NA;Interventional;Not Applicable;1549;Completed;Automatic Chlorination and Child Health in Urban Bangladesh;2015-07-01T00:00:00Z;2016-12-20T00:00:00Z;2016-12-20T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;Stanford University;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;266;NCT02302963;1;1;31095423;16.05.2019;;22.07.2019;24.11.2014;NA;Interventional;Not Applicable;85;Completed;USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D;2015-06-01T00:00:00Z;2017-01-01T00:00:00Z;2017-01-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;;Stanford;;First Stanford Sample
;272;NCT02171962;1;1;33025243;06.10.2020;;21.03.2017;18.06.2014;NA;Interventional;Not Applicable;178;Completed;Zilver? PTX? in China;2014-06-01T00:00:00Z;2017-02-09T00:00:00Z;2015-12-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;NA;NA;NA;NA;NA;Stanford University, CA, USA;NA;NA;NA;2014;2014;2017;;Stanford;;First Stanford Sample
;273;NCT02753101;1;1;28572487;01.06.2017;;01.03.2018;22.04.2016;NA;Interventional;Early Phase 1;24;Completed;[18F]FTC-146 PET/MRI in Healthy Volunteers and in CRPS and Sciatica;2016-02-09T00:00:00Z;2017-02-16T00:00:00Z;2017-02-09T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;278;NCT03037658;1;1;32628030;06.07.2020;;26.04.2017;27.01.2017;NA;Interventional;Not Applicable;450;Completed;Physical Activity Incentives;2013-09-01T00:00:00Z;2017-03-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2017;2013;2017;;Stanford;;First Stanford Sample
;281;NCT02553824;1;1;29038069;14.10.2017;;11.05.2018;21.08.2015;NA;Interventional;Phase 1;22;Completed;FDA Approved Medication to Reduce Binge Eating and/or Purging;2015-10-30T00:00:00Z;2017-04-15T00:00:00Z;2017-02-23T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;;Stanford;;First Stanford Sample
;290;NCT03275662;1;1;34256014;12.97.2021;;11.06.2020;06.09.2017;NA;Interventional;Not Applicable;37;Completed;Fermented and Fiber-rich Food (FeFiFo) Study;2016-08-29T00:00:00Z;2017-06-02T00:00:00Z;2017-06-02T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2017;2016;2017;;Stanford;;First Stanford Sample
;292;NCT01591148;1;1;33079873;01.11.2020;;27.12.2017;01.05.2012;NA;Interventional;Phase 1;30;Completed;A High Resolution Pharmacokinetic/Pharmacodynamic Model of Propofol in Morbidly Obese Subjects;2011-01-01T00:00:00Z;2017-07-01T00:00:00Z;2017-07-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2017;;Stanford;;First Stanford Sample
;295;NCT02442960;1;1;34969665;01.12.2021;;04.11.2020;23.04.2015;NA;Interventional;Phase 1;15;Completed;Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis;2014-12-01T00:00:00Z;2017-07-26T00:00:00Z;2017-07-26T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2017;;Stanford;;First Stanford Sample
;296;NCT02037022;1;1;29775078;18.05.2018;;21.02.2020;13.01.2014;NA;Interventional;Not Applicable;48;Completed;Pivotal Response Treatment Package for Young Children With Autism;2013-12-04T00:00:00Z;2017-07-28T00:00:00Z;2017-07-28T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2017;;Stanford;;First Stanford Sample
;297;NCT01406808;1;1;28856136;14.08.2017;eCollection 2017;03.10.2017;28.07.2011;NA;Interventional;Not Applicable;100;Completed;Personal Genomics for Preventive Cardiology;2011-08-01T00:00:00Z;2017-08-01T00:00:00Z;2016-10-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2017;;Stanford;;First Stanford Sample
;313;NCT02304848;1;1;32348346;29.04.2020;;07.03.2019;06.08.2014;NA;Interventional;Not Applicable;9;Completed;Effects of Deep Brain Stimulation (DBS) Frequency on Neural Synchrony;2012-10-01T00:00:00Z;2017-11-28T00:00:00Z;2017-11-28T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2012;2017;;Stanford;;First Stanford Sample
;314;NCT02079142;1;1;31693069;01.02.2020;;08.01.2018;03.03.2014;NA;Interventional;Not Applicable;223;Completed;Implementation of Evidence-based Treatments for On-campus Eating Disorders;2012-04-01T00:00:00Z;2017-12-01T00:00:00Z;2017-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2012;2017;;Stanford;;First Stanford Sample
;10;NCT01020812;0;;;;;27.06.2016;24.11.2009;05.12.2014;Interventional;Phase 1/Phase 2;11;Terminated;Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma;2009-09-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;;Stanford;;First Stanford Sample
;19;NCT02423447;0;;;;only conference abstract: https://www.cochranelibrary.com/central/doi/10.1002/central/CN-01057030/full;07.12.2015;03.02.2015;13.08.2015;Interventional;Not Applicable;25;Completed;Comparison of the Airway Clearance Efficacy of Electro Flo 5000 and the G5 Flimm-Fighter in Patients With CF;2013-11-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2013;2014;;Stanford;;First Stanford Sample
;20;NCT01506726;0;;;;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863444/ intervention doesnt fit ;31.08.2016;06.01.2012;26.10.2015;Interventional;Phase 2;11;Terminated;Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia;2012-03-01T00:00:00Z;2014-11-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;NA;NA;NA;Stanford University;NA;NA;NA;NA;NA;2012;2012;2014;;Stanford;;First Stanford Sample
;23;NCT01413516;0;;;;;04.11.2017;03.08.2011;25.02.2016;Interventional;Phase 2;17;Completed;Varenicline In-Patient Study;2011-08-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;;Stanford;;First Stanford Sample
;24;NCT02110238;0;;;;;12.02.2021;03.04.2014;01.03.2016;Interventional;Not Applicable;421;Completed;Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ? vs 3 Weekly Injections of Euflexxa? for Knee OA;2014-03-01T00:00:00Z;2015-02-01T00:00:00Z;2014-11-01T00:00:00Z;TRUE;Randomized;Double;INDUSTRY;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;26;NCT01981863;0;;;;keine Registrierung gefunden, nur diesen link: https://medals.jp/mfaers/drugs/81/clinicaltrials;23.05.2016;19.09.2013;01.04.2016;Interventional;Phase 4;40;Completed;Fibrinolysis Before Cardiopulmonary Bypass?;2013-07-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;;Stanford;;First Stanford Sample
;36;NCT01477463;0;;;;another article referrs to the study NCT;31.10.2016;17.11.2011;30.06.2016;Interventional;Not Applicable;24;Completed;Pilot Trial to Evaluate the Effect of Vitamin D on Melanocyte Biomarkers;2012-09-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2014;;Stanford;;First Stanford Sample
;53;NCT01305252;0;;;;;27.04.2017;02.11.2010;21.11.2016;Interventional;Phase 4;21;Completed;A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).;2010-07-01T00:00:00Z;2014-09-01T00:00:00Z;2014-09-01T00:00:00Z;TRUE;Randomized;Triple;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;;Stanford;;First Stanford Sample
;54;NCT01868503;0;;;;;21.06.2017;30.05.2013;21.11.2016;Interventional;Phase 2;7;Terminated;Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer;2013-07-01T00:00:00Z;2015-07-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;;Stanford;;First Stanford Sample
;55;NCT01406795;0;;;;;06.01.2017;22.07.2011;24.11.2016;Interventional;Not Applicable;1;Terminated;The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses;2010-12-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2010;2014;;Stanford;;First Stanford Sample
;58;NCT00185640;0;;;;https://ashpublications.org/bloodadvances/article/3/16/2454/260528/Nonmyeloablative-TLI-ATG-conditioning-for. Articel fits with date but not with participants (616/303);24.06.2021;12.09.2005;01.12.2016;Interventional;Phase 2;303;Completed;Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies;2003-03-01T00:00:00Z;2016-01-01T00:00:00Z;2014-04-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2005;2003;2016;;Stanford;;First Stanford Sample
;61;NCT01313884;0;;;;;20.10.2017;10.03.2011;07.12.2016;Interventional;Phase 2;3;Terminated;Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma;2011-05-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;;Stanford;;First Stanford Sample
;62;NCT01461473;0;;;;;14.04.2017;20.10.2011;08.12.2016;Interventional;Not Applicable;131;Completed;Comparative Outcomes Management With Electronic Data Technology (COMET) Study;2011-12-01T00:00:00Z;2014-06-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;NA;NA;NA;NA;NA;Stanford University;NA;NA;NA;2011;2011;2014;;Stanford;;First Stanford Sample
;64;NCT01893879;0;;;;;13.04.2017;02.07.2013;09.12.2016;Interventional;Not Applicable;14;Terminated;Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema;2014-04-01T00:00:00Z;2015-04-01T00:00:00Z;2015-04-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2015;;Stanford;;First Stanford Sample
;66;NCT01928030;0;;;;;13.02.2017;20.08.2013;13.12.2016;Interventional;Phase 1/Phase 2;3;Terminated;Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer;2013-12-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;;Stanford;;First Stanford Sample
;67;NCT01364259;0;;;;;16.02.2017;26.05.2011;16.12.2016;Interventional;Phase 3;17;Terminated;A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia;2008-09-01T00:00:00Z;2015-01-01T00:00:00Z;2014-01-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2008;2015;;Stanford;;First Stanford Sample
;79;NCT01769222;0;;;;;12.01.2017;14.01.2013;12.01.2017;Interventional;Phase 1/Phase 2;3;Terminated;Ipilimumab and Local Radiation Therapy in Treating Patients With Recurrent Melanoma, Non-Hodgkin Lymphoma, Colon, or Rectal Cancer;2013-02-01T00:00:00Z;2015-06-01T00:00:00Z;2014-11-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;;Stanford;;First Stanford Sample
;80;NCT02141581;0;;;;articles found on google didnt fit part/ date https://pubmed.ncbi.nlm.nih.gov/21182843/;05.04.2018;15.05.2014;13.01.2017;Interventional;Phase 4;86;Completed;Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014);2011-08-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2011;2014;;Stanford;;First Stanford Sample
;82;NCT03023709;0;;;;;30.03.2017;13.01.2017;19.01.2017;Interventional;Phase 4;3;Terminated;Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032);2015-09-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2017;2015;2015;;Stanford;;First Stanford Sample
;83;NCT01823679;0;;;;;15.03.2018;29.03.2013;20.01.2017;Interventional;Phase 2;2;Terminated;Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin;2013-03-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2014;;Stanford;;First Stanford Sample
;84;NCT02030405;0;;;;;01.04.2019;25.11.2013;20.01.2017;Interventional;Phase 2;4;Terminated;Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia;2014-03-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2015;;Stanford;;First Stanford Sample
;88;NCT02175745;0;;;;;30.01.2017;24.06.2014;30.01.2017;Interventional;Not Applicable;2;Terminated;18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas;2014-12-01T00:00:00Z;2015-12-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;103;NCT02203565;0;;;;;26.06.2017;28.07.2014;22.05.2017;Interventional;Phase 2;20;Completed;Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy;2014-07-01T00:00:00Z;2016-07-07T00:00:00Z;2016-07-07T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;;Stanford;;First Stanford Sample
;108;NCT03028987;0;;;;;10.08.2017;19.01.2017;11.07.2017;Interventional;Phase 4;10;Terminated;Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031);2014-11-19T00:00:00Z;2015-11-18T00:00:00Z;2015-11-18T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2017;2014;2015;;Stanford;;First Stanford Sample
;110;NCT02395653;0;;;;;25.09.2017;10.03.2015;16.08.2017;Interventional;Phase 3;71;Completed;Safety and Clinical Utility Study of SSEC Fentanyl 40 mcg for Acute Post-op Pain Management in Pediatric Participants;2015-06-29T00:00:00Z;2016-09-12T00:00:00Z;2016-09-12T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;Stanford Children's Health;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;111;NCT00899847;0;;;;;19.09.2017;08.05.2009;24.08.2017;Interventional;Phase 2;9;Completed;Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG;2009-05-01T00:00:00Z;2014-12-01T00:00:00Z;2014-04-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2009;2009;2014;;Stanford;;First Stanford Sample
;112;NCT02254772;0;;;;;17.11.2019;29.09.2014;04.09.2017;Interventional;Phase 1/Phase 2;9;Completed;A Phase I/II Study of Intratumoral Injection of SD-101;2014-09-01T00:00:00Z;2017-01-26T00:00:00Z;2016-11-10T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;;Stanford;;First Stanford Sample
;113;NCT00296296;0;;;;;04.10.2017;22.02.2006;06.09.2017;Interventional;Phase 4;29;Completed;Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM);2005-06-01T00:00:00Z;2014-10-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2006;2005;2014;;Stanford;;First Stanford Sample
;114;NCT01771666;0;;;;;07.11.2017;16.01.2013;06.09.2017;Interventional;Phase 2;23;Completed;Pilot Indocyanine Green Imaging for Mapping of Arm Draining Lymphatics & Nodes in Breast Cancer;2012-07-01T00:00:00Z;2015-03-17T00:00:00Z;2015-03-17T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2015;;Stanford;;First Stanford Sample
;120;NCT00481832;0;;;;;17.01.2018;31.05.2007;23.10.2017;Interventional;Phase 2;50;Terminated;Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma;2007-01-01T00:00:00Z;2017-03-30T00:00:00Z;2014-10-27T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2017;;Stanford;;First Stanford Sample
;136;NCT02877732;0;;;;;29.04.2018;09.08.2016;27.03.2018;Interventional;Not Applicable;12;Terminated;EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2;2016-07-01T00:00:00Z;2017-04-01T00:00:00Z;2017-04-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;139;NCT02415608;0;;;;;24.08.2018;24.03.2015;02.05.2018;Interventional;Phase 2;4;Terminated;Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis;2015-03-01T00:00:00Z;2017-06-14T00:00:00Z;2016-11-04T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;;Stanford;;First Stanford Sample
;141;NCT01550224;0;;;;;13.07.2018;07.03.2012;15.06.2018;Interventional;Phase 2;23;Completed;Temozolomide Plus Vorinostat in Relapse/Refractory Acute Myeloid Leukemia (AML);2013-05-01T00:00:00Z;2014-11-17T00:00:00Z;2014-11-17T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2014;;Stanford;;First Stanford Sample
;144;NCT01479478;0;;;;only conference poster, with results: https://www.ajog.org/article/S0002-9378(17)32155-5/fulltext;14.08.2018;22.11.2011;18.07.2018;Interventional;Not Applicable;251;Completed;Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy;2011-11-01T00:00:00Z;2017-07-26T00:00:00Z;2017-07-26T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;TRUE;Stanford University School of Medicine/Lucile Packard Children's Hospital;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2017;;Stanford;;First Stanford Sample
;149;NCT01846624;0;;;;;25.09.2018;30.04.2013;09.08.2018;Interventional;Phase 2;13;Terminated;Decitabine and Midostaurin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia;2013-06-01T00:00:00Z;2016-08-31T00:00:00Z;2016-07-22T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;;Stanford;;First Stanford Sample
;151;NCT01769209;0;;;;;14.10.2018;14.01.2013;12.09.2018;Interventional;Phase 2;18;Completed;Bortezomib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia;2013-03-01T00:00:00Z;2017-07-04T00:00:00Z;2016-11-25T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;;Stanford;;First Stanford Sample
;153;NCT02599194;0;;;;only conference abstract https://jnm.snmjournals.org/content/58/supplement_1/118.short;11.12.2018;01.11.2015;20.09.2018;Interventional;Phase 2;7;Completed;18F-FSPG PET/CT for Cancer Patients on Therapy;2015-07-01T00:00:00Z;2016-12-14T00:00:00Z;2016-12-14T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;154;NCT03206216;0;;;;;14.12.2018;29.06.2017;26.09.2018;Interventional;Not Applicable;1;Terminated;Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN;2017-08-04T00:00:00Z;2017-10-30T00:00:00Z;2017-10-30T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;Stanford University;NA;NA;NA;NA;NA;2017;2017;2017;;Stanford;;First Stanford Sample
;155;NCT02019069;0;;;;;17.01.2019;25.11.2013;03.10.2018;Interventional;Phase 2;11;Completed;CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome;2014-02-03T00:00:00Z;2017-12-18T00:00:00Z;2017-12-04T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2017;;Stanford;;First Stanford Sample
;156;NCT02928770;0;;;;only conference abstract: https://academic.oup.com/sleep/article/41/suppl_1/A207/4988593?login=false;18.12.2018;06.10.2016;01.11.2018;Interventional;Not Applicable;32;Completed;A Disposable Device NAS to Treat Obstructive Sleep Apnea and Snoring;2015-02-01T00:00:00Z;2017-12-31T00:00:00Z;2017-12-31T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2017;;Stanford;;First Stanford Sample
;157;NCT03028974;0;;;;no publication on primary outcomes found, e.g. this one https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803714/;20.11.2018;19.01.2017;20.11.2018;Interventional;Phase 4;77;Completed;Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029);2014-09-17T00:00:00Z;2017-11-20T00:00:00Z;2017-11-20T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2017;2014;2017;;Stanford;;First Stanford Sample
;165;NCT01472445;0;;;;;26.03.2019;11.11.2011;06.03.2019;Interventional;Phase 2;41;Terminated;Vitamin D and Breast Cancer: Does Weight Make a Difference?;2011-11-01T00:00:00Z;2015-10-01T00:00:00Z;2014-10-01T00:00:00Z;TRUE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;;Stanford;;First Stanford Sample
;170;NCT00780494;0;;;;only conference abstract found: https://ascopubs.org/doi/abs/10.1200/jco.2014.32.3_suppl.115;29.06.2021;23.10.2008;31.07.2019;Interventional;Phase 2;35;Completed;Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma;2009-02-01T00:00:00Z;2017-12-31T00:00:00Z;2017-12-31T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2008;2009;2017;;Stanford;;First Stanford Sample
;172;NCT00568633;0;;;;;11.09.2019;04.12.2007;16.08.2019;Interventional;Phase 3;58;Terminated;Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML;2007-08-01T00:00:00Z;2015-12-31T00:00:00Z;2015-12-31T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2015;;Stanford;;First Stanford Sample
;178;NCT03061279;0;;;;planned to recruit 500, recruited 1 in control group and terminated the trial;25.09.2020;11.02.2017;16.02.2020;Interventional;Not Applicable;1;Terminated;Clinical Trial Evaluating Acutrak Headless Compression Screw Fixation of Medial Malleolus Fractures;2017-04-01T00:00:00Z;2017-10-26T00:00:00Z;2017-10-26T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;NA;NA;NA;NA;NA;Stanford University School of Medicine, CA;NA;NA;NA;2017;2017;2017;;Stanford;;First Stanford Sample
;180;NCT02210286;0;;;;only conference poster: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242385/;29.01.2021;01.08.2014;27.07.2020;Interventional;Not Applicable;17;Completed;Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia;2014-07-01T00:00:00Z;2016-07-01T00:00:00Z;2016-04-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;;Stanford;;First Stanford Sample
;182;NCT02639884;0;;;;;09.03.2021;11.12.2015;06.01.2021;Interventional;Not Applicable;51;Completed;Correlation Endoscopic View of Airway Obstruction With RRa in OSA Patients Under DEX Monitored With SedLine EEG;2015-12-01T00:00:00Z;2017-10-01T00:00:00Z;2017-10-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;;Stanford;;First Stanford Sample
;184;NCT02952365;0;;;;has 1 patien reported out of 2 -  case report - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656928/;15.11.2021;27.10.2016;15.11.2021;Interventional;Phase 4;2;Completed;Tissue Sealant Use in LASIK Enhancement Surgery;2016-10-01T00:00:00Z;2017-05-22T00:00:00Z;2017-05-22T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;186;NCT01529437;0;;;;;24.11.2015;30.01.2012;NA;Interventional;Phase 1;31;Completed;Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies;2005-01-01T00:00:00Z;2014-01-01T00:00:00Z;2014-01-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;Stanford University Faculty;NA;NA;NA;NA;NA;NA;NA;NA;2012;2005;2014;;Stanford;;First Stanford Sample
;196;NCT01282736;0;;;;chapter found on google, not an investigative study;22.03.2019;14.01.2011;NA;Interventional;Not Applicable;86;Completed;Guided Self-Help for Binge Eating Disorder;2010-06-01T00:00:00Z;2014-07-01T00:00:00Z;2014-07-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2010;2014;;Stanford;;First Stanford Sample
;205;NCT01221220;0;;;;registerd only in Stanford registration;04.05.2021;13.10.2010;NA;Interventional;Not Applicable;174;Completed;Environmental Strategies & Behavior Change to Reduce Overeating in Obese Children;2010-09-01T00:00:00Z;2014-10-15T00:00:00Z;2014-10-15T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2014;;Stanford;;First Stanford Sample
;206;NCT01745354;0;;;;;17.11.2016;06.12.2012;NA;Interventional;Phase 1;6;Terminated;Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT);2012-08-01T00:00:00Z;2014-11-01T00:00:00Z;2014-11-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2014;;Stanford;;First Stanford Sample
;217;NCT01249014;0;;;;;06.06.2018;23.11.2010;NA;Interventional;Not Applicable;46;Completed;Temperature Study in Cesarean Section;2013-11-01T00:00:00Z;2015-04-30T00:00:00Z;2015-04-30T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;Stanford University;NA;NA;Stanford University;2010;2013;2015;;Stanford;;First Stanford Sample
;218;NCT01857752;0;;;;;26.01.2017;25.03.2013;NA;Interventional;Phase 2;3;Terminated;Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala;2012-03-01T00:00:00Z;2015-06-01T00:00:00Z;2015-06-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2015;;Stanford;;First Stanford Sample
;222;NCT01904643;0;;;;poster found: https://www.sciencedirect.com/science/article/pii/S0006497119401584;25.10.2018;17.07.2013;NA;Interventional;Phase 1;17;Terminated;Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia;2014-02-01T00:00:00Z;2015-07-18T00:00:00Z;2015-05-13T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2015;;Stanford;;First Stanford Sample
;224;NCT02075190;0;;;;;16.04.2019;27.02.2014;NA;Interventional;Not Applicable;89;Terminated;Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression;2014-02-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;;Stanford;;First Stanford Sample
;228;NCT02290665;0;;;;;14.08.2018;06.11.2014;NA;Interventional;Not Applicable;18;Completed;Localized Therapeutics for the Treatment of Gastrointestinal Disorders;2015-01-30T00:00:00Z;2015-09-28T00:00:00Z;2015-09-28T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2015;;Stanford;;First Stanford Sample
;234;NCT02267642;0;;;;only conference abstract: https://acrabstracts.org/abstract/efficacy-and-safety-of-neihulizumab-abgn-168h-in-patients-with-active-psoriatic-arthritis-24-week-results-from-a-phase-ii-open-label-study/;23.01.2017;10.10.2014;NA;Interventional;Phase 2;20;Completed;A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis;2015-01-01T00:00:00Z;2016-01-01T00:00:00Z;2015-10-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2016;;Stanford;;First Stanford Sample
;236;NCT01163487;0;;;;;02.09.2021;06.07.2010;NA;Interventional;Phase 1;17;Completed;Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers;2010-08-01T00:00:00Z;2016-02-01T00:00:00Z;2015-02-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2016;;Stanford;;First Stanford Sample
;238;NCT02142452;0;;;;;16.03.2021;08.05.2014;NA;Interventional;Not Applicable;55;Completed;Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain;2014-03-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;;Stanford;;First Stanford Sample
;239;NCT02436460;0;;;;;28.03.2017;01.05.2015;NA;Interventional;Phase 1;4;Terminated;A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant;2015-05-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;;Stanford;;First Stanford Sample
;249;NCT01415206;0;;;;;11.07.2019;09.08.2011;NA;Interventional;Not Applicable;250;Completed;The Total Health Study;2011-08-01T00:00:00Z;2016-06-21T00:00:00Z;2015-06-02T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2016;;Stanford;;First Stanford Sample
;252;NCT02749786;0;;;;;24.09.2019;18.04.2016;NA;Interventional;Not Applicable;10;Completed;Genetic Basis of Rosacea Study (Control);2016-01-21T00:00:00Z;2016-08-01T00:00:00Z;2016-08-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2016;;Stanford;;First Stanford Sample
;253;NCT01256229;0;;;;;11.11.2016;12.11.2010;NA;Interventional;Phase 1;303;Completed;Outcomes In Children With Developmental Delay And Deafness;2009-09-01T00:00:00Z;2016-09-01T00:00:00Z;2016-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2009;2016;;Stanford;;First Stanford Sample
;257;NCT01908166;0;;;;;06.06.2017;23.07.2013;NA;Interventional;Not Applicable;61;Completed;Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions;2014-01-01T00:00:00Z;2016-11-01T00:00:00Z;2016-11-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2016;;Stanford;;First Stanford Sample
;264;NCT02042157;0;;;;;17.10.2017;17.01.2014;NA;Interventional;Not Applicable;28;Terminated;Quality of Life in Adults Impaired Functioning - A Randomized Controlled Trial of Bidet vs Usual Toileting;2015-01-01T00:00:00Z;2016-12-31T00:00:00Z;2016-12-31T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2016;;Stanford;;First Stanford Sample
;267;NCT02452216;0;;;;;30.08.2017;20.05.2015;NA;Interventional;Early Phase 1;10;Completed;Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS;2015-06-10T00:00:00Z;2017-01-12T00:00:00Z;2017-01-12T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University Hospitals and Clinics;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;;Stanford;;First Stanford Sample
;268;NCT01943357;0;;;;;24.04.2017;09.09.2013;NA;Interventional;Not Applicable;1000;Completed;Improving Self Management Skills of Older Adults With Diabetes;2013-09-01T00:00:00Z;2017-02-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford School of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;;Stanford;;First Stanford Sample
;269;NCT01988610;0;;;;;23.01.2018;13.11.2013;NA;Interventional;Phase 1;23;Completed;Effects of Mifepristone on Biomarkers of Metabolic Function and Neuropsychological Performance Among Middle-Aged and Older Individuals;2013-10-01T00:00:00Z;2017-02-01T00:00:00Z;2017-02-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;;Stanford;;First Stanford Sample
;270;NCT02140983;0;;;;;23.01.2018;27.01.2014;NA;Interventional;Phase 1;41;Completed;Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes;2013-08-01T00:00:00Z;2017-02-01T00:00:00Z;2017-02-01T00:00:00Z;FALSE;Randomized;Triple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2017;;Stanford;;First Stanford Sample
;276;NCT02890875;0;;;;;30.04.2019;29.08.2016;NA;Interventional;Not Applicable;3;Terminated;Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections;2016-08-01T00:00:00Z;2017-03-01T00:00:00Z;2017-03-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;283;NCT01188486;0;;;;has a poster published - https://doi-org.stanford.idm.oclc.org/10.1016/j.ijrobp.2018.07.1856;13.04.2018;23.08.2010;NA;Interventional;Not Applicable;12;Terminated;Pulmonary Interstitial Lymphography in Early Stage Lung Cancer;2010-08-01T00:00:00Z;2017-04-30T00:00:00Z;2017-04-30T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2017;;Stanford;;First Stanford Sample
;286;NCT02429804;0;;;;;24.05.2017;17.04.2015;NA;Interventional;Phase 1;4;Terminated;NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer;2015-04-01T00:00:00Z;2017-05-15T00:00:00Z;2017-05-15T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;;Stanford;;First Stanford Sample
;291;NCT02774161;0;;;;;02.08.2021;02.05.2016;NA;Interventional;Not Applicable;45;Completed;B-mode Ultrasound Imaging in Detecting Early Liver Cancer;2016-05-01T00:00:00Z;2017-06-19T00:00:00Z;2017-06-19T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;300;NCT01593397;0;;;;found articles dont fit date;27.12.2017;30.04.2012;NA;Interventional;Phase 1;100;Completed;Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity;2011-11-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2012;2011;2017;;Stanford;;First Stanford Sample
;301;NCT01958541;0;;;;;25.04.2018;07.10.2013;NA;Interventional;Not Applicable;77;Completed;A Brief Behavioral Sleep Intervention for Depression Among Military Veterans;2013-03-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;;Stanford;;First Stanford Sample
;303;NCT02435225;0;;;;;17.07.2018;07.08.2013;NA;Interventional;Not Applicable;14;Terminated;Brain Connectivity and Mindfulness Training in Youth With Bipolar Disorder Not Otherwise Specified (NOS);2014-05-01T00:00:00Z;2017-09-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2014;2017;;Stanford;;First Stanford Sample
;304;NCT01988623;0;;;;two studies with comparators published;09.01.2021;13.11.2013;NA;Interventional;Not Applicable;21;Completed;Pivotal Response Treatment for Individuals With Intellectual Disabilities;2012-09-11T00:00:00Z;2017-09-30T00:00:00Z;2017-09-30T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2017;;Stanford;;First Stanford Sample
;307;NCT02708511;0;;;;;04.04.2018;16.11.2015;NA;Interventional;Phase 1;2;Terminated;Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer;2016-08-01T00:00:00Z;2017-10-11T00:00:00Z;2017-10-11T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;;Stanford;;First Stanford Sample
;308;NCT02049801;0;;;;;04.12.2017;28.01.2014;NA;Interventional;Phase 1;1;Terminated;MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia;2014-12-01T00:00:00Z;2017-11-01T00:00:00Z;2015-02-04T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;;Stanford;;First Stanford Sample
;309;NCT02687256;0;;;;single arm study on https://www.liebertpub.com/doi/full/10.1089/dia.2021.0540;01.06.2018;09.02.2016;NA;Interventional;Phase 1;24;Completed;Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set;2016-03-01T00:00:00Z;2017-11-01T00:00:00Z;2017-11-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;;Stanford;;First Stanford Sample
;311;NCT02635074;0;;;;;07.05.2018;16.12.2015;NA;Interventional;Phase 1;2;Terminated;Ibrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia;2016-11-01T00:00:00Z;2017-11-10T00:00:00Z;2017-07-18T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;;Stanford;;First Stanford Sample
;315;NCT04296266;0;;;;;03.03.2020;20.02.2020;NA;Interventional;Early Phase 1;10;Completed;Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery;2016-02-01T00:00:00Z;2017-12-21T00:00:00Z;2017-12-18T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2020;2016;2017;;Stanford;;First Stanford Sample
;318;NCT02598518;0;;;;;28.06.2018;27.10.2015;NA;Interventional;Not Applicable;38;Completed;Integrating Combined Therapies for Persons With Co-occurring Disorders;2015-07-01T00:00:00Z;2017-12-31T00:00:00Z;2017-09-30T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;;Stanford;;First Stanford Sample
;98;NCT01192776;1;1;25536254;24.12.2014;;15.02.2021;31.08.2010;31.03.2017;Interventional;Not Applicable;364;Terminated;Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE);2010-09-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;Stanford University;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;2010;2010;2016;;Stanford, UCLA;;First Stanford Sample
;107;NCT00614744;1;1;29067428;24.10.2017;;15.02.2021;11.02.2008;30.06.2017;Interventional;Not Applicable;168;Completed;Late Hypothermia for Hypoxic-Ischemic Encephalopathy;2008-04-01T00:00:00Z;2016-06-01T00:00:00Z;2016-06-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;Stanford University;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;2008;2008;2016;;Stanford, UCLA;;First Stanford Sample
;121;NCT02160002;1;1;30337189;15.10.2018;;20.03.2019;08.05.2014;28.11.2017;Interventional;Not Applicable;366;Completed;Incubator Weaning of Moderately Preterm Infants;2015-02-01T00:00:00Z;2017-06-01T00:00:00Z;2016-07-01T00:00:00Z;TRUE;Randomized;None (Open Label);NETWORK;TRUE;Stanford University;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;;Stanford, UCLA;;First Stanford Sample
;126;NCT01954082;1;1;34686832;22.10.2021;;20.03.2019;26.09.2013;29.12.2017;Interventional;Phase 3;638;Terminated;Inositol to Reduce Retinopathy of Prematurity;2014-04-17T00:00:00Z;2016-12-31T00:00:00Z;2016-12-31T00:00:00Z;TRUE;Randomized;Quadruple;NETWORK;TRUE;Stanford University;University of California, Los Angeles;NA;NA;NA;NA;NA;NA;NA;2013;2014;2016;;Stanford, UCLA;;First Stanford Sample
;147;NCT01471028;1;1;29171941;01.03.2018;;22.01.2019;07.11.2011;24.07.2018;Interventional;Phase 3;203;Completed;Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure;2013-02-01T00:00:00Z;2015-08-01T00:00:00Z;2015-01-01T00:00:00Z;TRUE;Randomized;None (Open Label);INDUSTRY;TRUE;CA - Stanford School of Medicine/Stanford University Medical Center;CA - Keck Hospital of University of Southern California;CA - University of California San Diego Medical Center - Hillcrest;NA;NA;NA;NA;NA;NA;2011;2013;2015;;Stanford, UCSD, USC;;First Stanford Sample
;302;NCT02139462;0;;;;outcomes different: https://jeatdisord.biomedcentral.com/articles/10.1186/s40337-020-00366-5...https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349507/#__ffn_sectitle : reports two studies participants different;03.10.2017;12.05.2014;NA;Interventional;Not Applicable;47;Completed;Optimizing Fidelity to Family-Based Treatment for Adolescent Anorexia Nervosa;2015-05-01T00:00:00Z;2017-09-01T00:00:00Z;2017-09-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;Stanford University;University of California, San Francisco;NA;NA;NA;NA;NA;NA;NA;2014;2015;2017;;Stanford, UCSF;;First Stanford Sample
70;28;NCT00279630;1;2;19022863;20.11.2008;;02.12.2014;17.01.2006;NA;Interventional;Phase 1;45;Completed;Exercise and Shoe Orthoses in Treatment of Posterior Tibial Tendon Dysfunction;2002-06-01T00:00:00Z;2014-12-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2006;2002;2014;2014;USC;;Mario
50;9;NCT00023595;1;1;19329820;29.03.2009;only part of the study, but correct outcome, more publications are also linked;17.09.2019;11.09.2001;23.12.2016;Interventional;Phase 3;2136;Completed;Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease;2002-01-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;Magnetic Resonance Imaging Core Lab, University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2001;2002;2015;2015;USC;;Stefanie
54;41;NCT01614652;1;1;23537969;19.02.2013;;21.06.2017;04.06.2012;NA;Interventional;Phase 3;331;Terminated;A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System;2012-12-01T00:00:00Z;2017-06-01T00:00:00Z;2017-06-01T00:00:00Z;FALSE;Randomized;None (Open Label);INDUSTRY;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2017;2017;USC;;Stefanie
48;2;NCT01454947;1;1;23806017;27.06.2013;;30.03.2017;04.08.2011;20.07.2015;Interventional;Not Applicable;248;Completed;Use of Behavioral Economics to Improve Treatment of Acute Respiratory Infections (Main Study);2011-08-01T00:00:00Z;2014-09-01T00:00:00Z;2014-04-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2014;2014;USC;;Stefanie
71;31;NCT00669656;1;2;25245366;23.09.2014;Also had an abstract - https://ascopubs.org/doi/abs/10.1200/jco.2013.31.15_suppl.e16020;18.04.2017;28.04.2008;NA;Interventional;Phase 2;43;Completed;Herbal Therapy for Treatment of Recurrent Prostate Cancer;2008-07-06T00:00:00Z;2014-10-14T00:00:00Z;2014-07-08T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2014;2014;USC;;Mario
5;8;NCT00442286;1;1;25331845;20.10.2014;;30.01.2017;27.02.2007;18.11.2016;Interventional;Not Applicable;591;Completed;Rheos? Pivotal Trial;2006-10-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;TRUE;Randomized;Quadruple;INDUSTRY;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2007;2006;2016;2016;USC;;Samruddhi
42;32;NCT00730314;1;3;26242764;12.10.2015;Am J Hematol17.08.2022: different sudy design;21.06.2016;06.08.2008;NA;Interventional;Phase 1/Phase 2;25;Completed;Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells;2008-08-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;Childrens Hospital Los Angeles, University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2008;2008;2015;2015;USC;;Stefanie
15;63;NCT02265120;1;3;26540622;05.11.2015;matching PICO, no reference to NCT;30.11.2015;30.09.2014;NA;Interventional;Not Applicable;1000;Completed;Primary Care Providers' Views and Understanding of Current Recommended Guidelines for Cervical Cancer Screening;2014-10-01T00:00:00Z;2015-03-01T00:00:00Z;2015-03-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;USC;;Samruddhi
7;1;NCT00140413;1;3;26937243;02.03.2016;;27.03.2015;31.08.2005;17.02.2015;Interventional;Phase 4;20;Completed;Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia;2004-12-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;"Childrens Hospital Los Angeles; University of Southern California";NA;NA;NA;NA;NA;NA;NA;NA;2005;2004;2014;2014;USC;;Samruddhi
69;7;NCT01291277;1;2;27082942;17.05.2016;;23.12.2016;04.02.2011;25.10.2016;Interventional;Phase 4;90;Completed;Time Interval for Endoscopic Variceal Ligation;2008-08-01T00:00:00Z;2015-12-01T00:00:00Z;2015-09-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2011;2008;2015;2015;USC;;Mario
14;61;NCT02197338;1;3;27377519;05.07.2016;interim analysis publication as study was stopped d/t significant difference in the safety end point ;13.04.2016;18.07.2014;NA;Interventional;Not Applicable;498;Completed;Randomized Trial of Wire and Sphincterotome Systems for Biliary Cannulation;2016-04-01T00:00:00Z;2016-04-01T00:00:00Z;2016-04-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2014;2016;2016;2016;USC;;Samruddhi
76;46;NCT01761539;1;3;28266591;07.03.2017;;31.07.2016;03.01.2013;NA;Interventional;Not Applicable;60;Completed;Moderate Versus Aggressive Fluids for Acute Pancreatitis;2013-04-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2015;2015;USC;;Mario
13;57;NCT02057991;1;2;28387949;07.04.2017;linked NCT, matching PICO, sample size deviation and mention of termination due to low accrual;27.11.2017;05.02.2014;NA;Interventional;Not Applicable;94;Terminated;Mindfulness-Based Exercise Video in Educating Hispanic/Latino Patients With Colorectal Cancer and Their Caregivers;2014-01-07T00:00:00Z;2017-11-09T00:00:00Z;2016-11-09T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2016;USC;;Samruddhi
6;54;NCT01999816;1;1;28414254;17.04.2017;matching PICO, linked NCT, primary outcome analysed, inconclusive study;26.10.2016;25.11.2013;NA;Interventional;Phase 3;170;Completed;Pressure Ulcer Prevention Study in SCI;2008-09-01T00:00:00Z;2015-09-01T00:00:00Z;2015-09-01T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2013;2008;2015;2015;USC;;Samruddhi
66;26;NCT00104923;1;1;28420721;18.04.2017;;18.07.2017;03.03.2005;NA;Interventional;Phase 1;29;Completed;Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer;2005-02-01T00:00:00Z;2017-04-01T00:00:00Z;2017-04-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);NETWORK;TRUE;NA;NA;NA;University of Southern California;NA;NA;NA;NA;NA;2005;2005;2017;2017;USC;;Mario
65;23;NCT02698735;1;1;28691931;10.07.2017;;15.10.2019;19.02.2016;31.05.2019;Interventional;Phase 1/Phase 2;5;Completed;Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients;2016-02-25T00:00:00Z;2017-06-30T00:00:00Z;2017-03-31T00:00:00Z;TRUE;Non-Randomized;Triple;OTHER;TRUE;University of Southern California Department of Dermatology;NA;NA;NA;NA;NA;NA;NA;NA;2016;2016;2017;2017;USC;;Mario
31;21;NCT02504827;1;1;28784670;22.09.2017;;29.10.2018;20.07.2015;04.09.2018;Interventional;Phase 4;12;Completed;Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis;2015-09-01T00:00:00Z;2016-10-01T00:00:00Z;2016-10-01T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;USC;;Susanne
53;30;NCT00574769;1;3;28826933;14.07.2017;;09.04.2017;14.12.2007;NA;Interventional;Phase 1/Phase 2;27;Completed;Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer;2010-02-17T00:00:00Z;2017-02-17T00:00:00Z;2016-02-17T00:00:00Z;FALSE;NA;None (Open Label);OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2007;2010;2017;2016;USC;;Stefanie
29;10;NCT01595581;1;1;28840147;09.08.2017;;08.02.2022;08.05.2012;30.03.2017;Interventional;Phase 3;14;Completed;Testosterone Administration and ACL Reconstruction in Men;2012-04-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;USC;;Susanne
72;45;NCT01759979;1;2;28866457;01.09.2017;;30.03.2017;31.12.2012;NA;Interventional;Not Applicable;60;Completed;Laser Versus Mechanical Lithotripsy of Bile Duct Stones;2013-01-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2016;2016;USC;;Mario
34;48;NCT01764698;1;1;29300100;01.01.2018;;24.10.2017;17.12.2012;NA;Interventional;Not Applicable;98;Completed;Delivery of Anxiety Disorder Treatment in Addictions Centers;2013-11-15T00:00:00Z;2016-11-15T00:00:00Z;2016-11-15T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2013;2016;2016;USC;;Susanne
74;11;NCT02091921;1;3;29329963;05.09.2017;;17.06.2019;17.03.2014;31.03.2017;Interventional;Phase 1/Phase 2;53;Completed;Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study;2014-02-16T00:00:00Z;2016-11-30T00:00:00Z;2016-11-30T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2016;2016;USC;;Mario
68;62;NCT02214641;1;1;29351961;19.01.2018;;02.10.2019;08.08.2014;NA;Interventional;Not Applicable;81;Completed;Resilient, Empowered, Active Living: REAL Diabetes Study;2014-10-01T00:00:00Z;2017-07-01T00:00:00Z;2016-06-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2017;2016;USC;;Mario
32;34;NCT01140282;1;1;29356607;22.01.2018;;17.06.2019;04.06.2010;NA;Interventional;Not Applicable;106;Completed;Exercise Program for Early Breast Cancer Survivors;2012-05-21T00:00:00Z;2018-10-01T00:00:00Z;2017-09-28T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2010;2012;2018;2017;USC;;Susanne
73;55;NCT02017158;1;2;29394102;02.02.2018;;29.03.2017;09.12.2013;NA;Interventional;Not Applicable;180;Completed;Virtual Sprouts: Web-based Gardening Games to Teach Nutrition and Combat Obesity;2011-09-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of Southern California;NA;NA;NA;NA;University of Southern California;NA;NA;NA;2013;2011;2016;2016;USC;;Mario
37;75;NCT03115385;1;2;29493105;28.02.2018;;10.04.2017;29.03.2017;NA;Interventional;Not Applicable;22;Terminated;Probiotics and the Gut Microbiome in Obese Hispanic Youth;2015-05-30T00:00:00Z;2016-04-11T00:00:00Z;2016-04-11T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2017;2015;2016;2016;USC;;Susanne
49;3;NCT00871715;1;1;29554849;01.02.2018;;14.06.2019;27.03.2009;17.02.2016;Interventional;Not Applicable;361;Completed;Arm Rehabilitation Study After Stroke;2009-06-01T00:00:00Z;2014-02-01T00:00:00Z;2014-02-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;University of Southern California;NA;NA;NA;NA;University of Southern California;NA;NA;NA;2009;2009;2014;2014;USC;;Stefanie
55;52;NCT01909440;1;1;29614993;03.04.2018;;17.06.2019;24.07.2013;NA;Interventional;Not Applicable;43;Completed;Resistance Training and Protein Supplementation for Prostate Cancer Survivors;2013-07-08T00:00:00Z;2018-08-07T00:00:00Z;2017-03-10T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2018;2017;USC;;Stefanie
10;20;NCT03483896;1;2;29881263;30.05.2018;NCT linked, matching PICO and primary outcome analysed;21.12.2018;21.03.2018;15.05.2018;Interventional;Not Applicable;83;Completed;Pilot Study to Examine Health Effects of Daylight Exposure on Dementia Patients;2017-01-30T00:00:00Z;2017-06-05T00:00:00Z;2017-05-10T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2018;2017;2017;2017;USC;;Samruddhi
19;71;NCT02790476;1;2;30093595;10.08.2018;time frame changed;06.02.2019;27.05.2016;NA;Interventional;Not Applicable;805;Completed;Behavioral Insights to Encourage Judicious Prescribing of Opioids;2017-01-27T00:00:00Z;2018-02-27T00:00:00Z;2017-05-27T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2016;2017;2018;2017;USC;;Samruddhi
57;72;NCT02850770;1;1;30291094;06.06.2017;;08.03.2017;12.04.2016;NA;Interventional;Not Applicable;42;Completed;Physical Activity and Social Support Prompting Via Phone Messaging;2015-04-01T00:00:00Z;2015-11-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2015;2015;USC;;Stefanie
9;15;NCT02513771;1;2;30535188;13.09.2019;"publication with linked NCT (NCT01426438) has same PICO and study results as NCT02513771, and same publication doesn?t have intervention and outcome linked to NCT01426438, its confusing, subject to discussion, writing NCT for doublecheck otherwise ""no publication found""";18.05.2018;13.07.2015;06.11.2017;Interventional;Phase 2;90;Completed;Sitagliptin for Reducing Inflammation and Immune Activation;2015-09-01T00:00:00Z;2017-01-10T00:00:00Z;2016-12-13T00:00:00Z;TRUE;Randomized;Double;NETWORK;TRUE;NA;NA;NA;University of Southern California;NA;NA;NA;NA;NA;2015;2015;2017;2016;USC;;Samruddhi
30;17;NCT02358135;1;1;30646223;05.10.2018;other earlier linked article does not describe the primary outcome;19.07.2019;06.01.2015;31.01.2018;Interventional;Not Applicable;300;Completed;Collaborative Connected Health (CCH) for PCORI;2015-02-02T00:00:00Z;2017-08-20T00:00:00Z;2017-08-20T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2017;2017;USC;;Susanne
64;19;NCT03040154;1;1;30679379;01.02.2019;;28.05.2021;31.01.2017;14.02.2018;Interventional;Not Applicable;217;Completed;Engaging Immigrants in Preventive Parenting Interventions;2016-06-01T00:00:00Z;2016-12-01T00:00:00Z;2016-12-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;Children's Hospital Los Angeles, University of Southern California Keck School of Medicine;NA;NA;NA;NA;NA;NA;NA;NA;2017;2016;2016;2016;USC;;Mario
33;43;NCT01723917;1;1;30889096;01.08.2019;;02.04.2019;06.11.2012;NA;Interventional;Not Applicable;71;Completed;Phytoserms for Menopause Symptoms and Age-Associated Memory Decline;2012-07-01T00:00:00Z;2015-01-01T00:00:00Z;2015-01-01T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2015;2015;USC;;Susanne
67;44;NCT01749358;1;1;31164067;05.06.2019;;04.04.2017;25.06.2012;NA;Interventional;Phase 1;60;Completed;Dose Optimization for Stroke Evaluation;2012-03-01T00:00:00Z;2016-08-01T00:00:00Z;2016-08-01T00:00:00Z;FALSE;Randomized;Single;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;University of Southern California;NA;NA;NA;2012;2012;2016;2016;USC;;Mario
56;64;NCT02358915;1;1;31200729;14.06.2019;;04.04.2017;29.01.2015;NA;Interventional;Early Phase 1;10;Completed;A Two-step Training Paradigm for Voluntary Control of the Peri-auricular Muscles;2015-02-01T00:00:00Z;2016-08-31T00:00:00Z;2016-08-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;USC;;Stefanie
17;74;NCT02971241;1;3;32216585;01.04.2020;"corresponding study results are from one study site out of two, results divided into different study; study reporting 2nd primary outcome (http://dx.doi.org/10.1086/705416), subject to discussion";03.05.2019;19.11.2016;NA;Interventional;Not Applicable;617;Completed;Intergenerational mHealth Diabetes Program OPPORTUNITIES PROGRAM IN TAIWAN;2015-10-01T00:00:00Z;2019-04-01T00:00:00Z;2017-05-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2016;2015;2019;2017;USC;;Samruddhi
51;25;NCT02158949;1;1;32496203;04.06.2020;;06.07.2020;03.06.2014;23.03.2020;Interventional;Not Applicable;48;Completed;Study of Mobile Phone Delivered Intervention to Reduce Alcohol Consumption;2014-05-01T00:00:00Z;2014-07-31T00:00:00Z;2014-07-15T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2014;2014;USC;;Stefanie
36;14;NCT02502019;1;2;32703005;01.01.2020;;08.10.2018;16.07.2015;21.07.2017;Interventional;Phase 1;27;Completed;HEMOBLAST Pilot Clinical Investigation;2015-08-01T00:00:00Z;2016-03-01T00:00:00Z;2016-03-01T00:00:00Z;TRUE;NA;None (Open Label);INDUSTRY;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;USC;;Susanne
77;69;NCT02576288;1;3;32881912;03.09.2020;;12.07.2019;12.10.2015;NA;Interventional;Phase 2;21;Completed;Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity;2016-01-01T00:00:00Z;2017-12-31T00:00:00Z;2017-12-31T00:00:00Z;FALSE;Randomized;Quadruple;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2016;2017;2017;USC;;Mario
35;66;NCT02459847;1;1;33244321;09.06.2020;;09.11.2021;07.11.2014;NA;Interventional;Not Applicable;21;Completed;Mind-Body Training for Hand Rehabilitation;2014-08-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;USC;;Susanne
28;5;NCT02344745;1;1;33626029;01.11.2021;;24.10.2016;07.01.2015;01.06.2016;Interventional;Not Applicable;80;Completed;Lavender Aromatherapy for Anxiety During Urodynamics;2014-10-01T00:00:00Z;2015-08-01T00:00:00Z;2015-08-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2015;2015;USC;;Susanne
58;77;NCT04176237;1;1;33971211;07.05.2021;;25.11.2019;21.11.2019;NA;Interventional;Not Applicable;3750;Completed;School-based Randomized Trial of SunSmart Interventions;2014-01-01T00:00:00Z;2018-11-30T00:00:00Z;2017-01-10T00:00:00Z;FALSE;Randomized;Single;OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2019;2014;2018;2017;USC;;Stefanie
38;76;NCT03645083;1;2;34239664;16.06.2021;;22.08.2018;22.08.2018;NA;Interventional;Not Applicable;121;Completed;Patient Adherence to Acupuncture Treatment;2017-02-20T00:00:00Z;2017-10-31T00:00:00Z;2017-08-24T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;NA;NA;NA;NA;NA;University of Southern California;NA;NA;NA;2018;2017;2017;2017;USC;;Susanne
39;37;NCT01240629;1;3;28668277;08.06.2017;;05.07.2017;30.06.2010;NA;Interventional;Phase 1/Phase 2;43;Completed;Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer;2010-11-02T00:00:00Z;2017-02-02T00:00:00Z;2017-02-02T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2017;2017;USC;;Susanne
12;56;NCT02026037;2;3;http://dx.doi.org/10.1093/jbcr/iraa024.030;03.03.2020;Abstract and Not OA, however mentioned for double checks, matching PICO;19.09.2017;31.12.2013;NA;Interventional;Not Applicable;16;Completed;Reducing PTSD in Hospitalized Burn Patients;2013-04-01T00:00:00Z;2015-05-01T00:00:00Z;2015-05-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;University of Southern California;NA;NA;NA;2013;2013;2015;2015;USC;;Samruddhi
18;38;NCT01302405;2;3;http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2501;20.05.2013;Not OA, meeting abstract and study terminated d/t low accrual;16.08.2017;18.02.2011;NA;Interventional;Phase 1;23;Terminated;Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors;2011-02-01T00:00:00Z;2015-06-01T00:00:00Z;2015-01-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2011;2011;2015;2015;USC;;Samruddhi
16;68;NCT02494661;1;2;28323473;21.03.2017;matching PICO, no reference to NCT;09.03.2017;05.06.2015;NA;Interventional;Not Applicable;218;Completed;Nutritional Video Intervention Using Mindfulness-based Principles;2014-10-01T00:00:00Z;2015-07-01T00:00:00Z;2015-07-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2014;2015;2015;USC;;Samruddhi
8;6;NCT02009046;1;3;26403840;01.10.2015;Not OA (access via scihub), linked sudy in registry does not report primary outcome;01.11.2018;18.11.2013;07.09.2016;Interventional;Not Applicable;1909;Completed;Randomized Evaluation of a Multi-Component, Rights-Based Sexuality Education Initiative for High School Students;2011-09-01T00:00:00Z;2014-05-01T00:00:00Z;2014-05-01T00:00:00Z;TRUE;Randomized;Single;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2013;2011;2014;2014;USC;;Samruddhi
52;27;NCT00183820;2;3;https://doi.org/10.1016/S0923-7534(20)33425-6;01.09.2012;https://ascopubs.org/doi/10.1200/jco.2013.31.15_suppl.4531 and https://www.sciencedirect.com/science/article/pii/S0923753420334256;05.07.2017;09.09.2005;NA;Interventional;Phase 2;30;Completed;Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma;2004-11-01T00:00:00Z;2016-08-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2005;2004;2016;2015;USC;;Stefanie
75;35;NCT01153919;1;3;https://doi.org/10.1182/blood.V122.21.3555.3555;15.11.2013;Preliminary findings poster but more than 500 words;09.04.2017;24.06.2010;NA;Interventional;Phase 2;27;Terminated;Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia;2010-06-30T00:00:00Z;2018-07-14T00:00:00Z;2014-07-14T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2018;2014;USC;;Mario
11;50;NCT01801046;1;3;https://doi.org/10.1182/blood.V124.21.5944.5944;06.12.2014;Not OA, however matching PICO (subject to discussion) poster but over 500 words;28.03.2018;26.02.2013;NA;Interventional;Phase 1;10;Terminated;Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia;2013-03-06T00:00:00Z;2017-08-20T00:00:00Z;2017-07-27T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2017;2017;USC;;Samruddhi
45;51;NCT01823458;1;2;Meeker, D., Knight, T., Childress, P., Aliyev, E. R., & Doctor, J. N. (2021). Combining a lottery incentive with protection against losing the lottery improves exercise adherence. Behavioral Science & Policy, 7(1), 27-38;29.06.2021;pdf here: https://healthpolicy.usc.edu/wp-content/uploads/2021/06/BSP-Journal_Vol7-Iss1_Meeker-Knight-Childress-Aliyev-Doctor_5th-Pass.pdf;31.03.2017;05.03.2013;NA;Interventional;Not Applicable;152;Completed;Behavioral Economics Incentives for Health Management;2012-04-01T00:00:00Z;2014-08-01T00:00:00Z;2014-08-01T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2014;2014;USC;;Stefanie
1;16;NCT00183872;0;;;;;21.01.2018;09.09.2005;21.01.2018;Interventional;Phase 2;40;Completed;Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma;2005-04-14T00:00:00Z;2015-10-20T00:00:00Z;2014-10-20T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of Southern California (U.S.C.)/ Norris Comprehensive Cancer Center;NA;NA;NA;NA;NA;NA;NA;NA;2005;2005;2015;2014;USC;;Samruddhi
2;36;NCT01238965;0;;;;terminated d/t adverse events;26.05.2015;03.11.2010;NA;Interventional;Phase 1;7;Terminated;Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy;2010-10-01T00:00:00Z;2015-04-01T00:00:00Z;2014-12-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2010;2010;2015;2014;USC;;Samruddhi
3;53;NCT01957995;0;;;;;08.04.2017;04.10.2013;NA;Interventional;Phase 1;13;Completed;Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors;2013-11-08T00:00:00Z;2016-07-14T00:00:00Z;2014-05-29T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2014;USC;;Samruddhi
4;59;NCT02122354;0;;;;;04.04.2022;17.04.2014;NA;Interventional;Not Applicable;90;Completed;Triggers and Responses to Simulator Sickness in Videogame Players;2014-04-01T00:00:00Z;2014-06-01T00:00:00Z;2014-06-01T00:00:00Z;FALSE;Non-Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;University of Southern California;NA;NA;NA;NA;NA;2014;2014;2014;2014;USC;;Samruddhi
20;22;NCT02650466;0;;;;;16.07.2019;12.11.2015;29.04.2019;Interventional;Not Applicable;24;Completed;Nanopulse Efficacy Study for the Treatment of Common Warts;2013-12-01T00:00:00Z;2016-09-26T00:00:00Z;2016-08-20T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2013;2016;2016;USC;;Susanne
21;29;NCT00556907;0;;;;https://onlinelibrary.wiley.com/doi/10.1002/jso.25347 much more patients enrolled otherwise seems to fit;05.07.2017;08.11.2007;NA;Interventional;Not Applicable;22;Terminated;Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast;2007-10-01T00:00:00Z;2016-11-01T00:00:00Z;2015-03-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2016;2015;USC;;Susanne
22;33;NCT00888498;0;;;;;01.07.2015;24.04.2009;NA;Interventional;Phase 2/Phase 3;189;Suspended;Ankle Manual Therapy for Ankle Sprains;2009-01-01T00:00:00Z;2015-12-01T00:00:00Z;2015-12-01T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;NA;NA;NA;NA;NA;University of Southern California;NA;NA;NA;2009;2009;2015;2015;USC;;Susanne
23;39;NCT01469338;0;;;;;21.11.2014;01.11.2011;NA;Interventional;Phase 2;9;Terminated;Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel;2012-07-01T00:00:00Z;2014-11-01T00:00:00Z;2014-10-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2011;2012;2014;2014;USC;;Susanne
24;60;NCT02190578;0;;;;;23.04.2015;11.07.2014;NA;Interventional;Not Applicable;1649;Completed;Clinical Performance of Reveal G4 Rapid HIV-1 Antibody Test;2014-07-01T00:00:00Z;2015-03-01T00:00:00Z;2015-03-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of Southern California - Los Angeles;NA;NA;NA;NA;NA;NA;NA;NA;2014;2014;2015;2015;USC;;Susanne
25;67;NCT02459873;0;;;;;14.04.2017;27.05.2015;NA;Interventional;Not Applicable;20;Completed;Modeling and Testing Change in Mental Abilities in Childhood;2015-06-01T00:00:00Z;2016-08-31T00:00:00Z;2016-08-31T00:00:00Z;FALSE;Randomized;Double;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2015;2016;2016;USC;;Susanne
26;73;NCT02967380;0;;;;;22.03.2017;13.09.2015;NA;Interventional;Not Applicable;14;Terminated;Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases;2011-12-14T00:00:00Z;2015-10-14T00:00:00Z;2014-10-14T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2011;2015;2014;USC;;Susanne
27;4;NCT02270684;0;;;;;01.04.2017;17.10.2014;10.05.2016;Interventional;Not Applicable;4;Terminated;StepRite Evaluation;2015-05-01T00:00:00Z;2016-01-01T00:00:00Z;2016-01-01T00:00:00Z;TRUE;Randomized;Single;OTHER;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2014;2015;2016;2016;USC;;Susanne
40;12;NCT01866423;0;;;;;31.07.2017;28.05.2013;03.07.2017;Interventional;Phase 2;4;Terminated;Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer;2013-10-25T00:00:00Z;2016-07-26T00:00:00Z;2015-07-23T00:00:00Z;TRUE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2013;2013;2016;2015;USC;;Stefanie
41;18;NCT00552071;0;;;;;13.08.2018;31.10.2007;09.02.2018;Interventional;Phase 4;15;Completed;Ultrasound Guided Octreotide LAR Injection in Acromegaly;2007-07-01T00:00:00Z;2014-03-01T00:00:00Z;2014-03-01T00:00:00Z;TRUE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2007;2007;2014;2014;USC;;Stefanie
43;40;NCT01518465;0;;;;;27.11.2017;18.01.2012;NA;Interventional;Phase 2;13;Terminated;Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma;2012-01-09T00:00:00Z;2017-10-31T00:00:00Z;2016-12-31T00:00:00Z;FALSE;Randomized;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2017;2016;USC;;Stefanie
44;49;NCT01779336;0;;;;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523345/  different study design, different NCT  but same outcome;26.09.2014;28.01.2013;NA;Interventional;Phase 1;70;Suspended;Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors;2012-12-01T00:00:00Z;2014-12-01T00:00:00Z;2014-11-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2013;2012;2014;2014;USC;;Stefanie
46;65;NCT02370264;0;;;;;11.04.2017;17.02.2015;NA;Interventional;Not Applicable;36;Terminated;Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer;2012-10-01T00:00:00Z;2016-10-21T00:00:00Z;2015-09-02T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2012;2016;2015;USC;;Stefanie
47;70;NCT02578602;0;;;;;14.10.2015;13.09.2015;NA;Interventional;Phase 1;26;Completed;MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer;2010-10-01T00:00:00Z;2015-06-01T00:00:00Z;2014-11-01T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2015;2010;2015;2014;USC;;Stefanie
59;13;NCT02127892;0;;;;;18.08.2017;19.10.2012;17.07.2017;Interventional;Phase 1/Phase 2;9;Terminated;SCID Bu/Flu/ATG Study With T Cell Depletion;2007-01-02T00:00:00Z;2016-08-01T00:00:00Z;2016-08-01T00:00:00Z;TRUE;Non-Randomized;None (Open Label);OTHER;FALSE;Children's Hospital Los Angeles, University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2007;2016;2016;USC;;Mario
60;24;NCT03104816;0;;;;;20.09.2019;29.03.2017;14.07.2019;Interventional;Phase 4;28;Terminated;The Effectiveness of IV/PO Acetaminophen in the Perioperative Period in Reducing Opiate Use After Lumbar Spine Fusion;2016-10-01T00:00:00Z;2017-12-01T00:00:00Z;2017-10-01T00:00:00Z;TRUE;Randomized;Quadruple;OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2017;2016;2017;2017;USC;;Mario
61;42;NCT01649258;0;;;;;15.11.2017;20.07.2012;NA;Interventional;Phase 1;29;Terminated;Fosaprepitant Dimeglumine and Granisetron Transdermal System in Preventing Nausea and Vomiting in Patients With Breast Cancer Undergoing Chemotherapy;2012-09-04T00:00:00Z;2017-09-30T00:00:00Z;2017-05-22T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2017;2017;USC;;Mario
62;47;NCT01762410;0;;;;;26.09.2014;20.12.2012;NA;Interventional;Phase 1;60;Suspended;Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors;2012-09-01T00:00:00Z;2016-03-01T00:00:00Z;2015-11-01T00:00:00Z;FALSE;NA;None (Open Label);INDUSTRY;TRUE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2012;2012;2016;2015;USC;;Mario
63;58;NCT02067884;0;;;;;23.01.2019;04.02.2014;NA;Interventional;Phase 1;34;Terminated;Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery;2013-12-19T00:00:00Z;2016-09-25T00:00:00Z;2016-09-25T00:00:00Z;FALSE;NA;None (Open Label);OTHER;FALSE;University of Southern California;NA;NA;NA;NA;NA;NA;NA;NA;2014;2013;2016;2016;USC;;Mario
